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affinity and the conformational equilibrium. All results are well explained by a Monod,
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a published value which should hold under in vivo conditions. We were able to use our
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cell crowding was considered. Finally we developed an autogenously regulated lac
repressor for AAV-mediated gene therapy. We were able to improve the gene regulation
of the autogenous switch by using multiple operator DNA sites, a tetrameric lac
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ABSTRACT
ALLOSTERY AND APPLICATIONS OF THE LAC REPRESSOR
Matthew Almond Sochor
Mitchell Lewis
The lac repressor has been extensively studied for nearly half a century; this long 
and complicated experimental history leaves many subtle connections unexplored.  This 
thesis sought to forge those connections from isolated and purified components up to 
functioning lac genetic switches in cells and even organisms.  We first connected the 
genetics and structure of the lac repressor to in vivo gene regulation in Escherichia coli.  
We found that point mutations of amino acids that structurally make specific contacts 
with DNA can alter repressor-operator DNA affinity and even the conformational 
equilibrium of the repressor.  We then found that point mutations of amino acids that 
structurally make specific contacts with effector molecules can alter repressor-effector 
affinity and the conformational equilibrium.  All results are well explained by a Monod, 
Wyman, and Changeux model of allostery.  We next connected purified in vitro 
components with in vivo gene regulation in E. coli.  We used an in vitro transcription 
assay to measure repressor-operator DNA binding affinity, repressor-effector binding 
affinity, and conformational equilibrium.  Only the repressor-operator DNA binding affinity 
disagreed with literature values from other in vitro experiments, however it did agree with 
a published value which should hold under in vivo conditions.  We were able to use our 
in vitro thermodynamic parameters to accurately predict the in vivo gene regulation when 
cell crowding was considered.  Finally we developed an autogenously regulated lac 
repressor for AAV-mediated gene therapy.  We were able to improve the gene regulation 
of the autogenous switch by using multiple operator DNA sites, a tetrameric lac 
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repressor, and point mutations to the lac repressor.  The autogenous switch was shown 
to function in various cell types and was capable of reversible regulation of luciferase in 
living mice.
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Chapter 1: 
The Lac Repressor and Gene Regulation
1.1 Introduction
All life exists in a universe of limited resources.  Cells contain a multitude of 
potential genes that they can express to achieve various aims and there is a significant 
advantage to the cell to be able to choose which genes it is currently expressing in order 
to best tailor itself to its environment.  A red blood cell expresses hemoglobin in order to 
maximize oxygen carrying capacity while a neuron does not.  Similarly, sodium channels 
are prevalent in the neuron to transmit electric pulses while they are utterly absent in the 
red blood cell.  Both carry the same genetic material, however they use a large 
complement of gene regulation techniques to adapt to their respective environments.  
The gene regulation of Escherichia coli (E. coli) is no different.  Bacteria must 
respond to changing environments: temperature changes, the availability of various 
carbon sources, pH, the presence of other bacteria, etc.  Bacteria that most efficiently 
adapt to their environment will thrive.  Those that express useless genes will waste 
precious resources and ultimately fail to compete.  It is no surprise then that a large 
family of proteins has been identified in E. coli and other bacteria that specifically 
regulate a huge complement of genes related to sugar metabolism.  The LacI/GalR 
family of proteins (Weickert & Adhya, 1992) includes more than 1000 members based 
upon a 2008 Swiss-Prot BLAST search (Swint-Kruse & Matthews, 2009) and regulates 
genes responsible for catabolism, toxicity, and nucleotide synthesis. In general, these 
proteins all have a helix-turn-helix motif that binds one or more specific DNA operator 
sequences and the affinity of this binding is allosterically modified by the binding of small 
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effector species (Swint-Kruse & Matthews, 2009).  Typically, the effector is related to the 
genes in question.  For example, the lac repressor controls the synthesis of three genes 
(lacZ, lacY and lacA encoding for β-galactosidase, β-galactoside permease and 
thiogalactoside transacetylase, respectively) that encode for proteins related to lactose 
metabolism (Lewis, 2005). The natural effector of the lac repressor is allolactose, a 
byproduct of lactose catabolism by β-galactosidase (the product of the lacZ gene).  
Allolactose binds the lac repressor and results in an allosteric conformational shift and a 
loss of affinity for operator DNA.  RNA polymerase is then free to transcribe the lacZ/Y/A 
poly-cistronic message and lactose metabolism begins in earnest.  This theme of the 
effector (allolactose), an intermediate of the process to be regulated (lactose 
metabolism), being sensed by a protein (lac repressor) that is used to change the 
expression of genes that are metabolically functional (lacZ/Y/A) is repeated throughout 
the LacI/GalR family (Swint-Kruse & Matthews, 2009).
This protein family is particularly fascinating because it combines in one  
package several essential features of protein biology: DNA binding, small molecule 
binding, and allostery.  Furthermore, the net effect, regulation of a gene or set of genes, 
is completely general: the lac repressor (and many other repressors and activators in the 
LacI/GalR family) can be used to regulate any gene that is under control of a promoter 
with a lac specific DNA operator sequence.  This realization has led to a multitude of 
generalized plasmids that constitutively express a repressor and have a second 
regulated promoter followed by a multiple cloning site that can be used to insert the 
researcher's gene of interest (e.g. the pET series for the lac repressor, the pBAD series 
for the arabinose repressor).  The system is so simple that it is not only applicable to the 
bacteria where it initially was identified.  The lac repressor has been used to control 
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genes in embryonic stem cells (Caron et al., 2005) and even to control gene expression 
in living mice (Cronin, Gluba, & Scrable, 2001). 
So if the lac repressor is such a triumph of translational science, why continue to 
study it?  What is left that is unknown?  First and foremost, the lac repressor has 
essentially been applied as-is.  The most commonly used protein is exactly that which 
was initially found in E. coli despite the long held knowledge that the repressor 
specifically evolved to optimally regulate lactose metabolism and not the multitude of 
scenarios it is actually utilized in, such as toxic gene repression/over-expression or 
eukaryotic gene regulation.  It is well established that the gene regulation phenotype is 
highly modifiable through point mutation (Kleina & Miller, 1990) leading to repressors 
that have less leakiness (useful for toxic gene control), that turn the genes more “on”, 
and that respond to different effectors and different concentrations.  An understanding of 
the physical basis for these phenotypic changes could lead to easier translation of 
specific lac repressor mutants for specific applications.  
The goal of this thesis was to take the current knowledge regarding the lac 
repressor and to achieve two goals: 
(1) to understand everything within a single theoretical framework or model, and
(2) to apply this knowledge to create genetic switches more ideal for their particular 
applications.
1.2 Structure and Function in the Lac Operon
The history of the study of the lac operon mirrors the history of modern 
biochemistry and biophysics.  The earliest studies were related to the observation that 
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cells could alter their ability to metabolize various compounds; one such compound was 
the metabolism of lactose by E. coli.  The “adaption” of cells from glucose to lactose 
metabolism resulted in a diauxic growth curve; cells follow the typical exponential growth 
as they metabolize glucose followed by a lag phase as glucose becomes depleted, then 
a secondary exponential growth is observed as the cells switch to lactose metabolism 
(Monod, 1942).  The metabolism of lactose was quickly linked to the enzyme β-
galactosidase which was observed to become more prevalent when bacteria were 
growing on lactose versus glucose (Cohn, 1957).  Studies measuring the accumulation 
of radio-labeled galactosides led to the discovery that lactose is actively pumped into the 
cell via β-galactoside permease which is also more prevalent during lactose growth 
(Buttin, Cohen, Monod, & Rickenberg, 1956).  The final regulated gene of the lac operon 
was identified through the discovery of thiogalactoside transacetylase (Zabin, Kepes, & 
Monod, 1962).  What remained however was how the expression of these three genes 
were tied to lactose metabolism.  Before any actual repressor proteins were identified, a 
groundbreaking analysis was performed to understand gene regulation.  A negative 
control scheme was described where the product of a gene, acting through the 
cytoplasm, was able to regulate the synthesis of another set of genes modulated by the 
presence of (usually metabolic) small molecules  (Jacob & Monod, 1961).  The 
cytoplasmic agent however, was unknown. The modulation by small molecules was of 
particular interest. It was known that other proteins exhibit a property wherein the binding 
of a small molecule causes a change in functionality at a structurally (-steric) separated 
(allo-) region (allostery).  A “plausible” model of allostery was proposed which would, in 
time, be shown to be applicable to the lac repressor (Monod, Wyman, & Changeux, 
1965).  The lac repressor was finally isolated one year later and determined to be the 
“cytoplasmic agent“ responsible for regulation of gene expression predicted by Jacob 
4
and Monod (Gilbert & Müller-Hill, 1966).  Shortly thereafter it was determined that the lac 
repressor reversibly binds to a specific DNA region (deemed the operator) to regulate 
gene synthesis (Gilbert & Müller-Hill, 1967).  Allolactose, a byproduct of lactose 
metabolism by β-galactosidase, was found to be the effector in the lac operon (Jobe & 
Bourgeois, 1972, 1973).  It was not known however that allolactose worked through an 
allosteric mechanism (the common prefix allo- means “other” or “different” and is simply 
coincidental). DNA sequencing techniques were developed which led to the sequencing 
of both the lac repressor (Farabaugh, 1978) and its operator DNA (O1) sequence 
(Gilbert & Maxam, 1973). The second and third DNA operators (O2 and O3, 
respectively) of the lac operon were discovered and found to also play a role in lactose 
metabolism (Pfahl, Gulde, & Bourgeois, 1979).  It was then shown that lac repressor 
does not prevent binding of RNA polymerase to the promoter, but it does prevent the 
initiation of transcription (Schmitz & Galas, 1979).  At this point it was established that 
the lac operon consisted of the lac repressor (constitutively expressed by the lacI gene) 
binding to the DNA operators preventing transcription of the downstream poly-cistronic 
message (lacZ/Y/A genes) in a reversible manner dependent upon the natural inducer 
molecule allolactose or gratuitous inducers such as isopropyl β-D-thiogalactoside 
(IPTG).
The focus at this point changed from identifying the players to identifying their 
roles.  Central to this focus was the slow problem of determining the three-dimensional 
structure of the lac repressor alone and bound to its ligands (DNA and effectors).  The 
journey from the identification of the lac repressor to the first crystal structure 30 years 
later includes a vast array of techniques to probe individual parts of the protein to 
determine their individual roles in the overall functioning of the repressor.  
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The first issue was simply understanding what part of the amino acid sequence 
of the lac repressor was responsible for what property or properties: folding, 
dimerization, tetramerization, DNA binding, effector binding, and allosteric signaling.  
Trypsin digestion provided the first clue as to the domain structure of the lac repressor.  
Tryptic digestion cleaved the 59 amino-terminal (N-terminal) residues and 20 carboxyl-
terminal (C-terminal) residues preserving a highly trypsin-resistant core (Files & Weber, 
1976).  These three regions of the protein proved highly relevant to the structure and 
function of the lac repressor.
The N-terminal region of the lac repressor was isolated and was determined to 
be necessary for DNA binding (Geisler & Weber, 1977) and found to specifically bind the 
known O1 lac operator (Ogata & Gilbert, 1978).  Modification of tyrosines with 
tetranitromethane showed that Y7 and Y17 modifications significantly impaired both 
specific and non-specific DNA binding, further indicating the role of the N-terminal region 
of the repressor in DNA binding (Hsieh & Matthews, 1981).  Genetic mapping was 
undertaken on tight DNA binding mutants of the lac repressor and they were found to 
correlate to two regions: the N-terminus and near amino acids 255 and 295 (Pfahl, 
1981).  A small angle X-ray scattering (SAXS) study indicated that the DNA binding sites 
of the tetrameric lac repressor consists of the N-terminal 59 residues and that they lie at 
opposite ends of an elongated tetramer (Mckay, Pickover, & Steitz, 1982).  A genetic 
study showed that of 131 amino acid substitutions in 38 of the first 62 N-terminal 
positions, almost all abolished DNA binding and only two, P3Y and S61L, showed tighter 
DNA binding (Miller, 1984).  A nuclear magnetic resonance (NMR) structure of the N-
terminal 51 residues showed the now classic helix-turn-helix motif and its structural 
homology with two other DNA binding proteins cI and λ (Kaptein, Zuiderweg, Scheek, 
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Boelens, & van Gunsteren, 1985)  The helix-turn-helix motif has a recognition helix that 
fits into the major groove of DNA and makes specific contacts with nucleotides and is a 
major determinant of specificity in DNA binding.  The specificity determining residues of 
the recognition helix were determined to be tyrosine 17 (Y17), glutamine 18 (Q18), and 
arginine 21 (R21) and they were thought to make specific contacts with positions 4, 5 
and 6 of the DNA operator.  Mutagenesis of Y17 and Q18 combined with changes at 
positions 4, 5 and 6 showed that not only could DNA affinity be destroyed, but specificity 
could be changed entirely (Sartorius, Lehming, Kisters, von Wilcken-Bergmann, & 
Müller-Hill, 1989). This work would later be extended to more fully screen these positions 
in both the operator and repressor in order to determine functional rules for specific DNA 
binding (Milk, Daber, & Lewis, 2010).  While two-dimensional NMR demonstrated 
specific contacts between headpiece residues and DNA (Kaptein, Lamerichs, Boelens, & 
Rullmann, 1990; Slijper, Bonvin, Boelens, & Kaptein, 1996), eventually an X-ray 
crystallographic structure of the lac repressor-operator DNA complex was solved that 
demonstrated exactly how the lac repressor binds DNA (Lewis et al., 1996; Pace, Lu, & 
Lewis, 1990).  
The next piece of the lac repressor was the trypsin-resistant core.  Early on it 
was found that a Y269S mutation and missense mutations at positions 210 and 216 
failed to form tetramers (Schmitz, Schmeissner, Miller, & Lu, 1976). A genetic study then 
linked approximately 2000 missense mutations to varying phenotypes and found most of 
the trypsin-resistant core to be relatively tolerant to mutation although many interesting 
phenotypes were still found within this region (Miller & Schmeissner, 1979).  Chemical 
modification of cysteine 281 decreased repressor affinity for inducer, indicating its 
potential role in sugar binding (Daly, Olson, & Matthews, 1986) and this role was later 
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confirmed through mutagenesis of C281 (Chakerian & Matthews, 1991).  Arginine 197 
was also found to be important for inducer binding (Spotts, Chakerian, & Matthews, 
1991).  Finally, a genetic study, wherein more than 4000 mutations were made along 328 
positions of the lac repressor, identified the amino acids spread throughout the linear 
sequence to be responsible for inducer binding (Markiewicz, Kleina, Cruz, Ehret, & 
Miller, 1994).  The crystal structure revealed an effector binding pocket that correlated 
well with the genetic data (Daber, Stayrook, Rosenberg, & Lewis, 2007; Lewis et al., 
1996).  Interestingly, there was a parallel evolution between the core region of the 
LacI/GalR family and periplasmic sugar-binding proteins of E. coli (Fukami-Kobayashi, 
2003).  The core region was also responsible for dimerization.  This dimerization could 
be disrupted through mutation (Dong et al., 1999; Spott, Dong, Kisters-Woike, & Müller-
Hill, 2000) and exhibited plasticity, such that 22 point mutations in the dimer interface 
could still form homo-dimers (Swint-Kruse, Elam, Lin, Wycuff, & Matthews, 2001).  This 
plasticity was elegantly demonstrated in a study that made a known mutant that 
disrupted dimerization and looked for compensating mutations in the other monomer, 
resulting in a hetero-dimeric lac repressor (Daber & Lewis, 2009).  There was also a 
structural realignment upon sugar binding within the core region (Barry & Matthews, 
1997). The C-terminal lobe of the core region remains relatively unchanged with and 
without sugar bound.  The more N-terminal lobe, which connects to the N-terminal DNA 
binding domain, exhibits a significant structural shift when sugar is bound.  The dimer 
interface of the N-terminal lobe is of particular interest.  Lysine 84 was found to lie along 
the dimer interface (Chang, Olson, & Matthews, 1993) and mutating this residue to 
leucine (K84L) was found to stabilize the dimer (Barry & Matthews, 1999; Bell, Barry, 
Matthews, & Lewis, 2001; Nichols & Matthews, 1997).  Curiously, this stabilizing mutant 
decreases both DNA and inducer affinity despite not directly being responsible for either 
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DNA or inducer binding, which points at an allosteric role.  Indeed other residues in this 
region were implicated to have allosteric importance, including alanine 110.  The 
mutation A110T lowered operator affinity and increased IPTG affinity, whereas A110K 
increased operator affinity while decreasing IPTG affinity (Müller-Hartmann & Müller-Hill, 
1996).  It was later found that positions 94-98, which are known to make re-
arrangements upon sugar binding, also play a significant role in allosteric signaling 
(Zhan, Camargo, & Matthews, 2010).  The transmission of the allosteric signal was 
beautifully mapped out through a targeted molecular dynamics simulation (Flynn et al., 
2003) and confirmed through mutations (Swint-kruse, Zhan, Fairbanks, Maheshwari, & 
Matthews, 2003).  They found L148F increased IPTG affinity and decreased operator 
affinity (analogous to A110T), whereas S151P had the opposite effect (analogous to 
A110K).  Clearly there is plasticity not only in dimerization but also allostery.  It was well 
elucidated then that the N-terminal domain binds DNA and that that binding is 
allosterically modified by inducer binding in the cleft of the core region.  The allostery 
could be altered not only in residues within the core but also in the hinge region of the N-
terminal DNA binding domain (Falcon & Matthews, 1999, 2001; Falcon, Swint-Kruse, & 
Matthews, 1997). 
The C-terminal segment is also extremely important to the overall function of the 
lac repressor.  Homology studies indicated that the the C-terminal region may have a 
leucine zipper motif.  Leucine to alanine mutations at positions 342, 349 and 356 
resulted in dimeric repressors which could bind inducer and operator DNA with reduced 
affinity (Chakerian et al., 1991).  It was then shown that removing 5, 11, 18 and 32 amino 
acids from the C-terminus also created a dimeric repressor capable of inducer binding 
and with reduced DNA affinity (Chen & Matthews, 1992).  Next, it was postulated that the 
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necessary heptad repeat of three leucines formed an abbreviated coiled-coil domain 
resulting in tetramerization.  A point mutation was known that resulted in a monomeric 
lac repressor species (Y282D).  The coiled-coil was tested by extending the C-terminus 
with one and two additional heptads, combined with the Y282D mutation, resulting in a 
dimeric lac repressor, likely through an extended coiled-coil at the C-terminus (Chen, 
Surendran, Lee, & Matthews, 1994).  The C-terminus was definitively identified as a 
coiled-coil responsible for tetramerization and many properties of the coiled-coil were 
soon determined (Fairman et al., 1995; Lewis et al., 1996).  Tetramerization of the 
repressor was of course central to the ability of the lac repressor to bind two DNA 
operators.  As noted previously, impairment of tetramerization typically decreased 
operator DNA affinity.  Obviously, this decrease is not a direct effect, as the N- and C-
terminii of the lac repressor are spatially separated; this points to an allosteric 
mechanism wherein binding of one DNA operator to a repressor dimer within the 
tetramer increases the affinity of the operator DNA for the second dimer.  It was known 
that the lac repressor bends DNA upon binding (Culard & Maurizot, 1981; Kim, Zweib, 
Wu, & Adhya, 1989) and it was soon discovered that when the lac repressor binds two 
DNA operators it creates a looped DNA structure (Kramer et al., 1987). Cooperativity of 
binding was observed in vivo between the O1 and O3 operators (Sasse-dwight & Gralla, 
1988), the O1 and O2 operators (Flashner & Gralla, 1988), and between all three 
operators (Oehler, Eismann, Kramer, & Müller-Hill, 1990).  A beautiful study was 
performed to understand how the spacing of the operators affected the cooperative 
binding and found a phase dependence to the spacing where repression, and hence 
operator binding, is maximal (Oehler, Amouyal, Kolkhof, von Wilcken-Bergmann, & 
Müller-Hill, 1994) and the optimal spacing was determined (Müller, Oehler, & Müller-Hill, 
1996).
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Overall a picture emerged that showed how a dimer of dimers looped DNA in 
order to shut off transcription and how the binding of small sugar molecules in a 
completely different region could result in the release of DNA to turn transcription back 
on.  The lac repressor exhibits allostery in its cooperative binding of DNA and allostery in 
its connection between DNA and effector binding.  While many individual residues were 
demonstrated to change or disrupt allostery, they fail to explain how its mechanism 
functions.  Amazingly, a conformation based model of allostery was already postulated in 
1965 by Monod, Wyman, and Changeux, the so-called MWC model, that wonderfully 
describes the half-century worth of research into the lac operon that followed.  In order to 
appreciate and understand the MWC model, we must first understand the physics of 
proteins and their conformations.
1.3 Protein Structure and the Boltzmann
Proteins are chains of amino acids and they are known to fold into specific 
conformations or structures.  A vast amount of work has gone into both experimentally 
determining and theoretically predicting protein structures from known amino acid 
sequence (Englander, Mayne, & Krishna, 2012).  The picture that has emerged of the 
so-called “folding problem” is that an energy landscape exists wherein each point on the 
landscape is a possible conformation of the protein and each point has a given energy.  
A given protein will sample this landscape as it folds and tend towards lower and lower 
energies, akin to water running downhill until it reaches a pool at the bottom.  Much like 
the surface of the earth, there can be many valleys, slight and deep depressions, hills 
and mountains in the energy landscape and just as water will pool in the low spots, 
proteins will fold into structures which have local energetic minima.  Proteins do not fold 
into a single conformation but instead they can fold into many conformations, some of 
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which are more energetically favorable than others.  Just how energetically favorable 
depends on a host of factors: solvent, binding partners, temperature, protein sequence, 
etc.  Therefore the energy landscape isn't static for a given amino acid sequence, it is a 
culmination of both the protein and its environment.  Furthermore, proteins have energy 
all their own in the form of thermal energy.  They may be comfortably sitting in a 
conformation which is a local minimum and then through the thermal jostling of their 
environment be pushed out of that well to find a new conformation in a new energy well.  
The thermal energy essentially defines the scale of features that are considered 
relevant.  At low temperatures, minute energetic differences become relevant and new 
minima are present.  At high temperatures, only the deepest energy minima are relevant; 
the protein has too much thermal energy to be stable in any of the lesser wells.
This abstraction not only leads to a clear intuitive picture of how proteins find 
their structural conformations and transition between conformations, it also provides a 
mathematical framework to quantify the relative occupation of each conformation for a 
given population of protein.  The Boltzmann distribution defines the fraction of proteins 
that will occupy each conformation based upon the energy and degeneracy of that 
conformation with respect to every other conformation,
Ni
N=
gi exp(
−Ei
kB T
)
Z(T)
(1)
Here Ni/N is the fraction of the protein in the ith conformation.  The degeneracy of 
each state, gi, defines the redundancy of the conformation.  This usually is a result of an 
internal symmetry of the protein; for example, a dimeric protein where each monomer 
can individually bind a small molecule.  The structure of the dimer bound to a single 
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molecule is degenerate, it could be bound to either monomer and it would look identical, 
thus gi = 2 in this case.  Typically, the degeneracy equals one (non-degenerate) as most 
conformations are unique.  The energy of the  ith conformation is Ei and the thermal 
energy of the system is given by the product of the Boltzmann constant, kB, and the 
temperature of the system, T.  The energy and the temperature are always positive 
values, so the exponential is maximized (and hence the fraction maximized) at lower 
energies.  At higher energies the numerator exponentially approaches zero and that 
conformation is effectively never populated.  The denominator is called the partition 
function and is defined as,
Z (T)=∑
i
gi exp(
−Ei
kBT
) (2)
The partition function essentially is a sum of the energetics of every 
conformation.  For simple energy landscapes that are fully defined by a mathematical 
function, the partition function becomes an integral over that function.  However, for 
extremely complex (and largely unknown) energy landscapes like that of a protein 
folding, the partition function will generally include just those states that significantly 
contribute: the local minima.  
An example is helpful to understand the Boltzmann distribution.  We can consider 
a theoretical protein that folds into two primary conformations which we will call T and R 
and see how the Boltzmann partitions the protein between the two states.  First we 
consider the case where the two conformations have the same energy (ET = 2, ER = 2, 
kBT = 1).  We see that,
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NT
N
=
NR
N
= e
−2
e−2+e−2
=1
2 (3)
Each state is equally likely because they have the same energy.  Now if the T 
state has an energy twice that of the R state (ET = 4, ER = 2, kBT = 1), we would expect 
most but not all of the protein to reside in the R state.  Indeed we find,
NT
N
= e
−4
e−4+e−2
=0.119 (4)
NR
N
= e
−2
e−4+e−2
=0.881 (5)
So roughly 88% of the protein is found in the lower energy, R, conformation.  
Clearly, this is an approximation as every protein will sample much more than two 
conformations, however it is generally observed that many proteins will primarily reside 
in a small subset of conformations which are significantly lower in energy than the other 
conformations.  Indeed, even a four fold difference in energy results in roughly 99.8% of 
the protein residing in the lower energy conformation. Therefore we typically try to 
identify the most prominent low energy conformations of a protein and seek to explain its 
experimental behavior through these conformations.
The Boltzmann is incredibly useful because it reduces a complex abstraction to a 
simple mathematical formula that tells us how often each structural conformation is 
occupied.  In particular, this foundation will be of use when we seek to understand and to 
model protein allostery.
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1.4 Monod, Wyman and Changeux (MWC) Model of Allostery
Proteins range from exquisitely simple to remarkably complex.  The simplest 
proteins have a single primary conformation and perform a single role: binding a ligand, 
catalyzing a reaction, binding another protein, etc.  More complex proteins have multiple 
stable conformations and modulate their role.  But how do they achieve this modulation?
We first consider a simple, theoretical protein that catalyzes a reaction in a 
structurally defined pocket on its surface.  The rate of catalysis is a culmination of many 
factors: buffer, amino acid sequence, the conformation of the protein, etc.  However, 
most often these things are relatively fixed for the cell.  The protein has a conformation 
that is defined by its energy landscape.  The amino acid sequence is defined by the DNA 
sequence.  The buffer might change (depending on environmental conditions in and 
around the cell) but most often it will be within a well defined range.  So what happens 
when it would be advantageous for the cell to have the catalysis sometimes fast and 
sometimes slow?  
The most obvious route is to competitively bind the catalytic pocket of the 
enzyme.  If the catabolic precursor cannot bind, because something else is there 
gumming up the works, the enzymatic rate is slowed.  This however requires evolution to 
come up with a close mimic to the catabolic precursor which is extremely specific and 
may not even be possible.  Despite this difficulty, many examples of competitively 
binding occur in nature, such as carbon monoxide and oxygen competitively binding to 
hemoglobin (which is why carbon monoxide is a poison).
A second route is to alter the amino acid sequence.  This can be achieved by 
chemically altering key side chains of the protein.  These post-translational modifications 
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(PTMs) include, but are not limited to, phosphorylation, acetylation, glycosylation and 
even cleavage of the protein.  One drawback to this approach is that a physical 
alteration of the protein is occurring.  Reversing PTMs is another business in and of itself 
in the cell (e.g. kinases and phosphatases constantly phosphorylating and removing 
phosphorylation). Many, many examples of PTMs exist in nature (Beltrao, Bork, Krogan, 
& van Noort, 2013).
The third route is to alter the conformation of the protein.  An altered 
conformation could have an altered catalytic pocket with a slower or faster rate of 
catalysis.  This can be achieved through a variety of mechanisms including the 
aforementioned PTMs and the binding of small molecules or other proteins.  The nature 
of this approach is that a specific part of the protein does not need to be targeted, 
instead any process that stabilizes an alternate conformation with different properties is 
potentially useful.  Allostery is the phenomenon wherein a function which occurs in one 
structurally defined region of a protein is altered from a secondary, spatially separated 
region of the protein.  Allostery is made possible by altering the energy landscape of a 
protein and changing the population of alternate conformations.  Again, many examples 
of allostery occur in nature (Edelstein & Le Novère, 2013; Lewis, 2013; Nussinov & Tsai, 
2013).
Allostery was first successfully modeled by Monod, Wyman and Changeux 
(Monod et al., 1965) typically shortened to MWC.  The MWC model considers a protein 
with two or more potential conformations which are in equilibrium.  Each conformation 
has its own set of properties related to the function of the protein (binding constants, 
catalytic constants, etc.).  The bulk behavior of the system at equilibrium will be the sum 
of behaviors of the protein in its Boltzmann defined combination of states.  Addition of an 
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allosteric binding partner changes the relative population of states and changes the bulk 
property of the system under study.  The MWC model boils down allosteric regulation of 
a protein to this: to alter a protein's function, do something to move more of the protein 
into a different conformation where the function of interest is different.  
To understand this idea, we need to more fully delve into the individual properties 
of the MWC model.  First, the conformational equilibrium is an intrinsic property of the 
protein given its environment (buffer, temperature, etc.).  Considering a hypothetical 
protein with two conformations, T and R, the conformational equilibrium, L, is defined as,
L=[T]
[R ] (6)
Here hard brackets denote concentrations of that species.  The total 
concentration of the hypothetical protein, P, is then defined as,
[P]tot=[T]+[R ]=[R ](1+L) (7)
The conformational equilibrium is of course fully defined by the energetic 
landscape of the protein, and hence the Boltzmann distribution.  Assuming that these 
conformations are non-degenerate, we can see,
L=
[T]
[P]tot
[R ]
[P]tot
=
exp(
−ET
kB T
)
Z(T)
exp(
−ER
kB T
)
Z(T)
=exp(
−(ET−ER)
kB T
) (8)
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So the conformational equilibrium is simply a function of the energy difference 
between the two conformations and is an intrinsic property of the protein.
Lets consider now a hypothetical molecule, X, that binds the protein.  It binds the 
T and R conformations with different affinities,
KT=
[TX ]
[T] [X ] (9)
KR=
[RX ]
[R ][X ] (10)
Here [TX] and [RX] are the X bound states of conformations T and R, 
respectively.  Again, the binding affinity constants are intrinsic properties of the protein 
given the environmental conditions.
How does all of this add up to allosterically regulate the protein?  An example is 
most illustrative.  We define the hypothetical energy of the system as the following: ET = 
4, ER = 2, kBT = 1.  Equations (4) and (5) show that roughly 88% of the protein is in the R 
conformation and 12% in the T conformation.  If the R conformation catalyzes a reaction 
at a rate of 10 per second and the T conformation at a rate of 1 per second and given 
100 proteins in a cell, there is an effective rate of,
keff=0.88∗10
rxn
sec
+0.12∗1 rxn
sec
=8.92 rxn
sec (11)
The effective rate, which is what is measured experimentally, is a bulk property of 
the system.  MWC would model this through the conformational equilibrium parameter,
18
L=exp (
−(ET−ER)
kBT
)=exp(−(4−2)
1
)=0.135 (12)
Using the MWC solution we typically use concentrations and rates with respect to 
concentrations.  Here we will assume that the total protein concentration is 1 mM, kR = 
10 rxn/sec/mM and kT = 1 rxn/sec/mM.  We can then calculate the concentration of the 
protein in the R and T conformations,
[R ]=
[P]tot
(1+L)
= 1mM
1+0.135
=0.881mM (13)
[L ]=[P]tot−[R ]=0.119mM (14)
And the effective rate is then,
keff=[R ]kR+[L ]kL
=0.88mM∗10 rxn
sec∗mM
+0.12mM∗1 rxn
sec∗mM
=8.92 rxn
sec
(15)
So the MWC route of course arrives at the same conclusion as the Boltzmann 
route.
This effective rate can be allosterically modified by binding ligand X.  This more 
complicated MWC model is solved by considering the total sums of each species, P and 
X, and the thermodynamic constants that link them,
[P ]tot=[R ]+[RX ]+[T ]+[TX ] (16)
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[X]tot=[X ]+[RX ]+[TX ] (17)
L=[T]
[R ] (18)
KT=
[TX ]
[T] [X ] (19)
KR=
[RX ]
[R ][X ] (20)
The general strategy is as before: calculate how much of each species is around 
and use that to determine the effective catalytic rate.  
If the ligand prefers binding to the lower catalytic state, T, we can effectively turn 
off the protein by adding ligand X.  For example, if KT = 10 mM-1, KR = 1 mM-1, and [X]tot = 
1 mM, then we can calculate the concentration of each species of the protein P by 
solving the equations (16) - (20).  We do this by solving all of the equations for the free 
concentration of the R conformation, [R], in terms of just known thermodynamic 
constants and then using [R] to measure the effective catalytic rate. We start by re-
organizing the above equations,
[T]=L[R ] (21)
[TX ]=KT[T ][X ]=KT L[R ][X] (22)
[RX ]=KR [R ] [X ] (23)
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Plugging these values into equation (17) we get,
[X]tot=[X ]+KR [R ][X ]+KT L[R ] [X]=[X](1+[R ](KR+KT L)) (24)
Re-organizing we get the free concentration of the ligand, [X], in terms of 
thermodynamic constants and [R],
[X]=
[X ]tot
1+[R ](KR+KT L) (25)
We can then insert equations (22), (23), and (25) into (16) to get,
[P]tot=[R ]+
KR [R ] [X]tot
1+[R ] (KR+KT L)
+L[R ]+
KT L[R ][X]tot
1+[R ](KR+KTL) (26)
We then simply need to solve for [R].  Start by multiplying the denominator of 
equation (25) on both sides of the equation,
[P ]tot+[P ]tot [R](KR+KT L)=
[R ](1+L)+[R]2(1+L)(KR+KTL)+KR [R ][X ]tot+KT L[R][X ]tot (27)
Re-organizing to solve for terms of [R],
[R ]2(1+L)(KR+KT L)+[R ](1+L+([X]tot−[P]tot)(KR+KT L))−[P]tot=0 (28)
We define the following constants and solve the second order polynomial,
A=(1+L)(KR+KT L)=(1+0.135)(1mM
−1+10mM−1∗0.135)=2.67mM−1 (29)
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B=(1+L+([X]tot−[P]tot)(KR+KT L))=
1+0.135+(1mM−1mM)(1mM−1+10 mM−1∗0.135)
B=1.135
(30)
C=−[P]tot=−1mM (31)
[R ]2 A+[R ]B+C=0 (32)
[R ]=
−B±√(B2−4AC)
2A
=
−1.135±√(1.1352−4∗2.67mM−1∗(−1mM))
2∗(2.67mM−1)
[R ]=0.44mM or −0.86mM
(33)
Since this is a biological system where [R] is a concentration of a protein we are 
constrained by reality. Therefore,
0mM≤[R]≤[P]tot (34)
Therefore [R] = 0.44 mM.  We can then use the value of [R] to calculate the 
remaining species,
[T]=L[R ]=0.135∗0.44mM=0.06mM (35)
[X]=
[X ]tot
1+[R ](KR+KT L)
= 1mM
1+0.44mM(1mM−1+10 mM−1∗0.135)
[X]=0.49mM
(36)
[RX ]=KR [R ] [X ]=1mM
−1∗0.44mM∗0.49mM=0.22mM (37)
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[TX ]=KT[T ][X ]=10 mM
−1∗0.06mM∗0.49mM=0.29mM (38)
And we can check the accuracy of our solution by making sure everything adds 
up,
[X]tot=[X ]+[RX ]+[TX ]=0.49mM+0.22mM+0.29mM=1mM (39)
[P ]tot=[R ]+[RX ]+[T ]+[TX ]
=0.44mM+0.22mM+0.06mM+0.29mM=1mM (40)
And of course, the entire point of this exercise is to see the effect of adding 1 mM 
of ligand X on the catalytic rate of protein P,
keff=([R ]+[RX ])∗kR+([T ]+[TX ])∗kT=
0.66mM∗10 rxn
sec∗mM
+0.34mM∗1 rxn
sec∗mM
keff=6.94
rxn
sec
(41)
The allosteric effect of adding 1 mM ligand X is to change the catalytic rate from 
8.92 rxn/sec to 6.94 rxn/sec.  This is achieved by altering the effective conformational 
equilibrium of the R and T states.  Adding ligand X, which prefers binding to the T state, 
pushes more of the protein to that state thereby lowering the bulk (effective) catalytic 
rate.  
The MWC model provides a mathematical framework for understanding the link 
between the fundamental thermodynamic parameters (conformational equilibrium, rate 
constants, binding constants) and the experimentally measurable values (decreased 
catalytic rate).  One primary drawback of doing these calculations that should 
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immediately be obvious is that even for simple systems, analytical solutions are 
complex.  For complex systems, such as the lac repressor, the MWC solution either is 
not used or simplifications are used to model the experimental behavior.
1.5 The MWC Model of Lac Repressor Genetic Regulation
The allosteric response of the lac repressor is classically modeled by MWC.  The 
lac repressor is a tetramer that is better understood as a dimer of dimers.  A single dimer 
of the lac repressor binds a single DNA operator through a pair of its N-terminal helix-
turn-helix motifs along with a larger DNA binding interface.  The N-terminal domain is 
linked to a larger clam-shell domain that contains at its center an effector binding 
domain.  Therefore, one dimer of lac repressor binds two effector molecules and a single 
DNA operator.  The dimers are then linked through a C-terminal coiled-coil domain that 
tetramerizes the protein.  A tetramer is therefore capable of binding two distinct DNA 
operators and four effector molecules.  
Two different allosteric effects are found within a lac repressor tetramer.  First, 
the binding of one dimer to one DNA operator increases the affinity of the second dimer 
to a second DNA operator.  However, this is only true when the two DNA operators are 
linked into a larger DNA strand and furthermore the cooperativity of binding is highly 
dependent upon the spacing between the two operators.  As DNA is not a small 
molecule, the conformations of the DNA come into play, but its the same old MWC idea: 
different conformations are populated when binding occurs and higher affinity is a net 
result.  
The second allosteric property found in the lac repressor is the link between 
effector binding and operator DNA binding.  Essentially this allostery occurs within the 
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individual dimers of the tetramer, and in fact a dimeric lac repressor is a fully functional 
gene regulator.  The dimer can be thought of as having two primary conformations, R 
and R*.  There of course exists a large number of conformations of the lac repressor 
dimer, but R and R* can be thought of as the two primary minima in the energy 
landscape.  The Boltzmann distribution defines the relative occupancies of the R and R* 
states at equilibrium and is fully dependent upon the energetic differences between the 
two states.  The conformational equilibrium of the lac repressor, KRR*, has been 
experimentally determined to slightly favor the R* state (Daber, Sharp, & Lewis, 2009; 
Daber, Sochor, & Lewis, 2011).
The two conformations each can bind one operator DNA with an affinity (KRO for 
the R state; KR*O for the R* state) and two effector molecules each with same affinity (KRE 
for the R state; KR*E for the R* state).  For the wild type lac repressor, we define the R 
state as the conformation with higher operator DNA affinity (KRO > KR*O).  The relative 
affinities of R and R* for effectors determines whether they are classified as inducers or 
co-repressors.  If KRE > KR*E then the effector prefers binding to the high DNA affinity 
state and will push more of the repressor into a DNA bound state; these effectors are 
termed co-repressors (such as orthonitrophenyl-β-D-galactoside (ONPG)).  If KRE < KR*E 
then the effector binds more strongly to the low DNA affinity state and will decrease 
operator DNA binding; these effectors are termed inducers and include allolactose and 
IPTG.
The lac operon of E. coli uses three DNA operators (O1, O2 and O3) and a 
tetrameric lac repressor and the effector is the inducer allolactose which is a short lived 
metabolic intermediate.  This is a highly non-trivial system to model and thus a simplest 
functional system has been developed which consists of a single operator DNA located 
25
within the DNA promoter sequence (where O1 is located), a dimeric lac repressor, and 
the effector is the non-hydrolyzable inducer IPTG.  This system isolates the allosteric 
interaction between effector and operator DNA binding.
1.6 Mutations to the Lac Repressor Alters Gene Regulation
Mutational studies of the lac repressor began as a means to discern structurally 
and functionally relevant regions of the protein.  The lac repressor was discovered 
before most standard biochemical techniques existed to answer these questions such as 
protein over-expression for purification, protein crystallography, protein NMR and 
modern PCR based cloning techniques.  
The earliest lac repressor mutants were discovered using mutating agents and 
selection pressure to try to isolate mutants.  For example, bacteria could be exposed to 
N-methyl-N'-nitro-N-nitrosoguanadine and given repeated rounds of forward and 
backwards selection pressures to identify tighter binding lac operon phenotypes (Gilbert 
& Müller-Hill, 1966).  A more refined approach was later developed using amber codon 
(UAG) suppression (Belin, 2003) where tRNAs could be used to suppress the amber 
stop codon and insert desired amino acids in its place.  For example, amber codon 
suppression was used to show that mutation of tyrosine 269 to serine (Y269S) inhibits 
tetramerization (Schmitz et al., 1976). 
The lac repressor was discovered before much of the standard biochemical 
approaches existed, therefore the literature of the lac repressor often follows the 
changing state-of-the-art of the time.  One of the fascinating results of this history is that 
studies of the lac repressor exist that would never be repeated for a newly identified 
protein today.  Chief amongst these studies is the series of 15 papers which sought to 
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link genetic alteration of the lac repressor to phenotype.  The end result was point 
mutations of every amino acid from positions 2 through 329 to 12 or 13 different amino 
acids (>4000 mutations in total) which were then phenotypically categorized (Suckow et 
al., 1996).  The phenotype I- indicates mutations where repression is impaired in the 
absence of inducer and are therefore defective.  I- mutations alter DNA binding, folding 
or aggregation of the lac repressor.  The phenotype IS indicates mutations that repress 
but do not respond to inducer (super-repressing).  IS mutations could alter inducer 
binding, allosteric signaling, or be the result of extremely tight DNA binding.  The 
phenotype Ir indicates mutations that co-repress with what is normally an inducing 
effector.  Ir mutations could be a result of changing DNA affinity, reversing the allostery, 
or altering inducer binding.  Essentially these studies created a map wherein different 
aspects of the lac repressor allostery was linked to different regions of the amino acid 
sequence.  
When the x-ray crystallographic and NMR structures of the lac repressor were 
solved (Lewis et al., 1996; Loth, Gnida, Romanuka, Kaptein, & Boelens, 2013), this body 
of mutational data was mapped onto the three-dimensional structure.  In general there is 
excellent agreement between these two techniques.  Mutations to the effector binding 
pocket typically result in the IS phenotype because inducer binding is destroyed; the lac 
repressor can bind operator DNA but not effector.  Similarly, Ir mutations typically are 
found in the effector binding pocket as they involve changing effector affinity.  Mutations 
to the N-terminal DNA binding domain typically result in the I- phenotypes because 
operator DNA binding is destroyed; the lac repressor can bind effector but not operator 
DNA.  A large fraction of the amino acid substitutions made were tolerated by the 
protein.  Disruptive amino acids (I-) were found to lie along the dimer interface and at key 
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locations of the lac repressor fold.  This large scale mutagenesis combined with 
structure provides a unique confirmation that the experimentally derived structures are 
extremely relevant to the phenotypes observed in living bacteria.  The central limitation 
of the genetic studies is that they could only identify bulk qualitative phenotypic effects of 
the mutations.  It took a confirmation with the structure to link mutations with 
thermodynamic binding parameters, however only qualitatively.  
Later studies began to identify other point mutations of the lac repressor and 
quantitatively assess the effects.  For example the mutation K84L was identified which 
creates a more thermostable repressor but impairs both DNA and effector affinities 
(Barry & Matthews, 1999).  This mutation was crystallographically characterized  and 
found to lock dimer interface of the lac repressor in a novel conformation (Bell et al., 
2001).  
1.7 Aims
It has been well established how the lac repressor functions within E. coli to 
regulate the lacZ/Y/A polycistronic message and induce lactose metabolism when it is 
needed.  Furthermore it is well known that the gene regulatory phenotype can be 
changed by point mutation of the lac repressor or by changing or moving operator DNA 
sequences.  
Several important gaps in knowledge however remain.  How do point mutations 
to the lac repressor affect the thermodynamic parameters of the MWC model?  Can we 
link specific regions of the lac repressor to specific thermodynamic constants?  
Furthermore, while we know the lac repressor is functional in purified in vitro conditions, 
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do the in vitro measured binding values match the in vivo measured values?  Finally, can 
we use these known lac repressor genetic switches to treat human diseases?
The specific aims of this thesis seek to address these questions:
1. Linking Mutation to Thermodynamics (Chapter 3).  We have taken mutations 
to two structurally specific regions and linked them to changes to specific 
thermodynamic parameters of the MWC model.  Mutations in the specificity 
region of the DNA binding domain are seen to alter the repressor-DNA affinity 
and potentially the conformational equilibrium.  Mutations in the specificity region 
of the effector binding pocket are seen to alter the repressor-effector affinities 
and the conformational equilibrium.  The interplay between the changes in the 
thermodynamic parameters results in a wide range of phenotypically interesting 
genetic switches ranging from more ideal on-off switches to inverted switches.
2. Linking In Vivo to In Vitro (Chapter 4).  We have created a quantitative in vivo 
assay that allows for accurate measurement of both regulated transgene (YFP) 
and fluorescently tagged lac repressor (lac-mCherry).  We measured the 
thermodynamic binding parameters of the lac genetic switch from an in vitro 
transcription assay and use these values to predict the in vivo phenotypic profile. 
We found that in general our measured in vitro thermodynamic values matched 
those of previous studies, except for repressor-DNA affinity.  Our affinity was 
several orders of magnitude weaker than previous studies.  Despite this, our 
values do recreate the in vivo gene regulatory profile when 40% cell crowding is 
modeled.  Furthermore, only our values could create functional genetic regulators 
at the modeled concentrations of the natural lac operon.  This study showed the 
seminal importance of confirming in vitro results with in vivo data.
29
3. An Autogenously Regulated Lac Repressor for AAV-Mediated Eukaryotic 
Gene Therapy (Chapter 5).  We have redesigned the lac repressor genetic 
switch to be autogenously regulated (regulates its own expression) with the goal 
of creating an AAV-mediated gene therapy regulatory tool.  This autogenous 
switch was shown to work in various cell types in cell culture.  We have improved 
regulatory behavior of the switch through the use of multiple operator DNA sites 
and the restoration of the tetramerization domain in the lac repressor.  We found 
further improvement by making point mutations to the lac repressor that are 
known to improve the phenotype in E. coli.  Finally, we packaged our 
autogenously regulated lac genetic switch in AAV vectors.  These vectors were 
used to reversibly regulate luciferase expression in the livers of living mice as a 
function of IPTG.
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Chapter 2: 
Materials and Methods
2.1 Bacterial Strains and Media
Several bacterial strains were used for prokaryotic experiments and all are 
derived from Escherichia coli (E. coli). 
The strain DH5α (E. coli fhuA2 Δ(argF-lac)U169 phoA glnV44 φ80’ Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17) was used for cloning, plasmid preparations, 
and for prokaryotic green fluorescent protein (GFP) regulation assays.  This strain does 
contain some of the lactose operon and therefore is not a clean background within which 
to perform the prokaryotic GFP regulation assay.  It was later replaced with the EPB225 
cell line (described below).  
The strain BL21(DE3) (E. coli B dcm ompT hsdS(rB-mB-) gal) was used for 
recombinant protein expression to make purified lac repressor and lac repressor 
mutants.
The strain EPB229 (E. coli F- λ- ilvG- rfb-50 rph-1 Δ(lacI-lacA)::frt) was used for 
prokaryotic GFP regulation assays.  This strain was made by the laboratory of Dr. Mark 
Goulian and derived from MG1655 (E. coli F- λ- ilvG- rfb-50 rph-1).  This strain is the 
“wild-type” K-12 strain and has a total deletion of the lac operon allowing for a clean 
background within which to study our lac genetic regulatory systems.  
Liquid media for standard bacterial growth (plasmid preparation, cloning, initial 
prokaryotic GFP regulation assays) was Luria-Bertain (LB) broth.  Similarly, LB-agar was 
used for growth on solid plates.  Later prokaryotic GFP regulation assays with EPB229 
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cells used MOPS minimal media supplanted with 0.4% glucose.  This media provided 
minimal auto-fluorescent background.
Antibiotics were used for selection of bacterial cells transformed with desired 
plasmids at the following concentrations:
Ampicillin = 100 μg/mL
Chloramphenicol = 50 μg/mL
Kanamycin = 50 μg/mL 
For most prokaryotic GFP regulation assays, a two plasmid selection method 
was used by using media with both ampicillin and chloramphenicol.
2.2 Eukaryotic Cell Lines and Media
The cell line HEK293T, derived from human embryonic kidney cells and stably 
expressing the Simian Vacuolating Virus (SV40) which codes for the large T-antigen, 
was used for Eukaryotic GFP and luciferase regulation assays and also in microscopy. 
These cells are highly adapted to cell culture conditions and are not thought to be 
particularly characteristic of healthy kidney cells.  This cell line is adherent and was 
grown on plastic cell culture plates.  The culture medium was Dulbecco’s modified 
Eagle’s medium (DMEM) containing 20% fetal bovine serum (FBS), L-glutamine and 
sodium bicarbonate.
The cell line Cos-7, derived from the African green monkey Cercopithecus 
aethiops fibroblast-like kidney cells, was used in Eukaryotic GFP and luciferase 
regulation assays.  This cell line was developed from the CV-1 line by transformation 
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with SV40 to express the T-antigen.  This cell line is adherent and grown on plastic cell 
culture plates. The culture medium was Dulbecco’s modified Eagle’s medium (DMEM) 
containing 20% fetal bovine serum (FBS), L-glutamine and sodium bicarbonate.
The cell line ARPE-19, derived from human retinal pigment epithelial cells, was 
also used in Eukaryotic GFP and luciferase regulation assays.  This is an adherent cell 
line and was grown on plastic cell culture plates.  The culture medium was Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with the F-12 nutrient mixture 
containing 20% fetal bovine serum (FBS), L-glutamine and sodium bicarbonate.
2.3 Plasmid Preparation
Plasmids were isolated using the NucleoSpin plasmid purification kit (Clontech).  
For both the repressor and reporter bacterial plasmids a slightly modified protocol was 
followed as they both are low-copy number plasmids.  A larger initial volume of LB is 
inoculated (8mL) and larger volumes of individual DNA purification buffers are used: 500 
μL A1, 500 μL A2, and 700 μL A3 of the Macherey-Nagel quick purification kit.  The 
remainder of the protocol was unchanged.
Large volumes of plasmid were obtained using the Plasmid Plus Maxi Kit 
(Qiagen).  This allowed for endotoxin free plasmid preparation for transient transfections 
and also for virus preparation from AAV encoding plasmids.
2.4 Cloning
Inverse PCR Mutagenesis
The following protocol was used for point mutations, deletions and small 
insertions (typically less than 10 base pairs).
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The primer design completely defines what the result of the cloning will be.  Each 
primer is broken down into two parts: an annealing region that overlaps with the starting 
plasmid and an optional un-matched 5’ tail.  The annealing region is designed to follow 
two basic rules. First, the melting temperature should be as close to 60C as possible.  
Second, both the 3’ and 5’ ends should be either cytosine (C) or guanine (G).  The 
reverse primer is designed to anneal to the left of the region to change/insert/delete and 
the forward primer is designed to anneal to the right of the region to 
change/insert/delete.
For a deletion, primers are chosen that skip the region to delete.  For a point 
mutation, a 5’ tail is added to one of the primers that matches the desired sequence.  
Similarly, for an insertion a 5’ tail is added to one of the primers that matches the desired 
insertion.  Finally, one of the primers is given a 5’ phosphorylation.
Full circle PCR is used with Phusion Hot Start High Fidelity DNA Polymerase 
(NEB) and the extension time is set to 20 seconds for every kilobase and follows the 
recommended thermal cycle.  PCR follows 15 rounds of amplification and is then held at 
4C until ready to proceed.  The mixture now contains plasmid (initially isolated from 
DH5α) and linearized PCR product which has the desired change/insert/deletion.  A 10 
minute ligation with 2000 Units T4 DNA Ligase (NEB), 10 μL quick ligation buffer (NEB) 
and 10 μL PCR product is used to ligate the linearized PCR product into closed plasmid.  
This is followed by a 1 hour digestion to remove the initial plasmid by adding 5 μL NEB 
#4 Buffer, 25 μL MilliQ, and 20 Units DpnI (NEB).  The DpnI enzyme specifically cleaves 
DNA with the methylation pattern given by DH5α cells, therefore specifically cleaving 
only the starting plasmid while sparing the ligated PCR product.  2.5 μL of this mixture is 
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transformed into 50 μL DH5α cells and plated onto LB agar with appropriate selection 
antibiotic.
Typically >90% of colonies that survive on the plate have the intended 
change/deletion/insertion.  Common difficulties are 5’ adenosine (A) or thymine (T) 
bases will not make it into the final plasmid which is why they are to be avoided if 
possible in the initial primer design step.  It is also commonly seen that the starting 
plasmid will survive the DpnI digestion so it is recommended to include a DpnI negative 
control where primers are omitted so only starting plasmid exists.
In-Fusion
This method is used to insert large DNA segments into plasmids.  The primer 
design exactly follows the recommendations of the In-Fusion HD Liquid Kit (Clontech).  
Long DNA regions (approximately greater than 1 kilobase) were amplified with Phusion 
Hot Start High Fidelity DNA Polymerase (NEB) following the standard thermal cycle and 
extension time of 20 seconds per kilobase.  Small DNA regions (approximately less than 
1 kilobase) were amplified with Vent DNA Polymerase (NEB) following the standard 
thermal cycle and extension time of 60 seconds per kilobase.  Linearized PCR 
fragments were isolated through 5% agarose gel filtration and the NucleoSpin Extract II 
(Clonetech) purification kit.  Alternatively, restriction enzyme digestion was used when 
appropriate to linearized DNA fragments as described in the In-Fusion protocol.
Essentially, two linearized fragments are desired: the vector which typically 
contains the desired new plasmid and the insert to be placed into that plasmid.  The 
vector and insert are designed such that 15 base pairs on each end perfectly match.  
The In-Fusion enzyme then anneals the insert and vector to create a final plasmid.  
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The In-Fusion reaction follows the recommended protocol and 2.5 μL is 
transfected into 50 μL DH5α cells and plated onto LB-agar with appropriate antibiotic.  
Again >90% of the colonies typically contain the designed insert.
2.5 Lac Repressor Purification 
Lac Repressor constructs were cloned into a pBAD expression vector which 
controls expression of a gene using the arabinose repressor system.  All repressor 
constructs were inserted into the multiple cloning site (MCS) of the pBAD vector and 
given a 6x-Histidine tag on the C-terminus.  Cloning was achieved using in-fusion.
Purification begins by first transforming the desired plasmid into BL21(DE3) cells 
and plating onto LB supplemented with ampicillin and incubating overnight at 37C.  The 
plate is used to innoculate 100 mL 2xYT medium (Sigma) supplemented with ampicillin 
in the morning.  I picked many colonies (>100) in the innoculation to prevent any 
potential bias from selecting a single colony.  This starter culture is incubated at 37C with 
shaking (~200 RPM) for 3-4 hours until the flask grows past the mid-log phase and 
approaches the stationary phase (optical density at 600 nm (OD600) > 1.0).  10mL of the 
starter culture is then used to innoculate 1L 2xYT medium supplemented with ampicillin.  
The large culture is incubated at 37C with shaking (~200RPM) until early mid-log growth 
phase (OD600=0.3-0.4).  At this point, the incubator temperature is reduced to 15C to 
slow bacterial growth.  Expression is also induced at this point by adding 10mL of 20% 
v/v arabinose that has been sterile filtered.  The liquid culture is allowed to grow 
overnight (~16 hours).
In the morning, the culture is removed from the incubator and placed into 1L 
centrifuge flasks.  The cells are centrifuged at 5000g for 10 minutes at 4C to pellet the 
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cells.  The supernatant is removed and cells are resuspended 20 mL in Nickel Lysis 
Buffer (300 mM NaCl, 50 mM NaH2PO4, pH 8.0). Cells are lysed using three passes 
through a cell homogenizer (Avestin) at ~18,000 PSI and whole cell lysate is 
immediately stored on ice.  Lysate is then centrifuged at 15,000g for 15 minutes at 4C to 
separate soluble protein from insolubate cell lysates.  Supernatant is filtered through 
filter paper (Whatman #3) at 4C to remove further insoluble materials.  A sample of the 
supernatant is collected for analysis on an SDS-PAGE gel.
A his-tag purification column is prepared by loaded 2 mL His60 Ni Superflow 
Resin (Clontech) into a Flex-Column (Kontes) fitted with a stopcock to regulate flow rate 
through the column.  All work with the his-tag column is undertaken in refrigeration at 4C. 
Resin is first equilibrated with 20 mL cold Nickel Lysis Buffer and the stopcock is set to 
very slowly drip out the buffer such that the nickel beads will form an equilibrated bed of 
beads.  Filtered supernatant is then carefully added to the column and flow again is set 
to very slowly drip.  A sample of the flow through is collected for SDS-PAGE gel analysis. 
The beads are then washed three times with Nickel Wash Buffer (50 mM NaH2PO4, 300 
mM NaCl, 20 mM Imidazole, 2.5% v/v glycerol, pH 8) and samples of each wash are 
collected for SDS-PAGE gel analysis.  His-tagged lac repressor is then eluted from the 
column using Nickel Elution Buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM Imidazole, 
2.5% v/v glycerol, pH 8) and elutant was collected.  A sample of elutant was saved for 
SDS-PAGE gel analysis.  
Nickel elutant is then buffer exchanged using an Amicon Ultra centrifuge filter 
with a 30,000 molecular weight cutoff (Millipore).  Elutant is centrifuged at 5,000g for 15 
minutes at 4C and the filter flow through is discarded.  Typically, depending on yield, 
200-300 μL concentrated protein remains above the filter.  Protein is carefully 
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resuspended in ~3-4 mL ice-cold Gel Filtration (GF) Buffer (200 mM Tris pH 7.4, 200 mM 
Kcl, 10 mM EDTA, 3 mM DTT).  Buffer replaced in this fashion reduces the initial buffer 
to about 7% of its starting concentration.  Buffer is replaced three times resulting in < 
0.1% of the elutant buffer remaining.  Protein is then concentrated a final time to achieve 
a protein concentration in the 1-10 mg/mL range as measured using absorbence at 
280nM (A280) on a spectrophotometer (NanoDrop).
Purified protein can be saved at this step by flash freezing the protein in liquid 
nitrogen and storing at -80C.  
All samples from the nickel purification are boiled in LDS sample buffer 
(Expedeon) for 10 minutes and run on a 4-12% SDS-PAGE gel (Expedeon) at 110V for 1 
hour.
Protein for in vitro transcription assay underwent a size exclusion 
chromatography step.  His-tag purified lac repressor in GF buffer was concentrated and 
loaded onto a Hi Load 16/60 Superdex 75 column and sample was driven by Akta Prime 
FPLC.  Fractions were collected and samples were SDS boiled and run on SDS-PAGE 
gels to determine purity.  Protein was concentrated again using centrifugal 30,000 MW 
filter and stored in GF buffer.  Protein was flash frozen and store at -80C.
2.6 Prokaryotic GFP and YFP Regulation Assays
GFP regulation assay 
EPB229 cells were co-transformed with a lac repressor plasmid providing 
chloramphenicol resistance and a reporter plasmid providing ampicillin resistance and 
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plated onto LB agarose plates with ampicillin and chloramphenicol.  Plates were 
incubated overnight at 37C and stored at 4C.
The repressor plasmids are all derived from pABD34 plasmid and constitutively 
express the LacI gene using its native promoter from E. coli.  The LacI sequence has 10 
C-terminal residues truncated to prevent tetramerization.  Point mutations to the LacI 
sequence made using inverse PCR mutagenesis.  For repressor quantification 
experiments a C-terminal mCherry tag was inserted using in-fusion cloning.  
Reporter plasmid were derived from the pBR plasmid and have a reporter gene, 
Green or Yellow Fluorescent Protein (GFP or YFP), under control of the native LacZ/Y/A 
promoter.  The operator sequences of the promoter used were:
O1: 5' AA TT GTG AGC G GAT AAC AA TT 3'
Lsym: 5' AA TT GTG AGC GCT CAC AA TT 3'
In the original assay, only GFP was monitored.  Single colonies were picked into 
1 mL LB supplemented with ampicillin and chloramphenicol and grown ~ 16 hours at 
37C with shaking (~200 RPM).  100 μL of the sample aliquoted into a 96-well clear 
bottom plate (Corning) and OD600 and fluorescence (excite: 488 nm, emit: 525 nm) were 
measured on Infinite M1000 plate reader (Tecan).
Samples to be assayed are typically picked in triplicate.  Fluorescence is 
normalized by OD600 and averaged across replicates.
YFP regulation assay 
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Reporter plasmid was made as previously reported with the O1 operator 
sequence (5’-AA TT GTG AGC G GAT AAC AA TT-3’) followed by YFP and providing 
ampicillin (AMP) resistance. Lac repressor was expressed on a second plasmid as 
previously described providing chloramphenicol (CAM) resistance. A C-terminal mCherry 
tag was added to the Lac repressor gene after an 11bp linker to create the Lac-mCherry 
construct.
We double transformed reporter and repressor plasmids into EPB229 cells (F- 
Δ(lacI-lacA)::frt). These cells were derived from the MG1655 “wild type” line.  Colonies 
were picked in triplicate into MOPS minimal media with 0.4% glucose, AMP and CAM 
and grown overnight at 37C with shaking. 50µL of the overnight culture was used to 
inoculate 1mL fresh MOPS minimal media supplanted with varying amounts of IPTG. We 
measured optical density at 600nm (OD600), YFP fluorescence (excite: 510 nm emit: 535 
nm), and mCherry fluorescence (excite: 585 nm emit: 610 nm) for all wells over a 12 
hour period using a TECAN M1000 plate reader in 384 well optical bottom plates 
(Corning).
In vivo data was normalized for growth by measuring cells in triplicate as they 
were growing. All data points collected were then fit to a 2nd order polynomial to obtain a 
curve which is fluorescence as a function of OD600. Positive control was established by 
co-transforming EPB229 cells with O1 YFP reporter and a CAM plasmid without Lac-
mCherry (pABD34). YFP signal was normalized to the polynomial fit from the positive 
control. Final values for fitting were calculated for cells at approximately mid-log growth 
phase (0.4 OD600). 
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2.7 Prokaryotic Lac Repressor Quantification Assay 
EPB229 cells were co-transformed with Lac-mCherry and O1 YFP reporter. An 
individual colony was picked into MOPS minimal media with 0.4% glucose, AMP and 
CAM and grown overnight at 37C with shaking. 50 µL was innoculated into fresh media 
and grown to mid-log phase.
Serial dilutions were made over 10 orders of magnitude and each dilution had 
OD600 measured (TECAN M1000 and Ultrospec 2100 pro) and 100 µL plated onto LB 
agar with AMP and CAM.
Purified Lac-mCherry was quantitated with both a BCA assay and optical A280 
measurements using a Nano-drop. Dilutions were made over 8 orders of magnitude and 
50 µL was loaded into clear bottom 384 well plates in triplicate. mCherry fluorescent 
measurements (excite: 585 nm emit: 610 nm) were made using various gains to 
establish linear regimes for the instrument (TECAN M1000).   
We established a raw cell count by plating dilutions of a culture of EPB229 cells.  
We found 1.92e6 cells/µL at mid-log growth phase which is similar to standard estimates 
of 1e6 cells/µL for E. coli.  Aliquots of known cell counts were then used to establish a 
linear relationship with OD600 on our plate reader.  Similarly, purified Lac-mCherry of 
known concentration was used to establish a linear relationship with mCherry 
fluorescence on our plate reader at a fixed gain.
EPB229 cells were co-transformed with plasmid constitutively expressing Lac-
mCherry and a reporter plasmid which has YFP under the control of the natural operator 
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O1.  We measured mCherry fluorescence at a fixed gain and OD600 from which we 
calculated the concentration of Lac-mCherry in the well and the number of cells in the 
well.  The approximate volume of E. coli was estimated to be 1x10-15 L.  Multiplying 
volume of E. coli by number of cells allows us to estimate what fraction of the well 
volume is intracellular.
Calibration of raw mCherry fluorescent signal and OD600 was converted to 
intracellular repressor concentration.
2.8 In Vitro Transcription
A reporter plasmid was made with the O1 operator after a T7 promoter. Reporter 
was linearized to 450bp and purified by spin column purification (Clontech).  
MaxiScript T7 kit (Ambion) was used to perform in vitro transcription. CTP[α-32P] 
was incorporated into mRNA transcripts and the water fraction of the standard reaction 
was supplanted with varying concentrations of Lac-mCherry and IPTG. Transcription 
was allowed to proceed for 30 minutes at 37C until halted by boiling. Samples were 
loaded onto polyacrylamide gels and electrophoresis was used to separate free CTP[α-
32P] from that incorporated into mRNA. Gels were dried and exposed to radiological 
plates. Plates were imaged on a Typhoon scanner and bands were quantitated using 
ImageJ (NIH).  
2.9 Transient Transfections
Cells were allowed to grow to approximately 50 to 70% confluence and split to 
prepare for transient transfection.  Cells were allowed to grow in 37C incubator with 5% 
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CO2 overnight to attach.  Media was changed in the morning and cells were now ready 
for transient transfection.
Plasmid DNA was prepared by first mixing with Opti-Mem (Invitrogen), vortexing, 
and letting sit at room temperature for 5 minutes.  Lipofectamine LTX (Invitrogen) was 
then added to the mixture, very briefly vortexed, and then allowed to sit at room 
temperature for 30 minutes.  The prepared solution is good for several hours at room 
temperature.  The final mixture is then added to cells which are then returned to the 
incubator.  Media should be changed after 24 hours.  The exact amounts of plasmid 
DNA, Opti-Mem, and Lipofectamine LTX (and potential additives such as Plus reagent) 
were determined by the cell type and can be found within the product literature.  
2.10 Native Gel Electrophoresis
We used the NativePage (Invitrogen) kit for native gel electrophoresis.  The 
primary advantage of this kit is that it is based upon Blue Native Polyacrylamide Gel 
Electrophoresis (BN Page) which uses Coomassie G-250 as the molecule to provide 
charge shift for proteins.  Coomassie G-250 binds to proteins providing a net negative 
charge without denaturing the protein.  
Purified protein was thawed and mixed in non-denaturing sample loading buffer.  
10 μL of samples and NativeMark (Invitrogen) protein standard were added to wells of 
NativePage 4-16% Bis-Tris Gels.  Gels were loaded within Novex Mini-cell (Invitrogen) 
gel running boxes.  
The interior (between the gels) was filled with NativePage cathode running buffer 
which contains Coomassie G-250.  The exterior was filled with NativePage anode 
running buffer.  Gels were run at 150V for 2 hours, then removed.  Gels were placed in 
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Fix (40% methanol, 10% acetic acid), microwaved on high for 45 seconds, and then 
shaken on an orbital shaker for 15 minutes to fix the gel.  The gels were then switched to 
Destain (8% acetic acid), microwaved on high for 45 seconds, and placed on an orbital 
shaker overnight to remove any unbound Coomassie G-250.  Gels were then imaged.
2.11 Eukaryotic Gene Regulation Assays
All gene regulation assays start by transiently transfecting the cell line of choice 
with the appropriate plasmid.  Media is supplemented with effector of varying 
concentration in wells (IPTG for lac repressor experiments and doxycycline for tet 
repressor experiments) and specific experimental conditions are typically grown side by 
side in triplicate.  Experimental measurement times varied depending upon cell 
confluence but typically occurs between 24 and 72 hours after transient transfection.
Fluorescence Microscopy
Fluorescence microscopy was performed in several different ways.  For live cell 
microscopy, cells were grown as previously described.  Media was switched to 
phosphate buffered saline (PBS) to reduce auto-fluorescence and cells were imaged on 
a Nikon Eclipse TE2000-U inverted microscope equipped with green and blue filters and 
a Nikon Intensilight C-HGFI power source.
High resolution fluorescence microscopy was also performed by growing cells in 
the Lab-Tek II 8 well Chamber Slides system (Nunc).  Cells followed the standard cell 
culture, transient transfection, and experimental conditions only scaled down for the 
smaller surface area of the individual wells.  To prepare for microscopy, cells were 
washed three times in DPBS with calcium and magnesium (Corning) and then all media 
was removed.  Cells were fixed for 1 hour at room temperature with 2% 
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paraformaldehyde (PFA) and then washed three times with DPBS with calcium and 
magnesium.  All liquid was removed and chamber supports were separated from the 
slide.  Cells were immersed in a small droplet of FluoroMount-G (Southern Biotech) 
supplemented with 4',6-diamidino-2-phenylindole (DAPI) to reduce fluorophore 
quenching and nuclear staining, respectively. Slide covers were then placed on top of 
cells and affixed with nail polish.  Slides were stored at 4C. Fixed slides were viewed on 
the a Zeiss AX100 microscope with an X-cite series 120Q light source.
Bulk Fluorescence Assays
Quantitative fluorescence data was achieved by measuring the bulk properties of 
eukaryotic cells.  Two assays were developed which were shown to give approximately 
the same result.  
First, cells were washed three times with DPBS, were lysed with Reporter Lysis 
Buffer (Promega) and the cells were scraped off of the bottom of the growth plates.  50 
μL whole cell lysate was then loaded into wells of a 384 well optical bottom plate 
(Corning) into the Tecan M1000 and fluorescent emission was read with the following 
excitation/emission wavelengths: GFP excite: 485nm emit: 510nm, YFP excite: 510 nm 
emit: 535 nm, and mCherry excite: 585 nm emit: 610 nm.
Second, cell culture plates were washed three times with DPBS and the entire 
cell culture plate was scanned on the Typhoon scanner.  The scanner was set with a 3.5 
mm vertical offset to better visualize the cells growing within the wells of the plate.  The 
473 nm blue excitation laser was used to excite GFP and the >520 nm filter was used to 
read emission.  Images were analyzed using ImageJ (NIH).
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Luciferase Assay
As before, cells were washed three times with DPBS, were lysed with Reporter 
Lysis Buffer (Promega) and the cells were scraped off of the bottom of the growth plates. 
5 μL of whole cell lysate was added to 45 μL of luciferase assay buffer (Promega) 
containing luciferin within a well of a 384 well optical bottom plate (Corning).  Plates 
were immediately loaded into the Tecan M1000 and luciferase signal was measured for 
each well over time.  Peak luciferase signal values were used for quantification.
2.12 Western
Whole cell lysate is first collected from cells of interest as previously described.  
Whole cell lysate is then mixed with 4x LDS sample buffer (Expedeon) and boiled at 70C 
for 10 minutes to denature the proteins.  Samples were loaded into wells of 10-20% 
SDS-PAGE gels (Expedeon) and electrophoresed at 110V for 1 hour using the RunBlue 
SDS Running Buffer (Expedeon).  
Gels were removed and washed with MilliQ water and then prepared for semi-dry 
transfer to Immobilon-P transfer membrane (Millipore). Gels were soaked for 10 minutes 
in western transfer buffer (25 mM Tris, 200mM glycine, 10% methanol).  Transfer 
membrane is placed in 100% methanol for 15 seconds, moved to MilliQ for 2 minutes, 
and then to western transfer buffer for 5 minutes.  Six pieces of 3mm filter paper 
(Whatman) are also soaked in western transfer buffer.  The transfer stack is prepared as 
follows: 3 pieces filter paper – equilibrated PVDF transfer membrane – equilibrated gel – 
3 pieces filter paper.  The sandwich is then loaded onto the semi-dry transfer plates and 
run at at 15V for 15 minutes.
PVDF membrane is then removed from the sandwich and blocked in Blotto (1g 
non-fat powdered milk in 20 mL PBS-T(PBS with  0.1% Tween-20)) for 1 hour.  
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Membrane was then washed three times for 10 minutes each with PBS-T.  Membrane 
was then placed in the primary antibody at 4C overnight on an orbital shaker.  The buffer 
and concentration of primary antibody were determined by the manufacturers 
recommendation for each antibody.   In the morning, the gel was washed three times 
with PBS-T and placed in the appropriate secondary antibody conjugated to horseradish 
peroxidase (HRP).  The gels were then exposed to chemiluminescent substrate specific 
to HRP and imaged.
2.13 Mouse Experiments
AAV8 viral vector was prepared using the University of Pennsylvania Vector Core 
from plasmid DNA.  
Individual mice were given tail vein injections of AAV8 at a viral dose of (1e11 
multiplicity of injection (MOI)) regardless of weight.  Weight in grams for each mouse 
was recorded throughout the experiment.  Mice were fed a normal diet and given two 
weeks to incorporate the virus in their liver tissue.  
Gavage protocol was 25 μL of 1M IPTG per 10 gm body weight, two times a day 
for 3 days.  IPTG was gavaged through an oral syringe into the stomach of the mice. 
Mice were either given normal water or gavaged IPTG throughout the experiment to 
either induce or repress expression of the transgene.
Luciferase imaging was performed by giving mice interperitoneal injections of 
luciferin and imaging them on a live mouse scanner.  Raw luciferase signal was 
quantified with ImageJ (NIH). 
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2.14 Modeling
All functions from text were coded into Matlab (Mathworks) scripts to calculate 
the MWC model outputs.  Standard linear regression minimization functions were used 
to minimize the difference between experimental and theoretical curves in order to fit for 
the thermodynamic parameters of interest.  Various minimization schemes were used 
and all were built in Matlab functions such as a genetic algorithm and direct-pattern 
search.  
The error estimates in fit parameters were done by a monte carlo approach.  
Each individual data point had some random fraction of its error added to it and the data 
was refit.  This process was repeated > 100 times and then the standard deviation of the 
individual parameters was taken to be the error in that fit parameter.  The best fit to the 
data without error added was taken to be the reported value for the individual 
parameters.
2.15 Plasmid Maps
The following is a list of all plasmids used throughout this thesis.
Prokaryotic plasmids
pBR series reporter plasmids were derived from giving ampicillin resistance and strict 
plasmid copy number of approximately 10-20 per cell (Figure 2.1).  The reporter cassette 
contains the natural lacZ/Y/A promoter from the lac operon of E. coli.  Only one operator 
is present in the plasmid and is located downstream of the promoter in the transcriptional 
initiation region (Figure 2.2).  Regulated genes downstream of the promoter included 
eGFP, YFP and the polycistronic message of dimeric lac repressor-mCherry fusion 
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followed by YFP.  An 18 base pair spacer which was the 18 base pairs that preceded the 
LacI-mCherry gene and were: 
5' CAA TTC AGG GTG GTG AAT 3'
Figure 2.1.  Plasmid map of the pBR-YFP plasmid.  
Figure 2.2.  Close-up of the operator placement within the lacZ/Y/A promoter of the pBR 
reporter plasmids.
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The pLacI series of plasmids provide chloramphenicol resistance and constitutive lac 
repressor from the natural lacI promoter of E. coli (Figure 2.3). The lacI gene has the 11 
C-terminal codons truncated.  The lac repressor-mCherry fusion includes an 18 base 
pair linker with the sequence:
5' GGC TCA GGT CTC GAG TTG 3'
Figure 2.3.  Plasmid map of the pLacI series plasmid with the lac repressor-mCherry 
fusion protein.
The arabinose expression plasmid is pBAD-DEST-49 (Invitrogen) and expression genes 
were placed within the first multiple cloning site.  
Eukaryotic Plasmids
The pIRES plasmid (Clontech) has a minimal CMVI promoter with two multiple cloning 
sites linked by the IRES sequence.  The original IRES plasmid put YFP in the first 
multiple cloning site and EuLacmCherry in the second multiple cloning site.  
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The EuLac sequence was taken from the codon optimized sequence for Eukaryotic cells 
with the splice site fixed (Cronin et al., 2001).  We first used a dimeric EuLac sequence 
with the 11 C-terminal codons removed.  Later we used the EuLacTet sequence with the 
11 C-terminal codons of wild type lacI restored for tetrameric lac repressor.  The 
following is the EuLacTet sequence with the 11 C-terminal amino acids that result in 
tetramerization highlighted in bold:
5'- ATG AAA CCA GTA ACG TTA TAC GAC GTC GCA GAG TAT GCC GGT GTC TCT 
TAT CAG ACT GTT TCC AGA GTG GTG AAC CAG GCC AGC CAT GTT TCT GCC AAA 
ACC AGG GAA AAA GTG GAA GCA GCC ATG GCA GAG CTG AAT TAC ATT CCC AAC 
AGA GTG GCA CAA CAA CTG GCA GGC AAA CAG AGC TTG CTG ATT GGA GTT 
GCC ACC TCC AGT CTG GCC CTG CAT GCA CCA TCT CAA ATT GTG GCA GCC ATT 
AAA TCT AGA GCT GAT CAA CTG GGA GCC TCT GTG GTG GTG TCA ATG GTA 
GAA AGA AGT GGA GTT GAA GCC TGT AAA GCT GCA GTG CAC AAT CTT CTG 
GCA CAA AGA GTC AGT GGG CTG ATC ATT AAC TAT CCA CTG GAT GAC CAG 
GAT GCC ATT GCT GTG GAA GCT GCC TGC ACT AAT GTT CCA GCA CTC TTT 
CTT GAT GTC TCT GAC CAG ACA CCC ATC AAC AGT ATT ATT TTC TCC CAT GAA 
GAT GGT ACA AGA CTG GGT GTG GAG CAT CTG GTT GCA TTG GGA CAC CAG 
CAA ATT GCA CTG CTT GCG GGC CCA CTC AGT TCT GTC TCA GCA AGG CTG 
AGA CTG GCC GGC TGG CAT AAA TAT CTC ACT AGG AAT CAA ATT CAG CCA ATA 
GCT GAA AGA GAA GGG GAC TGG AGT GCC ATG TCT GGG TTT CAA CAA ACC 
ATG CAA ATG CTG AAT GAG GGC ATT GTT CCC ACT GCA ATG CTG GTT GCC AAT 
GAT CAG ATG GCA CTG GGT GCA ATG AGA GCC ATT ACT GAG TCT GGG CTG 
AGA GTT GGT GCA GAT ATC TCG GTA GTG GGA TAC GAC GAT ACC GAA GAC 
AGC TCA TGT TAT ATC CCG CCG TTA ACC ACC ATC AAA CAG GAT TTT CGC CTG 
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CTG GGG CAA ACC AGC GTG GAC CGC TTG CTG CAA CTC TCT CAG GGC CAG 
GCG GTG AAG GGC AAT CAG CTG TTG CCA GTC TCA CTG GTG AAG AGA AAA 
ACC ACC CTG GCA CCC AAT ACA CAA ACT GCC TCT CCC CGG GCA TTG GCT 
GAT TCA CTC ATG CAG CTG GCA CGA CAG GTT TCC CGA CTG GAA AGC GGG 
CAG -3'
The operator was placed within the CMV\IE\Promoter region of the minimal CMV 
promoter 13 base pairs downstream of the TATA box.  The following is the sequence of 
the CMV\IE\Promoter region including the Lsym operator in bold:
5'- CGC CCC GTT GAC GCA AAT GGG CGG TAG GCG TGT ACG GTG GGA GGT CTA 
TAT AAG CAG AGC TCG AAT TGT GAG CGC TCA CAA TTG AGC TCG TTT AGT GAA 
CCG TCA GAT C -3'
The plasmid map of pIRES Lsym YFP IRES EuLacmCh is given in Figure 2.4. The pSW 
plasmid expresses EuLac followed by the 2A sequence followed by either the GFP or 
Luciferase gene Figure 2.5.  The entire cassette is flanked by ITR repeat regions for 
inclusion into AAV-viral capsids.  
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Figure 2.4.  Plasmid map of the pIRES plasmid with the minimal CMVI promoter under 
control of the Lsym operator.  The plasmid co-expresses YFP and the lac repressor 
fused to mCherry.
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Figure 2.5. pSW-GFP plasmid map.  The CMV promoter in this plasmid has one Lsym 
site in the same location as described above for the pIRES series plasmid.
54
Chapter 3: 
Linking Mutation to Thermodynamics
(Adapted from Daber, Sochor and Lewis (2011) Thermodynamic Analysis of Mutant lac 
Repressors. Journal of Molecular Biology. 409, 76-87.)
3.1 Introduction
The study of the lac repressor, like many proteins, includes a large body of work 
wherein the repressor itself is mutated and its altered function analyzed.  For the lac 
repressor, this history is complicated by the ever changing experimental techniques and 
knowledge of the repressor itself.  So while a huge body of lac repressor mutations and 
their phenotypes is present in the literature, there is no direct link between how mutating 
specific parts of the lac repressor could potentially change the thermodynamic 
equilibrium and binding parameters specified by the MWC model of allostery.  It is a 
much more stringent test of the MWC model if it can successfully explain not only the 
behavior of the wild type repressor, but also mutations to specific regions which should 
directly alter one or more of the thermodynamic parameters while leaving the others 
unchanged.  
As discussed previously, the tetrameric lac repressor is doubly allosteric.  First, 
the tetramer allosterically binds two DNA operators which has the effect of increasing the 
affinity of the repressor for operator DNA.  Second, each dimer allosterically lowers its 
operator DNA affinity upon inducer binding.  These two allosteric mechanisms work in 
concert to efficiently regulate the lac operon in E. coli.  The vast majority of studies on 
the lac repressor take place with a full length tetrameric protein where the effect of both 
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mechanisms are present.  It would be much more ideal to study the two processes in 
isolation in order to understand their individual effects.  
It is relatively straightforward to isolate the allostery of DNA binding by the 
tetramer.  One simply needs to study the properties of the repressor and operator DNA 
binding in the absence of any effector molecules.  The natural lac operon includes three 
operators: O1 which is located within the promoter, O2 which is 401 base pairs 
downstream of O1, and O3 which is 92 base pairs upstream of O1.  The operators are 
all pseudo-palindromic and have similar, yet distinct sequences and different affinities for 
the lac repressor.  The last operator that is typically studied is a fully symmetric operator 
that was created by copying the left half of the O1 operator and removing the central G 
base, which we call Lsym (Sadler, Sasmor, & Betzt, 1983).  The sequences of the four 
operators is given in Table 3.1.
Name L6-4 L3-1 P0 R1-3 R4-6
O1 5' - AA TT GTG AGC G GAT AAC AA TT -3'
O2 5' - AA AT GTG AGC G AGT AAC AA CC -3'
O3 5' - GG CA GTG AGC G CAA CGC AA TT -3'
Lsym 5' - AA TT GTG AGC GCT CAC AA TT -3'
Table 3.1. The sequences of the three natural operators of the lac operon and the left 
symmetric operator.
What is immediately obvious is that positions 1-6 of the left side (L1-6) of all of 
the operators is identical.  Affinity is essentially then a function of base pairing with the 
right side and the spacing (or lack thereof) created by the central guanine base at 
position 0 (P0). 
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An elegant study quantitatively established exactly how the lac repressor 
cooperatively binds its various operators (Oehler et al., 1994).  They used a quantitative 
β-galactosidase assay to quantify repression by either dimeric or tetrameric lac 
repressor on promoters with various combinations of DNA operators.  They first 
established that dimeric lac repressor and tetrameric lac repressor will repress a single 
operator in the O1 location (regardless of which operator) with the same efficiency.  
There is no inherent benefit to binding the first operator through tetramerization.  They 
also established that O1 represses ~4 times more than O2 and ~200 times more than 
O3.  Next they added a second downstream operator and showed an ~10 fold increase 
in repression for tetramer.  There was no improvement for dimeric lac repressor, as 
expected.  There is a similar benefit in placing additional operators upstream in the O3 
position for the tetrameric lac repressor.  The spacing between the two operators was 
later shown to be critical with a specific phase of approximately 11 base pairs between 
repression maximums (Müller et al., 1996).  This phasing is understood to be related to 
the structure of DNA.  DNA has the famous double helix structure with a minor and major 
groove.  The helix-turn-helix of the lac repressor binds within the major groove of DNA 
making specific contacts with bases 4, 5 and 6 of the operator.  Since the DNA twists 
with every additional base and the lac repressor dimers are linked through the coiled-coil 
tetramerization domain, specific spacing is required between the two operators such that 
the major groove for positions 4, 5 and 6 (for both the left and right halves) is facing the 
helix-turn-helix of each dimer of the lac repressor tetramer.  Taking an MWC view of 
tetrameric lac repressor binding two operators requires considering multiple structures of 
not only the repressor, but also the DNA.  Conceptually however, there are two 
combinations of conformations that matter.  In one, only one dimer binds one operator 
with a mild affinity.  In the second conformation, the tetramer and the DNA are twisted 
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such that an extremely stable pairing exists and both dimers bind both operators with 
very high affinity.  The two sets of conformations are in equilibrium and adding a second 
operator within the DNA molecule at the correct spacing will alter the effective 
conformational equilibrium towards the higher DNA affinity state.  The net effect is an 
approximately 10 or higher fold increase in repression.
While the allosteric binding of two DNA operators is useful for bacteria to more 
completely shut off the lac operon, it is confounding if we want to study the allosteric 
relationship between effector and DNA binding.  If we want to isolate this effect, we must 
work only with the dimeric lac repressor and a single DNA operator.  The next goal is to 
isolate perturbations to DNA binding from perturbations from effector binding.  This is 
achieved by targeting residues in the lac repressor that contribute to either specific DNA 
binding or effector binding.  A quantitative assay must be employed that measures DNA 
binding as a function of effector concentration (or vice versa). Finally, a comprehensive 
MWC allosteric model and solution to the model must be defined.  Using all of these 
tools it should be possible to globally compare wild type lac repressor to mutants and 
measure how those mutations alter the thermodynamic parameters of the MWC model 
of allostery.
3.2 The MWC Model of the Dimeric Lac Genetic Switch
First we will establish an MWC model of the dimeric lac repressor binding to effectors 
and operator DNA (Figure 3.1).
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Figure 3.1. MWC model of dimeric lac repressor (R and R*) binding to a single DNA 
operator (O) and one or two effector molecules (E).  The conformational equilibrium 
between the two conformations of the lac repressor (R and R*) is denoted by KRR*.  The 
remaining parameters are the equilibrium affinity constants of the two states for operator 
(KRO and KR*O) and effector (KRE and KR*E).
The dimeric lac repressor exists in two primary conformations in this model, R 
and R*.  The R conformation is designated as the higher DNA affinity conformation.  
Each lac repressor dimer can bind one operator DNA (O) and two effector molecules (E). 
The model assumes that the dimeric structures of the lac repressor are symmetric.  
Therefore for each given conformation the two effector binding sites are the same and 
have the same affinity of for effector.  We assume that this symmetry is not broken upon 
binding of the first effector molecule, hence the binding of the second molecule to the 
second site has the same affinity as the first.  
Experimentally, we would like to measure the output from a promoter regulated 
by the lac genetic switch.  It is assumed that transcription by RNA polymerase from the 
promoter is linearly related to the occupancy of the DNA operator within the promoter by 
the lac repressor, 
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transcription∝ [O]
[O]tot (42)
In order to model experimental data, we need to compute the occupancy of the 
DNA operator in terms of the thermodynamic constants (KRR*, KRE, KR*E, KRO, and KR*O) 
and the total concentration of repressor, effector and operator ([R]tot, [E]tot, and [O]tot).
We begin by defining the constants,
KRR *=
[R *]
[R ] (43)
KRE=
[RE]
[R ][E] (44)
K[R*E ]=
[R*E]
[R ][E] (45)
KRO=
[RO]
[R ][O] (46)
KR*O=
[R*O]
[R* ][O ] (47)
We also need to define the total concentrations of operator in terms of the 
individual bound and conformational states,
[O ]tot=[O ]+[RO]+2 [REO ]+[RE2O]+
[R*O ]+2[R*EO]+[R*E2O] (48)
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The factors of 2 in from of the [REO] and [R*EO] states are due to the 
degeneracy of effector binding to the dimer.  The effector could be bound to either the 
left monomer or right monomer which look identical, hence they are degenerate.  To 
account for both species we need to multiply by two.
We can state the various bound species from Equation (48) in terms of the 
thermodynamic constants and the unbound concentrations of repressor, operator and 
effector ([R], [O], and [E], respectively),
[RO]=KRO [R ][O] (49)
[REO]=KREKRO[R ][E] [O ] (50)
[RE2O]=KRE
2 KRO[R ][E]
2[O ] (51)
[R*O ]=KRR*KR*O [R ] [O ] (52)
[R*EO]=KRR* KR*E KR*O[R ] [E][O] (53)
[R*E2O]=KRR* KR*E
2 KR*O [R ] [E ]
2 [O ] (54)
We then note the following equality for simplification,
(1+[E]KRE)
2=1+2[E]KRE+[E]
2KRE
2
(55)
Plugging in Equations (49) - (54) and using the equality in Equation (55) into 
Equation (48),
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Otot=[O ]+[O ][R ]KRO(1+[E]KRE)
2+[O ][R ]KRR*KR*O(1+[E]KR*E)
2
(56)
We then rearrange put Equation (56) in the form which is proportional to 
transcription as in Equation (42),
[O ]
[O]tot
= 1
1+[R ] (KRO(1+[E]KRE)
2+KRR* KR*O(1+[E]KR*E)
2) (57)
We now have the occupancy of the operator in terms of the thermodynamic 
parameters and the free species of repressor and effector.  Unfortunately, we do not 
know the free species concentrations, only the total concentrations.  
The experiment we would like to model however allows for some simplifications 
of Equation (57).  We measured GFP production from a reporter plasmid which has a 
single operator within the promoter region.  This plasmid  has a very low copy number 
and hence the number of DNA operators in the cell is approximately 20.  Meanwhile, the 
repressor is constitutively expressed from a second plasmid with also with a low copy 
number (~10-20) (Daber et al., 2009).  This promoter, the natural promoter of the lacI 
gene in E. coli, has been estimated to make approximately 40 lac repressor dimers per 
promoter (Oehler et al., 1994), hence we have approximately 400-800 dimers per cell.  
Since a fraction of the operator itself is free, and the affinity of repressor for operator is 
high, we can assume that free operator concentration is approximately 0 with respect to 
the total repressor concentration,
[R ]tot≫[O]≈0 (58)
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We then can approximate the total repressor concentration in terms of free 
species and thermodynamic binding constants,
[R ]tot=[R ]+2[RE ]+[RE2 ]+[R*]+2[R*E]+[R*E2]+
[RO]+2[REO]+[RE2O ]+[R*O]+2[R*EO]+[R*E2O ] (59)
Using the assumption of Equation (58), we can say that all of the operator bound 
species of the repressor only marginally contribute to the total, which leads to the 
approximation that,
[R ]tot≈[R ]+2 [RE]+[RE2]+[R*]+2[R*E]+[R*E2 ] (60)
[R ]tot≈[R ]((1+[E]KRE)
2+KRR*(1+[E]KR*E)
2) (61)
Solving for the free repressor concentration,
[R ]≈
[R ]tot
(1+[E]KRE)
2+KRR*(1+[E]KR*E)
2 (62)
We then can substitute Equation (62) into Equation (57)to arrive at,
[O ]
[O]tot
= 1
1+
[R ]tot (KRO (1+[E]KRE)
2+KRR* KR*O(1+[E ]KR*E)
2)
(1+[E]KRE)
2+KRR*(1+[E ]KR*E)
2
(63)
We then define the two following constants,
f=
(1+[E]KRE)
2
(1+[E]KRE)
2+KRR*(1+[E]KR*E)
2 (64)
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s=
(1+[E]KR*E)
2
(1+[E]KRE)
2+KRR*(1+[E]KR*E)
2 (65)
r=[R ]tot KRO (66)
r*=[R ]totKRR*KR*O (67)
[O ]
[O]tot
= 1
1+rf+r*s (68)
The final assumption required is regarding the free effector concentration, [E].  
We assume that free effector concentration does not significantly differ from the total 
effector concentration.  The error in this assumption will decrease as total effector 
concentrations comes to greatly exceed total repressor and total operator 
concentrations, which occurs in our experimental system at full induction.  We then 
approximate Equations (64) and (65),
f≈
(1+[E]tot KRE)
2
(1+[E]tot KRE)
2+KRR*(1+[E ]tot KR*E)
2 (69)
s≈
(1+[E]totKR*E)
2
(1+[E]tot KRE)
2+KRR*(1+[E ]tot KR*E)
2 (70)
Using these assumptions we have finally stated the occupation of the operator 
solely in terms of total repressor and effector concentrations and the thermodynamic 
constants.  We will use Equations (68), (69), and (70) to understand our experimental 
data in this chapter in the frame of the MWC model of allostery.
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The phenotypic properties of the lac genetic switch can also be understood in 
terms of this model.  We define three phenotypic properties: leakiness is the expression 
without effector (basal expression), dynamic range is the difference between maximal 
induction or co-repression and the leakiness, and [E]50 is the concentration of effector 
needed for half maximal induction or co-repression.  
To model leakiness, we set [E]tot = 0 and find,
f=s= 1
1+KRR* (71)
Leakiness(L)= [O]
[O ]tot
([E ]tot=0)=
1
1+ r+r*
1+KRR*
(72)
Similarly we can find dynamic range by measuring the operator occupancy at 
saturating effector concentration ([E]tot → ∞) and subtracting leakiness.  At very large 
effector concentrations, the terms multiplied by [E]tot are much larger than 1, hence,
f ([E]tot→∞)≈ f≈
([E]tot KRE)
2
([E]tot KRE)
2+KRR*([E]totKR*E)
2 =
f ([E]tot→∞)=
KRE
2
KRE
2 +KRR*KR*E
2
(73)
s([E]tot→∞)=
KR*E
2
KRE
2 +KRR* KR*E
2 (74)
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[O ]
[O]tot
([E]tot→∞)=
1
1+
r KRE
2 +r* KR*E
2
KRE
2 +KRR*KR*E
2
(75)
DynamicRange (D)= [O]
[O]tot
([E ]tot→∞)−L=
D= 1
1+
r KRE
2 +r*KR*E
2
KRE
2 +KRR*KR*E
2
 - 1
1+ r+r*
1+KRR*
(76)
Finally, the [E]50 is calculated by solving for the effector concentration at half 
maximal induction which is equal to the leakiness plus half of the dynamic range.  We 
therefore need to solve the following equation for [E]tot,
L+D /2= 1
1+rf+r*s (77)
A solution for [E]50 exists if we assume that the R* conformation has effectively 
very low affinity for DNA (relative to r) and we set r* = 0.  In that case we have,
L+D /2= 1
1+
r (1+[E]50 KRE)
2
(1+[E]50KRE)
2+KRR*(1+[E]50KR*E)
2
(78)
We then define the following constant and use it to re-arrange Equation (78),
1
ϕ=
1
L+D
2
−1
(79)
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1
ϕ=
r(1+[E]50KRE)
2
(1+[E]50KRE)
2+KRR*(1+[E]50 KR*E)
2 (80)
We then multiply the denominators on both sides of the Equation and find,
[E ]50
2 (KRE
2 (ϕr−1)−KRR*KRE
2 )+
[E ]50(2KRE(ϕ r−1)−2KRR* KR*E)+ϕ r−KRR*−1=0 (81)
If we then define the following constants we can easily solve for [E]50,
A=KRE
2 (ϕr−1)−KRR*KRE
2
(82)
B=2KRE(ϕ r−1)−2KRR*KR*E (83)
C=ϕ r−KRR*−1 (84)
[E]50=
−B±√(B2−4AC)
2A (85)
Equation (85) of course only holds when r* = 0 and [E]50 must be real and greater 
than zero.  Now that we have a solution to the MWC model, we can generate mutants of 
the lac repressor and test them using the solution.
3.3 Mutations to the DNA Recognition Domain
The DNA recognition domain of the lac repressor has been shown to be positions 
1, 2 and 6 of the DNA recognition helix which corresponds to positions tyrosine 17 (Y17), 
glutamine 18 (Q18), and arginine 21 (R21).  The recognition helix is aligned within the 
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major groove of DNA and makes specific contacts with positions 4, 5, and 6 of the lac 
DNA operators.  
The recognition domain of the lac repressor has been an important target for 
mutagenesis in order to explore how proteins use helix-turn-helix motifs to specifically 
bind DNA.  First it was shown that specificity could be changed by combining Y17, Q18, 
and R22 mutations with mutations to the operator at positions 4, 5 and 6 (Sartorius et al., 
1989).  Next, a mutant library was created where all three positions were mutated to all 
20 amino acids creating approximately 8000 mutant repressors.  This library was 
screened against the  O1 and Lsym operators with the goal of finding tighter binding 
mutants (Daber & Lewis, 2009).  They found 33 different mutants that repressed 
transcription through O1, however only with mutations to positions 17 and 18; any 
mutation to position 22 failed to repress.  Interestingly, only one mutant, Q18M, was 
found to bind O1 tighter than wild type repressor.  Finally, they found a relationship 
between the repression of these mutants and dynamic range; tighter binding could lead 
to less leakiness of expression but it also decreased the maximal inducibility.  This led to 
the hypothesis that DNA specificity mutants primarily change the lac repressor-DNA 
operator affinity (KRO).
We sought to test this hypothesis in vivo by globally modeling the transcriptional 
regulation phenotype of dimeric lac repressor with and without mutations to the DNA 
specificity residues.  
Three point mutations were selected for analysis: Y17I which is leakier in 
regulating O1 than wild type, Q18A which is also leakier, and Q18M which is less leaky 
in regulating O1.  All three point mutations were separately cloned using inverse PCR 
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mutagenesis into the pLacI plasmid which constitutively expresses dimeric lac repressor 
(11 C-terminal residues are truncated) from the natural constitutive promoter of the lacI 
gene from E. coli.  
The wild type repressor and three point mutants were tested using the 
prokaryotic GFP regulation assay (Figure 3.2).  
Figure 3.2. Regulation of GFP by headpiece mutants of the lac repressor and O1.  
Positions 17 and 18 both reside within the recognition helix of the N-terminal headpiece 
of the lac repressor and are known to be important for specificity in DNA binding.  Point 
mutations Y17I and Q18A both are leakier (higher expression without IPTG) than wild 
type lac repressor whereas Q18M is less leaky.  The dynamic range is decreased in all 
mutants with respect to wild type lac repressor.
Figure 3.2 shows that all three point mutants can still regulate GFP expression 
using the O1 operator.  Y17I is the leakiest mutant (~50% leakiness) and it essentially 
induces to constitutive expression of the promoter at [IPTG] ≥ 0.1 mM.  Q18A is 
marginally less leaky than Y17I (~25% leakiness) and also reaches constitutive levels of 
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expression upon induction with [IPTG] ≥ 0.1 mM.  Q18M is approximately half as leaky 
(~2% leakiness) than wild type (~4% leakiness) and its maximal induction is severely 
limited.
It is of note that the dynamic range of the genetic switch appears to be limited by 
the upper and lower bounds.  We can model this behavior using our MWC model of the 
lac genetic switch.  Figure 3.3 shows simulated lac genetic switch data where only the 
affinity for the R state of DNA is changed (r = [R]totKRO is altered).  Figure 3.3.B clearly 
demonstrates the limiting nature of the upper and lower bounds on dynamic range; a 
median value of r produces a minimally leaky switch that maximally induces.  This is 
precisely the relationship we see in the experimental data of Figure 3.2 where the only 
mutation is to the specificity region of the N-terminal DNA binding domain.  We 
hypothesize therefore that point mutations to this regions specifically change the affinity 
of repressor for DNA (KRO and KR*O).  It of course is possible  that the point mutations 
change the total concentration of repressor ([R]tot), however given the current experiment 
we have no means of measuring the repressor concentration.  This is a limitation of this 
study and it will be addressed later in this chapter.
We globally modeled the three headpiece mutants of the lac repressor dimer 
along with the wild type by assuming the only difference could be in the KRO 
thermodynamic parameter.  We therefore performed regression between simulated 
curves and experimental curves looking for thermodynamic parameters that fit the data.  
For the four data sets there are 11 fit parameters (rWT, rY17I, rQ18A, rQ18M, r*WT, r*Y17I, r*Q18A, 
r*Q18M, KRE, KR*E, KRR*) however it was previously found that for wild type dimeric lac 
repressor KR*O is effectively zero (Daber et al., 2009) so we will set all of the r* 
parameters to zero and fit the remaining 7 parameters.
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Figure 3.3.  Simulated lac genetic switch data as a function of changing r.  The 
following thermodynamic parameters were used: r* = 0, KRE = 4 mM-1, KR*E = 60 mM-1, 
KRR* = 2.  (A) Simulated induction curves with an effector shows that lower r (lower Rtot 
and/or KRO) makes a leakier switch that more fully induces, whereas higher r leads to 
tighter and tighter switches that cannot fully turn on.  (B) The dynamic range shows that 
a happy medium exists when altering r where the switch is minimally leaky and 
maximally inducible.
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There is another complication to the modeling that also needed to be addressed 
before thermodynamic parameters could be measured.  Figure 3.4 shows the effect of 
altering KRR* on the induction of the genetic switch.
Figure 3.4.  Simulated lac genetic switch data as a function of changing r.  The 
following thermodynamic parameters were used: r=50, r* = 0, KRE = 4 mM-1, KR*E = 60 
mM-1.  Changes to KRR* mirror changes to r because it effectively makes more or less of 
the high affinity conformation, R, of the protein.  Since the r parameter also contains the 
repressor concentration, these two parameters become linked.
Changes to KRR* on the induction curve of the lac genetic switch look very, very 
similar to changes to KRO.  From the model alone, it is unclear whether the headpiece 
mutants are altering DNA affinity or the conformational equilibrium.  From a structural 
perspective, the location of the point mutations in the recognition domain of the DNA 
binding domain strongly indicates the former, however it would be better if we could 
eliminate the possibility that KRR* is changing.  Analyzing the limits of the MWC 
equilibrium actually provides a mechanism to isolate KRR* from r, and hence investigate 
which may be changing for this data.  We start by re-defining Equation (75),
72
y2=
[O ]
[O]tot
([E]tot→∞)=
1
1+
rKRE
2 +r* KR*E
2
KRE
2 +KRR*KR*E
2
(86)
Looking at the formula for leakiness, Equation (72), we can isolate r in both 
equations pretty easily (assuming r* = 0),
1
y2
−1=
r KRE
2
KRE
2 +KRR*KR*E
2 (87)
1
L
−1= r
1+KRR* (88)
The ratio of Equations (87) and (88) then eliminates the r parameter and gives us 
an experimental measure that isolates KRR*,
z=
1
y2
−1
1
L
−1
=
KRE
2 +KRR* KRE
2
KRE
2 +KRR*KR*E
2 (89)
Figure 3.3.A and Figure 3.4 show the same resultant phenotype from changing r 
and KRR* separately, however Figure 3.5 shows a large difference in the z parameter.  
Obviously, there is no effect when altering r, as z is independent of r.  There is however a 
significant decrease in z when you increase KRR*.  
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Figure 3.5. Calculation for the z parameter as a function of either r or Krr*.  
Thermodynamic parameter values for the blue bars (where r changes) were: r* = 0, KRE 
= 4 mM-1, KR*E = 60 mM-1, KRR* = 2.  Since z is independent of r, there is no change.  The 
thermodynamic parameter values for the red bars (where KRR* changes) were:  r=50, r* = 
0, KRE = 4 mM-1, KR*E = 60 mM-1.  As KRR* increases (more repressor in the R* 
conformation) the z parameter decreases.
Figure 3.6 shows the z values for wild type and the three headpiece mutants.  
Y17I and Q18A are approximately unchanged from wild type, while Q18M has a much 
higher value.  The z parameter calculation is especially sensitive to small changes in 
small numbers due to the inversion, hence small changes in the leakiness measurement 
will have large effects on the experimental calculation of z.  The question is then: is the 
difference between wild type and Q18M z due to experimental error in measuring small 
signals or does Q18M alter the KRR* parameter.  We can address this question by fitting 
the Q18M data set while changing either r or KRR*, calculating z and seeing if the 
magnitude of the z change is comparable with experiment.
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Figure 3.6. Calculated z values from wild type and the three headpiece mutants of 
the lac represor.  Y17I and Q18A have approximately the same z value as WT, 
indicating the altered phenotype is a result of changing the r parameter.  Q18M has a 
higher value which could be due to changes in KRR*.
The final complication in fitting arises from the non-uniqueness of solution due to 
the compensatory nature of r and KRR*.  We will bootstrap our value of r based upon the 
findings of Daber, Sharp, and Lewis who determined that r = 150 +- 50 for a hetero-
dimeric form of the lac repressor (Daber et al., 2009).  Their finding was based upon 
fitting z parameters for their experimental data.
We then globally fit the four experimental curves given rWT = 150 fitting for three 
parameters common to all four experiments (KRR*, KRE, and KR*E) and with one 
independent parameter for each of the headpiece curves (r Y17I, rQ18A, and rQ18M). Table 3.2 
shows the fit parameters.  We then refit the Q18M looking for altered KRR* given: r=150, 
KRE = 60 mM-1, KR*E = 500 mM-1.  This fit is given in Table 3.3.
75
Construct r KRR* KRE (mM-1) KR*E (mM-1) Leakiness
Dynamic 
Range
log10 [E]50 
(mM)
Wild Type 150 ± 50 5.8 ± 0.07 60 ± 0.2 500 ± 5 0.044 0.7 -1.94
Y17I 8.6 ± 0.07 5.8 ± 0.07 60 ± 0.2 500 ± 5 0.44 0.5 -2.66
Q18A 18.0 ± 0.2 5.8 ± 0.07 60 ± 0.2 500 ± 5 0.28 0.7 -2.49
Q18M 1404 ± 1 5.8 ± 0.07 60 ± 0.2 500 ± 5 0.005 0.2 -1.56
Table 3.2.  Fit values where only the r parameter was altered between the 4 different 
experimental curves. 
Construct r KRR* KRE (mM-1) KR*E (mM-1) Leakiness
Dynamic 
Range
log10 [E]50 
(mM)
Wild Type 150 ± 50 5.8 ± 0.07 60 ± 0.2 500 ± 5 0.044 0.7 -1.94
Q18M 150 ± 50 0.65 ± 0.1 60 ± 0.2 500 ± 5 0.005 0.2 -1.56
Table 3.3.  Fit values where Q18M were re-fit looking for changes in KRR* instead of 
changes in r.
We then calculated z and compared to experimentally calculated z to determine if 
Q18M primarily changes r or KRR*.  Table 3.4 shows the results and the difference 
between theoretical and experimental z values.
Construct z Predicted z Experimental |Δz|/z
Wild Type 0.017 ± 0.0003 0.014 ± 0.003 0.15
Y17I 0.017 ± 0.0003 0.016 ± 0.004 0.02
Q18A 0.017 ± 0.0003 0.013 ± 0.002 0.25
Q18M 
(Table 3.2) 0.017 ± 0.0003 0.058 ± 0.008 2.45
Q18M
(Table 3.3) 0.040 ±  0.007 0.058 ± 0.008 0.47
Table 3.4.  Predicted z values versus experimental values of z.  The last column 
shows the difference relative experimental z where lower values are better.
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The normalized difference values in Table 3.4 show that Y17I and Q18A 
phenotypes are well explained by only changing the r parameter whereas the Q18M 
mutant is best explained by altering the KRR* parameter.
It would be expected that the Y17I and Q18A mutations primarily alter KRO due to 
their location within the DNA recognition helix of the lac repressor, however these 
mutations could also alter the total concentration of the repressor, [R]tot.  It is unclear how 
Q18M could alter the conformational equilibrium parameter but we also do not have a 
good structural picture of the N-terminal domain of the lac repressor in the effector 
bound conformation.  Crystal structures do not show density (likely indicating mobility of 
this region) for the N-terminal domain when IPTG is bound in the effector binding pocket. 
Q18M makes the conformational equilibrium go from greater than 1 (favoring the low 
operator DNA affinity conformation R*) to less than 1 (favoring the R conformation).  This 
mutation takes a large polar residue (glutamine) and changes it to a still large, more 
apolar residue (methionine).  Perhaps the solvation of residue 18 between the R and R* 
states plays a significant role in the very close energetic balance between these two 
states, significant enough to alter the conformational equilibrium.  Central to this idea, 
however, is that the methionine can still make good specific contacts within the major 
groove of DNA.
Figure 3.7 shows the experimental data with the best fit MWC curves for wild 
type lac repressor and the three head piece mutants.
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Figure 3.7. Best fit values for wild type, dimeric lac repressor and three point 
mutations to the DNA recognition domain.  The MWC model is very accurate at re-
producing the experimental curves.
3.4 Mutations to the Effector Binding Pocket
The effector binding pocket of the lac repressor includes a large number of 
residues that both make specific contacts with the repressor and which are important for 
making secondary, stabilizing contacts.  The residues arginine 197 (R197), asparagine 
246 (N246), and aspartic acid 274 (D274) form hydrogen bonds to the O2 and O3 
hydroxyls of sugar effector molecules.  As these are essential for effector binding, they 
are poor candidates for mutation if we are trying to change the thermodynamic binding 
parameters without completely destroying binding.  Much like our approach in the DNA 
binding domain, the residues that are responsible for specificity in effector binding were 
instead targeted.  Effectors are known that are inducers, co-repressors and neutral and 
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the difference between the molecules is on the substituent groups on the first and sixth 
carbons of the sugar ring (Barkley, Riggs, Jobe, & Bourgeois, 1975).  These substituent 
groups make contacts with residues 79, 148, 161, 291, 293 and 296.  These residues 
were targeted by making 6 libraries where each site was individually mutated to all 20 
amino acids (120 mutants screened) and their in vivo GFP regulatory phenotype was 
recorded (Daber et al., 2011).
Here we analyze a subset of these mutations that have phenotypes which are of 
particular interest.  Again, we would like to globally fit the GFP regulation of these 
mutants with the goal of linking effector pocket point mutations to changes in the effector 
binding parameters (KRE and KR*E).  It is also possible that point mutations in the effector 
binding pocket could alter the conformational equilibrium (KRR*) (Figure 3.4). The two 
effector binding parameters can change in two significant ways: first, the magnitudes 
could change (stronger or weaker binding) and second, the relative magnitudes between 
the two affinities could change.  Here we define the relative magnitude as,
X=
KR*E
KRE (90)
We can then use the MWC model to predict how these two changes alter the 
regulatory phenotype.  Changes in the magnitudes of the binding affinities cause either a 
left or right shift in the curve, which is reflected as a change to the half maximal effector 
concentration, [E]50 (Figure 3.8).  Lower magnitudes of KRE and KR*E increase [E]50 (more 
effector is needed to bind) whereas higher affinities decrease [E]50 (less effector is 
needed).  Alternatively, changing the ratio between the two effector binding affinities 
changes the dynamic range of the switch (Figure 3.9).  Larger X makes a more inducible 
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switch because more repressor goes to the R* conformation upon addition of effector.  
The effector binding affinities, predictably, do not change the leakiness.  Any changes in 
leakiness must be due to either changes in r (likely due to changes in [R]tot) or KRR*.
Figure 3.8. Effect of changing the magnitudes of the effector affinity on MWC gene 
regulation.  Leakiness and dynamic range are unchanged.  There is however a 
significant effect on the midpoint of maximal induction, [E]50. Higher affinity to effector 
decreases the [E]50, and vice versa.
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Figure 3.9.  Effect of changing the relative magnitudes of the effector affinities (X) 
on MWC gene regulation.  Leakiness is unchanged.  There is however a significant 
increase in dynamic range as X increases due to effector more efficiently moving lac 
repressor to the R* conformation.  [E]50 is marginally affected by changing the ratio X.
We then want to select effector pocket mutants that change the gene regulatory 
phenotype in various ways with the goal of globally linking these phenotypic changes to 
the underlying thermodynamic parameters.  Our hypothesis is that we can model every 
effector pocket mutant phenotype only through changes to KRE, KR*E, and KRR*.  
Table 3.5 shows the selected point mutants along with an effector that gives rise 
to a particular phenotype.  This list includes many interesting phenotypes: tighter and 
weaker IPTG binding, more ideal on-off genetic switches, and even inverted switches 
which go from on to off with a dynamic range comparable to wild type lac repressor. 
Three mutations to phenylalanine 161 (F161) were found to have a more ideal 
on-off behavior (Figure 3.10).  All three mutants are less leaky than wild type and induce 
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to a higher level with IPTG.  We hypothesize that this region alters both the 
conformational equilibrium and the effector binding.  
Mutation Effector Phenotype
Wild Type IPTG Canonical inducing
Wild Type ONPG Canonical co-repressing
L148D ONPG Inverted genetic switch
L148W ONPG Inverted genetic switch
F161N IPTG Better on-off switch
F161S ONPG Weakly inducing with canonical co-repressor
F161T IPTG Better on-off switch
F161W IPTG Better on-off switch
Q291I IPTG Decreased leakiness
Q291K IPTG Weaker IPTG binding
Q291M IPTG Stronger IPTG binding
Q291R IPTG Non-responsive to IPTG
L296W IPTG Less leaky but weaker IPTG binding
L296W ONPG Weakly inducing with canonical co-repressor
Table 3.5.  Point mutations to the effector binding pocket of the lac repressor and their 
phenotypic response with specific effectors. 
Four point mutations to glutamine 291 (Q291) primarily change maximal 
expression (higher for Q291M and much, much lower for Q291R) or the mid-point of 
induction (lower effector needed for Q291M and higher effector needed for both Q291I 
and Q291K) (Figure 3.11).  We hypothesize that this region primarily alters the effector 
binding affinities in both magnitude and in relative affinity between the two 
conformational states of the lac repressor.
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Figure 3.10. IPTG induction profiles of lac repressor dimer and point mutants in 
the effector binding domain.  Mutations to F161 appear to create more ideal 
repressors.  L296W is still inducible with IPTG but at a much, much lower affinity than 
wild type.
Two point mutations to leucine 148 (L148) have the the notable phenotype of 
being inverted switches with the effector ONPG (Figure 3.12).  They exhibit much leakier 
expression and co-repress very effectively.  We hypothesize that these mutations alter 
the conformational equilibrium while ONPG binding remains similar to wild type lac 
repressor which normally co-represses with ONPG.  Alternately, two point mutations, 
F161S and L296W, are seen to induce with ONPG.  Of particular interest is L296W 
which also induces with IPTG (Figure 3.10).  Somehow, wild type is co-repressable with 
ONPG and inducible with IPTG, whereas L296W is inducible with both.  We hypothesize 
that these two point mutations alter the relative effector binding affinities of the two 
conformational states of the lac repressor.
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Figure 3.11. IPTG induction profiles of lac repressor dimer and point mutants in 
the effector binding domain.  Mutations to Q291 alter the affinity of the lac repressor 
for effector, both higher and lower and between the two conformations.
Figure 3.12. ONPG induction and co-repression profiles of lac repressor dimer and 
point mutants in the effector binding domain.  Mutations to L148 appear to create 
inverted repressors.  F161S and L296W on the other hand change ONPG from a co-
repressor to an inducer.
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We globally fit the effector pocket mutants along with wild type dimeric lac 
repressor induction and co-repression curves.  We assumed that total repressor 
concentration is the same for every mutant and that operator DNA affinity is unchanged, 
hence we used rWT = 150 for every pocket mutant.  The  same thermodynamic 
parameters from the headpiece fitting were used for wild type with IPTG.  Table 3.6 gives 
the final fit parameters.
Construct Effector r KRR* KRE (mM-1) KR*E (mM-1) Leakiness
Dynamic 
Range
Log10 [E]50 
(mM) 
Wild Type IPTG 150 ± 50 5.8 ± 0.07 60 ± 0.2 500 ± 5 0.044 0.7 -1.94
Wild Type ONPG 150 ± 50 5.8 ± 0.07 13 ± 1.5 1.3 ± 0.9 0.044 0.7 -1.94
L148D ONPG 150 ± 50 525 ± 7 2.4 ± 0.2
0.46 ± 
0.05 0.78 -0.7 -0.012
L148W ONPG 150 ± 50 325 ± 6 18 ± 0.7 3.2 ± 0.2 0.69 -0.6 -1.13
F161N IPTG 150 ± 50
0.98 ± 
0.34 23 ± 0.8 670 ± 127 0.013 0.8 -1.64
F161S ONPG 150 ± 50
26.5 ± 
0.01 0.25 ± 0.1
0.54 ± 
0.02 0.16 0.3 0.57
F161T IPTG 150 ± 50 2.7 ± 1.4 82 ± 6.5
1415 ± 
293 0.024 0.8 -2.21
F161W IPTG 150 ± 50
0.47 ± 
0.23 18 ± 9 615 ±307 0.01 0.8 -1.42
Q291I IPTG 150 ± 50
0.07 ± 
0.02 26 ± 2.8 1889 ±294 0.007 0.7 -1.46
Q291K IPTG 150 ± 50 5.9 ± 0.04 11 ± 0.3 86 ± 5 0.044 0.7 -1.18
Q291M IPTG 150 ± 50 8.9 ± 0.6 44 ± 3.1 515 ± 51 0.062 0.8 -2.07
Q291R IPTG 150 ± 50
1.33 ± 
0.03 251 ± 19 296 ± 25 0.015 0.0 -2.36
L296W IPTG 150 ± 50
0.04 ± 
0.01 3.8 ± 0.1 409 ± 38 0.007 0.73 -0.66
L296W ONPG 150 ± 50
0.04 ± 
0.01 0.4 ± 0.01 17.5 ± 1.7 0.007 0.36 0.65
Table 3.6.  Globally fit thermodynamic parameters from fitting wild type dimeric lac 
repressor and effector pocket mutants to the MWC model of allostery.
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Effector pocket point mutants alter leakiness through changes in conformational 
equilibrium 
The assumption that effector pocket mutations do not alter DNA binding affinity 
means the conformational equilibrium must change if leakiness differs from wild type.  
This set of mutants shows a wide variety of altered leakiness. L148D and L148W are 
much, much leakier with ~85% and ~75% basal expression, respectively.  This requires 
nearly 100 fold and 55 fold increases in KRR* to push more of the repressor in the low 
operator DNA affinity conformation, R*.  Conversely Q291I and L296W are extremely 
non-leaky with ~1% and ~0.5% basal expression, respectively.  These mutants push the 
conformational equilibrium to ~80 and ~150 fold less than wild type.  Equation (8) links 
conformational equilibrium and energy changes which we can re-state for the lac 
repressor conformational equilibrium,
KRR*=exp (
−ΔG
kB T
) (91)
Experiments were carried out at 37C, so we can measure the energy difference 
between the two states,
kBT=1.987e
−3 kcal
molK
310 K=0.616 kcal
mol (92)
ΔG=−kB T ln(KRR*) (93)
Table 3.7 gives energy differences for all of the effector pocket mutants and also 
double difference measurements from wild type where,
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ΔΔG=ΔGmut−ΔGWT (94)
Construct Krr* ΔG ΔΔG
WT 5.8 ± 0.07 -1.08 ± 0.01
L148D 525 ± 7 -3.86 ± 0.01 -2.78 ± 0.01
L148W 325 ± 6 -3.56 ± 0.01 -2.48 ± 0.01
F161N 0.98 ± 0.34 -0.01 ± 0.21 1.1 ± 19
F161S 26.5 ± 0.01 -2.02 ± 0.002 -0.94 ± 0.0001
F161T 2.7 ± 1.4 -0.61 ± 0.32 0.47 ± 0.25
F161W 0.47 ± 0.23 0.47 ± 0.30 1.55 ± 1
Q291I 0.07 ± 0.02 1.64 ± 0.18 2.72 ± 0.29
Q291K 5.9 ± 0.04 -1.09 ± 0.01 -0.01 ± 4x10-5
Q291M 8.9 ± 0.6 -1.35 ± 0.04 -0.26 ± 0.01
Q291R 1.33 ± 0.03 -0.18 ± 0.01 0.91 ± 0.07
L296W 0.04 ± 0.01 1.98 ± 0.15 3.07 ± 0.24
Table 3.7. Calculated differences in energy between the two structural conformations 
(ΔG) in kcal/mol based upon the conformational equilibrium parameter, KRR*.  Double 
energy differences are also given which is the difference from the wild type (WT) value 
(ΔΔG) in kcal/mol. 
Wild type lac repressor has an energy difference between its two conformational 
space of only about 1 kcal/mol, which is small.  It has however been noted that for 
simple two state folding proteins the entire folding energy is only on the order of 1-10 
kcal/mol due to enthalpic and entropic concerns (Muñoz & Eaton, 1999). The energy 
difference between R and R* of 1 kcal/mol is therefore very significant.  This difference is 
made more prominent in the aforementioned point mutations: L148D and L148W which 
stabilize the R* conformation by 2-3 kcal/mol relative to R and Q291I and L296W which 
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stabilize the R conformation by 2-3 kcal/mol relative to R*.  Three of these mutations are 
apolar to polar residues and the third is polar to apolar so none is conservative and each 
could potentially play a significant role in the stability of each conformation.  Interestingly, 
the only mutation that does not appear to alter the conformational equilibrium is Q291K 
which are both polar and of similar size but lysine is positively charged.  This may be a 
close to neutral mutation with respect to conformation but Q291K has a drastically lower 
affinity for IPTG.
In general, the energy scale of 0-3 kcal/mol due to point mutation is not 
unreasonable given a range of 1-10 kcal/mol folding energy.  It is plausibile that these 
mutations are indeed altering the conformational equilibrium.  
Effector pocket point mutants alter [E]50 through a subtle interplay between effector 
affinity and conformational equilibrium
Several of the mutants we tested have altered affinity for their effectors.  This 
altered affinity takes two forms: changes in amount of effector needed to induce or co-
repress ([E]50) and changes in maximal expression which alters the dynamic range.
First, we look at mutants that have altered [E]50.  Only two mutants had higher 
[E]50 for IPTG than wild type repressor: F161T and Q291M.  Interestingly, these two 
mutants show the flexibility of the allosteric approach in altering phenotype.  Normally to 
improve binding a more perfect pocket must be developed.  F161T has essentially the 
same IPTG affinity for the R state as wild type (82 ± 6.5 mM-1 and 60 ± 0.2 mM-1, 
respectively) but has a 3-fold higher affinity in the R* state (1415 ± 293 mM-1 and 500 ± 5 
mM-1, respectively).  F161T does indeed form a better pocket for only one of the lac 
repressor conformations.  This however is not the only way to improve [E]50 in an 
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allosteric system.  Q291M has approximately the same IPTG affinity in the R* state as 
wild type (515 ± 51 mM-1 and 500 ± 5 mM-1, respectively) but actually impairs binding of 
the R conformation to IPTG by nearly a third (44 ± 6.5 mM-1 and 60 ± 0.2 mM-1, 
respectively).  Nature does not always need to make a more perfect pocket, it could 
simply break the right part while leaving the rest in tact.  Central to both mutations 
however is conformational equilibrium greater than 1 which means the lac repressor 
mutants still favor the R* state.  Both mutants have increased the inducibility factor X 
(Equation (90)) and the protein prefers the low operator DNA affinity state.  The net 
effect is less IPTG is needed to do the same job: induce the genetic switch.
Most of the mutants had lowered [E]50. The mutation F161W is a good counter-
example to Q291M.  Much like Q291M, the R affinity for IPTG is reduced versus wild 
type (18 ± 9 mM-1 and 60 ± 0.2 mM-1, respectively) while maintaining R* affinity relative 
to wild type (615 ± 307 mM-1 and 500 ± 5 mM-1, respectively). On the surface, F161W is 
an even better example with an even higher inducibility factor X, however the [E]50 is 
much lower than both Q291M and wild type.  This is the result of the point mutation 
switching the conformational equilibrium towards the R state (0.47 ± 0.23).  Repressor is 
too favorable to the R state and despite the better X it still takes more IPTG to induce.  
F161N follows the same route as F161W; higher X cannot compensate for a lower 
conformational equilibrium so [E]50 is lower.  Q291I provides the same counter-example 
for F161T.  It drastically improves R* binding of IPTG nearly four-fold but it comes at the 
cost of a conformational equilibrium vastly in favor of the R conformation (0.07 ± 0.02). 
Q291K maintains a positive conformational equilibrium, however the affinity for 
effector in the R* state is decreased over 5-fold.  L296W simply is worse across the 
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board; both IPTG affinities are lower and conformational equilibrium greatly favors the R 
state. Both mutants have a lower [E]50 than wild type.
The final mutant of interest is Q291R.  This mutant very weakly induces and does 
so because the inducibility factor X is nearly 1.  Q291R strengthens the ability to bind 
ITPG in the R conformation while weakening binding to R* until they are approximately 
the same.  The repressor binds effector but it fails to push the effective equilibrium 
between the two conformations; they both just bind the same amount of IPTG and DNA 
occupancy is unaffected.  
Effector pocket point mutants alter the dynamic range by changing the relative effector 
affinities (X) and leakiness
Dynamic range is of course tied intimately to leakiness which has been 
established to be a function of conformational equilibrium.  We will instead focus on how 
effector pocket mutants can maximize dynamic range by maximizing the relative effector 
affinity, X.  
Q291R of course is the best example of a flattened dynamic range.  X has been 
brought nearly to unity resulting in the collapse of the dynamic range of the switch.
Alternately, several mutants excel at separating the two conformations affinities 
for effector.  L296W has the highest X for IPTG with a greater than 100-fold preference 
for the R* state.  Despite the greatly decreased leakiness of this mutant it can induce the 
nearly wild type levels.  The cost of course is paid in [E]50 as discussed previously.  
Q291I follows nearly an identical path but doesn't have quite as poor an [E]50.
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F161N, F161T, F161W and Q291M all have dynamic ranges that exceed wild 
type lac repressor and do so by having larger X.  Only F161T achieves the necessary 
balance of effector binding and conformational equilibrium to be less leaky, have a larger 
dynamic range and do so with less IPTG (lower [E]50) than wild type.  F161T is a simply 
a more ideal on-off genetic switch than wild type dimeric lac repressor.  
In the case of co-repression, a decreased X is desirable.  L148D and L148W 
both bind ONPG weaker than wild type lac repressor however they maintain 
approximately the same co-repressing factor X.  Given the large increase in the 
conformational equilibrium of both L148D and L148W such that the repressor vastly 
favors the R* state, the very low ratio X suddenly becomes much more relevant.  
Leakiness is now very large (~80% and ~70%) and so the dynamic range for co-
repression with ONPG goes from practically non-existant for wild type to negative 60-
70% for the two mutants.  
3.5 Relative Lac Repressor Concentrations in Prokaryotes
One key assumption was made throughout this chapter. Namely, that repressor 
concentration does not change with point mutation.  It proved non-trivial to reproducibly 
measure the very small amount of lac repressor produced by the cells and a repressor 
tagging strategy was developed to enhance the signal.  The fluorescent protein mCherry 
was fused to the C-terminus of the lac repressor to allow for direct measurement of the 
lac repressor in living cells.
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Figure 3.13. Verifying that Lac-mCherry functions in vivo.  The assay conditions 
have changed (EPB229 cells in MOPS minimal media) and a C-terminal tag was added, 
however the induction profile with IPTG is relatively unchanged.  In particular, Lac-
mCherry is slightly less leaky and does not induce quite as high as previously.  It is close 
enough however to compare between mutants to see if overall levels of repressor have 
changed upon point mutation.
The lac repressor-mCherry fusion protein (hereafter called Lac-mCherry) was 
cloned into the pLacI plasmid with an 11-base pair linker to make a construct that has 
been previously shown to be functional (Lau et al., 2004).  This plasmid was first used in 
the previous assay with DH5α cells double transformed with reporter and repressor 
plasmids grown in LB media.  Unfortunately, no mCherry signal could be measured as 
the media contributed considerable autofluorescence in that excitation/emission range.  
We found MOPS minimal media did not have autofluorescence in the mCherry region.   
DH5α cells however did not grow in MOPS minimal media supplemented with glucose 
presumably due to significant amount of alterations to the bacteria, many of which impair 
infectivity and growth.  We did find that a strain, EPB229, developed from MG1655 cells  
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with the natural lac operon deleted, was capable of growing in the MOPS minimal media 
with glucose.  We therefore altered the assay to EPB229 cells, double transformed with 
Lac-mCherry repressor and a reporter plasmid, grown in MOPS minimal media with 
glucose.
We first verified that the IPTG induction of wild type lac repressor was the same 
as Lac-mCherry.  Figure 3.13 shows Lac-mCherry does function correctly in E. coli but it 
has altered leakiness and maximal expression compared to wild type dimeric lac 
repressor in the original assay.  The addition of the weakly dimerizing mCherry could 
potentially change the conformational equilibrium and even the overall level of repressor 
in the cell.  The fact is however that Lac-mCherry is functional and can be used to 
measure differences in expression upon point mutation.
We next made point mutations to Lac-mCherry and measured both GFP 
regulation and mCherry signal in vivo.  We saw no significant deviations from expected 
GFP regulatory phenotype due to the addition of the mCherry tag.  Figure 3.14 shows 
the relative signal from mCherry normalized to wild type Lac-mCherry.  All of the tested 
mutants have expression slightly higher than wild type repressor, however all the 
changes are less than two-fold.  As the phenotypic changes were much more significant 
than this, we can safely say that our initial assumption was correct: [R]tot is relatively 
unchanged by point mutation.  The fitting and conclusions regarding the r parameter are 
then valid.
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Figure 3.14. Relative expression of Lac-mCherry and point mutants.  All of the 
mutants tested had expressions that varied less than two-fold from wild type repressor.  
This verifies the initial assumption that [R]tot is unchanged upon point mutation.  
3.5 Discussion
We sought to link point mutations in structurally interesting regions of the lac 
repressor to specific changes in thermodynamic parameters.  We were able to definitely 
link headpiece mutants to repressor-operator affinity and effector pocket mutants to 
repressor-effector affinities, however both stories are complicated by changes to the 
conformational equilibrium between the R and R* state.
We found mutations to the specificity domain of the DNA binding region can have 
phenotypes explained by changes to the r parameter of our MWC model solution.  
Furthermore, we found that the in vivo concentration of lac repressor does not change 
enough upon point mutation, hence changes to r must be reflected in changes to the 
affinity of repressor for operator DNA (KRO).  One point mutation, Q18M, is potentially 
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better explained by altering the conformational equilibrium, KRR*.  We also cannot rule out 
this mutation changing both KRR* and KRO with the net effect of a less leaky repressor.  
Any experimental measurement of Q18M – operator DNA affinity will be an effective 
affinity that is a combination of the entire MWC equilibrium and hence it may still not be 
possible to discern changes between KRO and KRR*.  Our approach where we use 
normalized expression at saturating effector to separate the two thermodynamic 
parameters may be the only way to accurately separate these two parameters.  It would 
not be unreasonable however that the conformational equilibrium is capable of being 
altered by this point mutation as the balance between the two states appears to be 
incredibly malleable as evidenced by the effector pocket mutant data.
Mutants in the effector pocket were incredibly effective in creating phenotypically 
interesting genetic switches through single point mutations.  Nearly every point mutant 
changed the leakiness of the switch. Repressor-operator affinity should be unchanged 
and the overall concentration of the lac repressor does not greatly change, hence the r 
parameter is the same same for effector pocket mutants.  Leakiness changes must then 
be reflected in changes of the conformational equilibrium, KRR*.  The conformational 
equilibrium was able to change in both directions (in favor of either the R or R* 
conformation) by up to 3 kcal/mol of energy upon single point mutations which provides 
an astounding ability to increase leakiness up to 70% or lowers it nearly 7-fold.  
Furthermore, effector pocket point mutations were able to both increase and decrease 
the magnitudes of the repressor-effector affinities for both conformations.  More 
importantly, the affinity changes did not always mirror each other, as in both don't 
increase together or decrease together.  This means the ratio of the two affinities, X, can 
increase or decrease allowing for bold changes in the dynamic range of the switch; 
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higher dynamic range than wild type and even flipped dynamic range creating induction 
from co-repression.  Of note was the precise interplay between the three thermodynamic 
parameters KRE, KR*E, and KRR*.  Only one mutant, F161T, had all three parameters move 
in the correct directions to make a switch with improvements in all three phenotypic 
parameters necessary for making a more ideal on-off genetic switch.  
We showed a link between structural regions of the lac repressor and the 
thermodynamic binding parameters associated with these regions.  Furthermore, we 
showed that the conformational equilibrium of the dimeric lac repressor is balanced on a 
razors edge and is easily tipped one way or the other through point mutation.  The 
interplay between binding affinity and conformational equilibrium leads to a wide array of 
genetic switches that are potentially relevant given the right gene that needs regulation.
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Chapter 4: 
Linking In Vivo to In Vitro
4.1 Introduction
In Chapter 3 we sought to link the in vivo functioning of the lac genetic switch to 
the thermodynamic parameters of the MWC model by specifically perturbing the switch 
in key structural locations and looking for corresponding changes in the model 
parameters.  This approach worked very well, linking DNA affinity to the DNA binding 
domain and effector affinity to the effector pocket and finally showing that the 
conformational equilibrium is malleable.
A study by Poelwijk, et al. looked for unique phenotypes through random 
mutagenesis of the lac repressor (Poelwijk, de Vos, & Tans, 2011). Mutants were 
identified which exhibited an inverted repression behavior; a phenotype also found by in 
Chapter 3 by mutating the effector binding domain.  Interestingly, Poelwijk’s mutations 
were in regions physically distinct from either the DNA or effector binding domains. One 
potential explanation is that the mutations destabilize the folded form of the repressor, 
altering the conformational landscape. Mutagenesis of the repressor can result in more 
than just predictable changes of thermodynamic binding constants.
Central to all of these studies is the use of in vivo data to understand the 
behavior of genetic switches.  It has been pointed out that a lack of corroborating in vitro 
evidence prevents the identification of other processes which may significantly play into 
the equilibrium, such as non-specific DNA binding or effector uptake (Tungtur, Skinner, 
Zhan, Swint-Kruse, & Beckett, 2011).  They attempted to measure the thermodynamic 
binding of a LacI/GalR hybrid repressor both in vitro and in vivo.  Notably, a DNA pull 
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down assay was used to quantify the in vivo concentration of their hybrid repressor.  
Unfortunately, they were unable to rectify a greater than 25-fold difference between their 
two data sets.  This indicates that they are missing a significant contributor to the genetic 
switch by only analyzing in vivo data.
Here we sought to overcome the limitations of past studies three ways: 1.) 
measure the in vivo concentration of the lac repressor, 2.) measure the in vitro 
transcription of purified lac genetic switch, and 3.) use an assumption free solution to the 
MWC equilibrium to model both in vitro and in vivo data.
We were able to measure lac repressor concentration in vivo and use in vitro 
transcription to assess the purified lac genetic switch.  Furthermore, we found excellent 
agreement between in vitro and in vivo data when molecular crowding was taken into 
consideration.  We do however find that the repressor-DNA affinity is much lower than 
has previously been measured. Additional concerns, such as effector uptake and non-
specific DNA binding do not appear to play significant roles.
4.2 Measuring the In Vivo Concentration of the Lac Repressor
We sought a method where we could simultaneously measure repressor 
concentration and transcriptional regulation and thus chose to fluorescently tag the 
repressor. The fluorescent protein mCherry was chosen due to minimal auto-
fluorescence from MOPS minimal media and minimal spectral overlap with our reporter 
gene YFP. Furthermore, a dimeric Lac-mCherry fusion construct is known to be 
functional in vivo (Lau et al., 2004).  The goal is to measure raw mCherry fluorescence 
and OD600 in growing E. coli cells and convert those measurements to an intracellular 
concentration of lac repressor (Figure 4.1). 
98
Figure 4.1. Measuring intracellular Lac-mCherry concentration. Raw mCherry 
fluorescence and OD600 are measured on a plate reader. Calibration curves for both 
were established given our experimental setup (cell line, plasmids, media, amount of 
sample loaded, plates and plate reader). Raw fluorescent signal is converted to 
concentration of Lac-mCherry per well. Raw OD600 signal is converted to the fraction of 
well volume that is intracellular. Dividing Lac-mCherry well concentration by intracellular 
volume fraction effectively concentrates the Lac-mCherry to be intracellular. These two 
measurements, combined with the appropriate calibrations, allow a quick and accurate 
measurement of intracellular Lac-mCherry concentration.
A linear relationship was established for OD600 and cell count.  We estimate the 
volume of E. coli growing in glucose supplemented minimal media to be 1x10-15 L 
(Tungtur et al., 2011).  We then measured OD600, calculated the number of cells and 
multiplied by volume of the cell to calculate the fraction of the well that is intracellular. A 
linear relationship was also established for purified Lac-mCherry fluorescence and 
concentration of Lac-mCherry.
99
We assume all of the Lac-mCherry is intracellular; therefore we divided the Lac-
mCherry concentration by the fraction of volume that is intracellular.  Using this method, 
we can quickly and accurately measure in vivo Lac-mCherry concentrations.
Intracellular Lac-mCherry concentration in EPB229 cells 
Figure 4.2. In vivo Lac-mCherry and YFP regulation show no growth dependence. 
(A) Lac-mCherry was calculated for growing E. coli cells and found to have minimal 
OD600 dependence. As expected for a constitutively expressed gene, there is no change 
in Lac-mCherry concentration with increasing IPTG concentration. (B)  Normalized YFP 
simultaneously measured and again no OD600 dependence was found throughout the 
exponential growth phase.  In stark contrast the Lac-mCherry, a distinct induction profile 
is measured for YFP.
EPB229 cells expressing Lac-mCherry and the reporter plasmid were grown in 
varying concentrations of the inducer IPTG.  Intracellular concentration of Lac-mCherry 
was calculated from mCherry fluorescence and OD600 and found to be 664 ± 90 nM at 
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mid-log growth phase (OD600 = 0.6) (Figure 4.2.A).  As expected for a constitutively 
expressed gene, minimal variation was seen with IPTG and cell growth (Figure 4.2.B). 
We then converted to molecules per cell,
6.6e−7M∗1e−15 L
cell
∗6.022e23 molecules
mole
=397 molecules
cell (95)
We have previously estimated the copy number of our plasmid to be ~10-20 
plasmids/cell (Daber et al., 2009).  This corresponds to approximately 20-40 Lac-
mCherry dimers per plasmid which agrees well with previous estimates of ~40 Lac 
repressor dimers per plasmid for our promoter (Oehler et al., 1994).
4.3 Measuring the In Vivo Regulation of YFP
In addition to mCherry fluorescence and OD600 measurements, YFP 
fluorescence was measured in cells as a function of IPTG.  Unregulated expression was 
established by measuring OD600 and YFP in cells co-transformed with O1 YFP reporter 
and a plasmid which does not contain any repressor (pABD34).  These positive control 
cells were grown in tandem with cells containing both reporter and repressor and grown 
in a variety of IPTG concentrations.
Positive controls showed no IPTG dependence as expected, so data from every 
sample was combined to determine an overall positive control polynomial fit. YFP 
fluorescence is seen to increase as cells grow as would be expected due to the 
increased number of cells per µL.  We remove this bias and normalize regulated YFP 
expression by dividing by the positive control fit curve.
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Normalized YFP expression was then measured as a function of OD600 and 
IPTG (Figure 4.4, blue squares).  Almost no OD600 dependence can be noted in the 
induction profile (Figure 4.2.B).  The YFP signal is repressed without IPTG and is 
approximately 1-5% of unregulated expression.  Upon induction with saturating IPTG we 
see a robust YFP increase to approximately 60% of the unregulated expression. 
4.4 Measuring the In Vitro Regulation of mRNA
While the in vivo experiment measures translation product (fluorescing YFP) we 
know the lac repressor actually regulates mRNA production.  Previously, our lab has 
determined a linear relationship between mRNA and fluorescence protein signal allowing 
us to use fluorescence as a proxy for mRNA regulation in vivo.  The situation in vitro is 
reversed; it is much easier to measure mRNA production. 
We used the Maxiscript T7 in vitro transcription kit (Ambion) which produces 
mRNA from linearized DNA with a T7 promoter.  We then measured incorporation of 
radioactive labeled CTP into mRNA.  The T7 promoter was modified to add an O1 
operator DNA site and we were able to modulate Lac-mCherry and IPTG concentrations. 
A positive control of constitutive mRNA production is established by not adding any Lac-
mCherry. 
We first established that radioactively labeled mRNA was linearly observable by 
constitutively producing mRNA and loading various dilutions onto polyacrylamide gels 
and established that mRNA concentration was linearly related to the concentration of 
mRNA loaded on the gel.  Positive controls were included for every experiment and were 
used for normalization. 
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The additional benefit of in vitro transcription is the flexibility in dosing not only 
IPTG, but also Lac-mCherry.  We exploited this flexibility by first titrating in Lac-mCherry 
without IPTG present and with saturating IPTG (1mM) (Figure 4.3.A). As expected, 
increasing concentration of Lac-mCherry decreases mRNA production.  Furthermore, 
addition of IPTG returns mRNA signal to near constitutive levels.
Figure 4.3. In vitro transcription controlled by the lac repressor is accurately fit by 
the MWC model. (A) Lac-mCherry was added at varying concentrations with 11nM O1 
DNA and mRNA was quantitated (blue squares). The repression was relieved upon 
addition of 1mM IPTG (orange diamonds). The data was globally fit by the MWC model 
and an accurate solution was found for the Lac-mCherry titration (solid blue line). 
Unfortunately, the model predicts higher induction than was measured experimentally 
(solid orange line). (B) IPTG was added at varying concentrations with 333nM Lac-
mCherry and 11nM O1 DNA and again mRNA was quantitated (blue squares). A robust 
induction profile was measured showing induction up to approximately 90% of 
constitutive expression. The global fit also accurately fits the IPTG titration data (solid 
blue line).
We then titrated IPTG at a fixed Lac-mCherry concentration (Figure 4.3.B).  The 
induction of mRNA is seen to very closely resemble that of the in vivo data, but it is 
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noticeably leakier.  Maximal repression was about 5% and maximal induction was 
approximately 90%.
4.5 Modeling Using MWC Thermodynamic Equilibrium
Finally, we sought to simultaneously model the in vivo and in vitro data using the 
Monod, Wyman, and Changeux (MWC) model of thermodynamic equilibrium.  
Previously, we have relied upon approximate solutions of the lac genetic switch 
equilibrium to model in vivo induction profiles.  This solution assumes that the total 
repressor concentration greatly exceeds operator concentration (Rtot >> Otot).  This 
condition does not hold for our in vitro experiment where we titrated in Lac-mCherry nor 
would it necessarily be true in all in vivo systems. Therefore, we sought a solution to the 
equilibrium that held for every potential input. 
We modeled transcription using the Monod, Wyman and Changeux (MWC) 
thermodynamic equilibrium. Normalized expression is then modeled as free operator 
concentration, [O], divided by total operator concentration, [O]tot. 
We then want to take known quantities and measured normalized regulation ([O]/
[O]tot) and measure the equilibrium thermodynamic parameters of our model.  We know 
the total concentrations of repressor ([R]tot), operator DNA ([O]tot), and effector ([E]tot).  
We also will act as if we know all of the thermodynamic constants.  We want to make no 
assumptions so that both in vivo and in vitro data can be directly compared.
In Section 3.2 we started the problem by defining all of the thermodynamic 
parameters in Equations (43) - (47) and formulas for total operator in Equation (48) and 
total repressor in Equation (59). We have also already defined some of the bound 
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species in Equations (49) - (54).  We therefore need to define the missing formula for 
total effector concentration,
[E]tot=[E]+2[RE]+2[RE2]+2 [R*E ]+2[R*E2 ]
+2 [ROE ]+2[ROE2]+2[R*OE]+2[R*OE2 ] (96)
We therefore begin by writing the equation for total repressor solely in terms of 
free species and thermodynamic constants,
[R ]tot=[R ]+2[R ][E]KRE+[R ][E]
2KRE
2
+[R]KRR*+2[R] [E]KRR* KR*E+[R ][E]
2KRR* KR*E
2
+[R] [O ]KRO+2[R ][O] [E]KROKRE+[R ][O ][E]
2KROKRE
2
+[R ][O]KRR* KR*O+2[R] [O ][E]KRR*KR*OKRE+[R ][O] [E]
2KRR* KR*O KRE
2
(97)
We then make the following definitions,
α1=1+KRR* (98)
β1=2KRE+2KRR*KR*E (99)
γ1=KRE
2 +KRR*KR*E
2
(100)
γ2=2KROKRE (101)
δ1=KROKRE
2
(102)
β2=KRR*KR*O (103)
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γ3=2KRR*KR*O KR*E (104)
δ2=KRR* KR*O KR*E
2
(105)
Substituting into Equation (97),
[R ]=
[R]tot
α1+[E ]β1+[E ]
2γ1+[O](KRO+[E] γ2+[E]
2δ1+β2+[E] γ3+[E]
2δ2) (106)
The equation has been organized such that polynomials in [E] are apparent.  As 
long as we only add and multiply polynomials, they can trivially be treated as symbolic 
functions for further simplification.  We define the following polynomials,
B1=α1+[E]β1+[E]
2 γ1 (107)
B2=KRO+β2+[E](γ2+γ3)+[E]
2(δ1+δ2) (108)
Now substituting back into Equation (109),
[R ]=
[R ]tot
B1+[O ]B2 (109)
We next want to follow the same path for [E] and [O].  Inspection of Equations 
(48), (59), and (106) show that we have already done the most complicated case. We 
can then quickly arrive at, 
[O ]=
[O]tot
1+[R ]B2 (110)
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The effector equation is similar, but it has a few extra coefficients of two within its 
equations.  We define two more polynomials,
A1=β1+[E]2γ1 (111)
A2=γ2+γ3+2[E] (δ1+δ2) (112)
Substituting into Equation (106),
[E]tot=[E ]+[R ][E]A1+[R ][E][O]A3 (113)
We can then eliminate [O] by substituting Equation (110) into Equations (107) 
and (113). Since we can only multiply and add polynomials, we multiply the denominator 
of Equation (110) on both sides.
Substituting into Equation (107), 
[R ]tot+[R]B2[R]tot=[R]B1+[R ]
2B1B2+[R]B2[O]tot (114)
We then define the following polynomials,
ϕ1=B1B2 (115)
ϕ2=B1+B2([O ]tot−[R]tot) (116)
Substituting into Equation (114),
[R ]2ϕ1+[R]ϕ2=[R ]tot (117)
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The substitution of Equation (110) into Equation (113) requires the following 
definitions,
ψ1=[E ]A1B2 (118)
ψ2=[E](B2+A1+A2 [O ]tot)−B2[E]tot (119)
We then arrive at,
[R ]2ψ1+[R ]ψ2=[E ]tot−[E ] (120)
In principal we can get this down to a single equation, but in order to do so the 
final polynomial becomes of a much higher order which prevents accurate computational 
solutions.
The strategy is then to guess at the free effector concentration to calculate 
Equations (115)-(116) and (120)-(121). Equations (117) and (120) can then be solved for 
[R] by looking for the roots to the equation. When the correct free effector concentration 
is found the roots of Equation (117) and Equation (120) will converge. By minimizing the 
difference between the roots a solution can be reached. All other concentrations are then 
trivial to calculate once [R] and [E] are known. Custom Matlab (Mathworks) software was 
written to numerically solve the MWC equilibria (Matlab File Exchange ID #40602).
The accuracy of the solution is easily checked by using the bound and free 
species concentrations to calculate the total species concentrations and thermodynamic 
parameters. Calculated values should agree with input values.
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Using the assumption-free solution to measure thermodynamic parameters
Experimentally we know the total concentrations ([R]tot, [E]tot, [O]tot) and 
normalized transcription/expression ([O]/[O]tot).  We want to measure the 
thermodynamic constants (KRR*, KRE, KR*E, KRO, KR*O).  This leaves 5 independent 
constants in the MWC model to fit to the experimental data.  The large number of 
independent constants results in a myriad of non-unique solutions to the equations. This 
complication was limited by the following algorithm.
First, since it is widely reported to be effectively zero, KR*O was set to be very, 
very small (1x10-10 nM-1).  This leaves four independent parameters.
Next, it had been observed from previous studies that the ratio of KR*E to KRE is 
well defined when the concentration of repressor greatly exceeds that of operator. Under 
this assumption, a simpler solution of the MWC equilibrium exists as explored in Section 
3.2. We isolated a subset of the in vitro data where this condition was true and used a 
non-linear least squares fitting algorithm to measure the ratio X = KR*E/KRE as a function 
of conformational equilibrium.  The ratio was seen to asymptote at approximately 13.75. 
This value is then used to reduce the number of independent constants to 3 (KRR*, KRE, 
and KRO).
We then simultaneously fit the in vitro data to obtain the best fit thermodynamic 
parameters using a non-linear least squares algorithm in Matlab (Table 4.1). The model 
accurately fits both the IPTG (Figure 4.3A) and the lac repressor doping (Figure 4.3B) in 
vitro transcription experiments.  The fit values agree well with values obtained in the 
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literature with the exception of repressor-DNA affinity.  The repressor-DNA affinity was 
measured to be 0.4 ± 0.2 nM-1.  This is significantly weaker than the 100-3333 nM-1 that 
has been measure previously (Sharp, 2011).  It does agree well with an estimated value 
of 1 nM-1 for lac repressor-DNA affinity that prevails under conditions within the E. coli 
cell (Muller-Hill, 1996). The thermodynamic equilibrium value (6.3 ± 3.3) does not 
significantly differ from that measured previously by our group. The repressor-IPTG 
affinity (7.6x10-4 ± 2.5x10-4 nM-1 for the higher affinity conformation) was found to be 
slightly higher than previously published values (2.3x10-4 nM-1) but it is generally within 
agreement.  The ratio of affinities for the two conformations (13.7) was in good 
agreement with previously measured values. 
Using the in vitro thermodynamic parameters to predict in vivo genetic regulation
The raison d’être for in vitro measurements is to inform what is occurring in vivo.  
One of the central difficulties in using in vitro measurements is the lack of a well enough 
defined in vivo system to directly compare it with.  Furthermore, a model is required 
which can accurately function in both circumstances and provide useful predictions.  We 
then seek to fully define our in vivo experiment to model it with the in vitro determined 
thermodynamic parameters.
We estimate the copy number of our operator reporter plasmid to be ~ 20 copies 
per cell (Daber et al., 2009).  This then gives us,
[O ]tot=
20molecules
6.02e23 molecules
mole
∗ 1
1e−15L
∗1e9 nM
M
=33nM
(121)
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The strain of E. coli used has the lac genetic switch deleted from the genome; 
therefore lac permease is also deleted.  It is then assumed that IPTG enters the cell 
through passive diffusion and has the same concentration as the media.
This 
study
Daber, 
Sharp, 
and 
Lewis† Chapter 3
Sharp, Set 
1 ‡
Sharp, Set 
2 ‡
Sharp, 
Set 3 ‡
Müller-
Hill §
KRR* = 
[R*]/[R] 6.3 ± 3.4 2 ± 0.5 5.8 ± 0.07
KRO 
(nM-1)
0.42 ± 
0.21 3330 100 1510 1
KRE 
(nM-1)
5.6x10-5 ± 
1.8x10-5
6x10-5 ± 
2x10-7
KR*E 
(nM-1)
7.6x10-4 ± 
2.5x10-4
5x10-4 ± 
5x10-6 2.3x10-4 2.3x10-4 2.3x10-4
KR*O 
(nM-1) 1.0x10-10
Rtot 
(nM)
[with 40% 
crowding]
664 ± 90
[1660 + 
225]
r =
KRO * Rtot
[with 40% 
crowding]
278
[697] 150 ± 50 150 ± 50
X = 
KR*E / KRE
13.7 ± 
0.13
15 ± 3
8.28
Table 4.1. Fit values from the MWC models compared with literature values. All fit 
parameters agree with the exception of repressor-operator DNA affinity (KRO). †(Daber 
et al., 2009) ‡(Sharp, 2011) §(Müller-Hill, 1996).
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Figure 4.4. In vivo regulation by the lac repressor is accurately predicted with 
molecular crowding. (A) YFP under control of the lac repressor was measured in E. 
coli cells at varying concentrations of IPTG (blue squares).  We used the measured 
intracellular concentration of the lac repressor (660nM) and the fit values from in vitro 
transcription to predict the in vivo induction curve with the MWC model (solid blue line). 
The model agrees at low IPTG concentrations but shows a significant over-prediction at 
full induction. Our repressor-DNA affinity was much lower than previously published 
values, so we also modeled three curated data sets from Sharp [10] (dashed orange, 
dotted purple, and solid green lines). All three predict greatly over-repressed YFP 
expression and do not fit the in vivo data. (B) Molecular crowding is known to play a 
significant role in cells. We modeled this by estimating the available volume in 
percentage for our repressor and calculated an effective repressor concentration. We 
modeled several percentages and 40% available volume (solid purple line) accurately 
reproduces the in vivo regulation from the in vitro transcription derived thermodynamic 
constants. This corresponds to an effective repressor concentration of 1.6μM.
Figure 4.4.A shows the simulated in vivo data along with experimentally 
determined values.  Clearly, the model predicts accurate leakiness but higher induction 
than is observed.  There is a known molecular crowding effect in living cells due to the 
density of molecules.  Figure 4.4.B shows the effect of including molecular crowding on 
the predicted in vivo induction curve.  The model shows excellent agreement with 
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experiment at a molecular crowding of 40% which estimates effective in vivo repressor 
concentration to be 1.6 μM.  Furthermore, this value agrees well with estimates of 20%-
40% available space in vivo (Kubitschek & Friske, 1986).
Since there is a notable deviation in repressor-DNA affinity with previous 
measurements, the same analysis was carried out for the three curated data sets from 
Sharp (Sharp, 2011). Using the values from the literature, we find that they do not in any 
case come close to replicating our in vivo data (Figure 4.4.A). The DNA affinities are 
much too high for the measured DNA and repressor concentrations. At these affinities 
the switch is essentially completely off and cannot be induced with any concentration of 
IPTG. Crowding only enhances the deviation from experiment as it further increases the 
concentration of repressor.
Simulating native in vivo lac genetic switch phenotype
The thermodynamic constants from our in vitro data better represents our in vivo 
model system. The question then is: which set of thermodynamic parameters could 
effectively regulate the native lac genetic switch?
Essentially we have rebuilt the lac operon with the lacZ, lacY and lacA 
polycistronic message replaced by the reporter gene YFP and the dimeric lac repressor 
constitutively expressed by its native promoter. We have a higher copy number of both 
the reporter and repressor plasmids (~20 copies per cell) which increases both the 
operator and repressor concentrations above that normally found in the cell. A secondary 
deviation is the removal of the tetramerization domain and multiple operator DNA sites 
(O2 and O3 additionally exist on the genome) which simplifies our analysis. The 
cooperativity of the native tetrameric lac repressor is known to decrease leakiness 
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approximately 10-fold, so we might expect a dimeric lac repressor with one operator 
(O1) to have some leakiness in its repression (Oehler et al., 1994).
As previously mentioned, in vivo lac repressor dimer concentration was 
measured to be ~40 dimers per cell, which gives,
[R ]tot=
40 molecules
6.02e23 molecules
mole
∗ 1
1e−15 L
∗1e9 nM
M
=66nM
(122)
And we know there is one operator per cell,
[O ]tot=
1molecules
6.02e23 molecules
mole
∗ 1
1e−15L
∗1e9 nM
M
=1.7nM
(123)
Using these values, along with the experimentally determined binding constants 
derived from this study and those curated by Sharp, we can simulate dimeric lac 
repressor induction curves at native conditions. Figure 4.5.A shows that the values 
determined in this study predict a leaky repressor that is maximally inducible. The much 
higher DNA affinities of the curated data sets all produce over-repressed curves that do 
not show good induction.
The over-repression is even more prominent as cell crowding is considered. 
Using the value of 40%, which gives Rtot = 66 nM / 0.4 = 165 nM, we find that the over-
repression of the high affinity DNA sets all produce curves that weakly induce or do not 
induce at all (Figure 4.5.B). The predicted curve using our thermodynamic parameters 
again provides reasonable induction (~10% leakiness up to ~95% maximal induction). 
While this level of leakiness would be intolerably high for efficient regulation of the lac 
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operon, the restoration of the tetramerization domain would significantly decrease the 
leakiness while minimally impairing inducibility.
Figure 4.5. Simulating a simplified lac operon from in vitro derived thermodynamic 
constants. The correct repressor-DNA affinities must be able to provide robust 
switching under conditions naturally experienced by E. coli. With this in mind, we 
modeled a dimeric lac repressor regulating a gene with a single operator sequence. (A) 
The natural lac promoter makes ~66nM of lac repressor dimer and one operator is at ~ 
1.7nM in the cell. We modeled these conditions for the thermodynamic parameters from 
this study and for the three curated data sets of Sharp. The predicted curve from this 
study shows a reasonable repression and induction profile (solid blue line). Only Set 2 
from Sharp is weakly inducible (dotted purple line). (B) Including molecular crowding 
(40% available volume) enhances the situation. The curated data sets do not make 
useful switches. Alternately, the predicted induction curve from in vitro transcription 
derived constants shows a leaky switch that induces very well (solid blue line). (C) We 
next sought to model the minimal possible repressor to find a condition where the 
curated data sets produce reasonable induction curves. 1 molecule of dimer per cell 
(~1.7nM) does show good induction profiles for set 2 (dotted purple line) and set 3 (solid 
green line). Set 1 still shows a switch that can marginally be induced and would likely not 
be useful (dashed orange line). (D) Molecular crowding effects again enhance the 
repressor concentration and only set 2 could reasonably regulate a gene (dotted purple 
line). The values from this study (solid blue line) predict a very leaky switch. Although the 
second curated set could effectively regulate the gene at this concentration, in reality a 
single dimer and single operator DNA binding would be dominated by stochastic events 
creating an inherently unstable switch. 
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If we consider the lowest possible concentration of lac repressor (1 molecule/cell; 
Rtot = 1.7 nM; with 40% crowding Rtot = 4.25 nM) we find that second curated data set 
does produce reasonable induction curves, even if 40% crowding is taken into 
consideration (Figure 4.5.C and Figure 4.5.D). Unfortunately, in this regime the binding 
would be highly stochastic and hence noisy, which would not produce stable repression. 
Furthermore, this level of repressor expression does not agree with published values. 
While it is technically possible for these affinities to be accurate, it is highly improbable. 
The first and third data sets would require less than 1 molecule of dimeric lac repressor 
per cell to be functionally useful according to our model.
Given the wide range of repressor-operator DNA affinities (100nM – 3333nM) it 
can be reasonably concluded that these values must contain significant artifacts from the 
experimental techniques. Techniques such as gel shift assays, where molecular “caging” 
effects are known to be significant, and nitrocellulose filter binding assays, where the 
binding is removed from the solution phase, were used to create the curated data sets. 
Our measurement of repressor-DNA binding affinity did require an indirect 
measurement, namely transcription; but it did occur in the solution phase. We attribute 
the difference in values to differences in experimental setup.
4.6 Discussion
We have reproduced the transcriptional regulation of the lac repressor dimer in 
vitro and shown that it accurately reproduces the in vivo repression of YFP under control 
of the lac repressor. Accurate modeling of the in vivo data required an estimate of 40% 
cellular crowding in the cell, which agrees with previous estimates. Non-specific DNA 
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binding and IPTG uptake did not appear to have any significant effect.   Crowding could 
be tested in vitro through crowding agents such as BSA or PEG.  Alternative 
explanations are potentially possible such as fluctuations in the size of the E. coli.  What 
is essentially important is that the concentration of lac repressor in the cell greatly affects 
the maximal induction given our thermodynamic parameters.  The curve is extremely 
sensitive in that region to changes in repressor concentration.  So only an approximately 
two-fold increase in repressor concentration is sufficient to replicate the in vivo data.  
Whether the lac repressor concentration is increased by molecular crowding or by 
decreased E. coli volume would have to be tested by further experiments.
The measured thermodynamic binding parameters match well for IPTG binding 
and conformational equilibrium, except there is significantly lower repressor/operator 
DNA affinity measured (by approximately 3-4 orders of magnitude). This discrepancy 
was modeled and it was demonstrated that the affinity measured in this study is capable 
of reproducing not only the in vivo data from this study, but also can predict reasonable 
induction curves at concentrations of repressor and DNA that are naturally seen by E. 
coli. We therefore conclude that lac repressor DNA affinity is significantly weaker than 
previous in vitro measures and more in line with the estimates for repressor-DNA affinity 
at in vivo conditions where we do find good agreement with previously published values.
Finally, this study highlights the difficulty in using in vitro data generated from 
experimental techniques that are divorced from conditions closer to that of the cell. 
Experimental artifacts may greatly overshadow actual values, which should come as no 
surprise in the case of lac repressor binding to operator DNA where the published 
binding constant has changed 33-fold as experimental techniques have changed. The 
difficulty in in vitro measurements is well known in the field as is evidenced by the large 
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consideration given to differences in buffer conditions (Ha, Capp, Hohenwalter, 
Baskerville, & Record, 1992), DNA length (Khoury, Lee, Lillis, & Lu, 1990), and even 
hydrostatic pressure (Royer, Chakerian, & Matthews, 1990).  Techniques such as gel 
filtration or nitrocellulose filter binding assays are excellent at differentiating binding 
strength between point mutants; they are limited in comparison with in vivo results. 
Using experimental setups which more closely mimic the in vivo system can significantly 
improve the ability of the predictive capabilities of in vitro experiments. They do come 
with the caveat that the data interpretation is not as straightforward as simple binding 
experiments.
118
Chapter 5: 
An Autogenously Regulated Lac Repressor for AAV-mediated Eukaryotic Gene 
Therapy
5.1 Introduction
Bacterial gene regulation is interesting due to its simplicity.  The lac genetic 
switch consists of a single protein that binds to a known short operator DNA sequence 
all regulated by a small sugar molecule.  Eukaryotic gene regulatory systems are not so 
simple (Roeder, 2003).  Could we use the much simpler bacterial systems to regulate 
specific genes of interest in eukaryotes?
The first attempt to translate any bacterial gene regulation to eukaryotes was the 
lexA protein.  LexA was shown to block transcription when its operator was placed within 
a promoter (Brent & Ptashne, 1984).  The lac repressor was then tested in a mouse L 
cell line for the ability to regulate a transgene (Hu & Davidson, 1987).  Prior to this paper 
it was unknown if the protein could fold, dimerize, tetramerize, migrate to the nucleus, or 
even bind DNA which might be in a chromatin bound state.  Hu and Davidson found that 
not only does the lac repressor block transcription, it can do so with an operator located 
in three different regions within the promoter: between the start codon and the 
transcription start site, between the transcription start site and the TATA box, and 
upstream of the TATA box.  Not only does the lac repressor bind, it is capable of stopping 
transcription from a wide variety of locations.  Furthermore, they showed that repression 
was relieved upon addition of IPTG.  They did, however, note that only 10% of the 
repressor was localized to the nucleus.  Addition of a nuclear localization signal localized 
all of the repressor to the nucleus but with the odd caveat that operator DNA binding was 
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reduced 6-fold (Hu & Davidson, 1991).  The lac genetic switch was shown to transiently 
and stably regulate a Simian Virus promoter, SV40, in cell culture (Brown et al., 1987; 
Figge, Wright, Collins, Roberts, & Livingston, 1988). A quantitative assay was developed 
that showed stable HEK293 cell lines expressing constitutive lac repressor and 
regulated lacZ were capable of 5-fold induction with IPTG from an Epstein-Barr virus 
derived promoter (Biard, James, Cordier, & Sarasin, 1992; Liu, Feliciano, & Stambrook, 
1989).  The lac repressor was shown to work in tandem with the Tet repressor to create 
a regulatory cascade capable of responding to IPTG, tetracycline, or both (Aubrecht, 
Manivasakam, & Schiestl, 1996).  Plant cells were also shown to be capable of 
regulating gene expression using the lac genetic switch (Ulmasov, Capone, & Folk, 
1997).
Up till this point, the lac genetic switch was shown to be functional in both 
transient and stable eukaryotic cell lines with the operator in varying positions in various 
promoters.  The next logical step was to test the lac repressor in a transgenic mouse 
model (Scrable & Stambrook, 1997).  This first required re-encoding the lacI gene to use 
more optimal mammalian codons (synlacI) (Zhang, Zubay, & Goldman, 1991).  Scrable 
and Stambrook found that the E. coli lacI gene was transcriptionally silenced whereas 
the mammalian optimized synlacI gene was ubiquitously transcribed.  The full lac 
genetic switch was then shown to functional in the mouse (Cronin et al., 2001).  Mice 
were developed with the tyrosinase gene under control of the lac operator and it was 
shown that coat color of the mice could reversibly be changed upon feeding of IPTG.  
Interestingly, they found that the synlacI gene previously described did not form 
measurable protein product nor was it functionally capable of regulating gene 
expression.  The found a cryptic splice site within the synlacI gene that, when reverted to 
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the lacI sequence, creates functional lac repressor in cells.  This mouse model was later 
used to investigate the timing of tyrosinase expression in embryogenesis to study 
occulocutaneous albinism (Cronin, Ryan, Talley, & Scrable, 2003).  The lac genetic 
switch functionality was also shown to persist through embryonic stem cell differentiation 
(Caron et al., 2005) and it was shown to be functional in living plants (Moore, Gälweiler, 
Grosskopf, Schell, & Palme, 1998).
Clearly the lac repressor is capable of functioning in gene regulation in 
eukaryotes.  It is not, however, optimized for that purpose.  Furthermore, the use of the 
lac genetic switch on the animal level has required making transgenic animals where the 
genome has directly been modified.  These approaches are not useful in human gene 
therapy for both practical and safety reasons.  One leading method of gene therapy 
delivery is the use of Adeno-Associated Virus (AAV).  AAV virus can be targeted to 
specific tissues and the delivered genes exist on an episomally separate from the 
genome (Penaud-Budloo et al., 2008), and the delivered genes can be stably expressed 
over long periods of time.  One serious drawback is that the size of the viral capsid 
creates an upper limit on the length of the gene that can be delivered to the cell; only so 
much DNA can be packed within the AAV viral capsid.
With this in mind, we sought to develop a lac genetic switch that would provide 
robust gene regulation in AAV-mediated gene therapy.  This required making a genetic 
switch that is as small as possible and optimizing the minimal switch for gene regulation 
in Eukaryotes.
5.2 Development of an Autogenously Regulated Lac Repressor
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The lac repressor is constitutively expressed in E. coli from its own promoter.  
Therefore, the lac genetic switch is usually applied by inserting a promoter driving lac 
repressor and a second promoter driving the gene of interest under control of a lac 
operator DNA sequence.  Constitutively expressed repressor is the exception, not the 
rule, in the LacI/GalR family (Swint-Kruse & Matthews, 2009). Many repressors are 
autogenously regulated; they control their own expression.  
The question then is: what will happen if we make an autogenously regulated lac 
repressor?  It is first instructive to consider the behavior of a properly tuned constitutively 
expressed lac repressor on the lac genetic switch.  Looking back on the modeling of 
Chapter 3, we saw that the effect of changing repressor concentration was the same as 
changing the repressor-operator DNA affinity, KRO.  Figure 3.3.A shows that higher 
repressor concentration (higher r) will make a less leaky switch that is not as inducible.  
Lower concentration of repressor will make a leakier switch that easily maxes out 
induction.  Figure 3.3.B shows that an ideal lac repressor concentration exists where the 
dynamic range is maximal and this spot coincides with a non-leaky switch.  The wild type 
lac repressor promoter has evolved to constitutively express the lac repressor at just this 
correct range.  If we want to utilize the constitutively expressed lac repressor genetic 
switch in a different organism we would need to optimize the promoter and/or the 
repressor-operator DNA affinity to get the maximal dynamic range.  In making stable cell 
lines, one alternative approach is to incorporate a random number of repressor 
promoters and reporter promoters into the genome and then select for optimal dynamic 
range.  This is just not possible for gene therapy; you cannot select for good cells in a 
patient.
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An autogenously regulated switch on the other hand auto-tunes the repressor 
concentration at equilibrium.  As repressor is made it begins to shut off the promoter.  At 
equilibrium, the promoter will make just enough repressor to maintain its off state.  This 
means however that the autogenously regulated is inherently leaky; it must let enough 
transcription occur to keep the repressor concentration high enough to shut off the 
switch.  A constitutively expressed switch has no necessary leakiness.   There are 
benefits to autoregulation however; the effector response is linearized (Nevozhay, 
Adams, Murphy, Josic, & Balázsi, 2009), the response to effector is faster (Rosenfeld, 
Elowitz, & Alon, 2002), and the genetic switches are more stable (Becskei & Serrano, 
2000). All of these benefits, combined with a smaller overall transgene, led us to develop 
an autogenously regulated lac genetic switch with the goal of minimizing the inherent 
leakiness of the switch.
An autogenously regulated lac genetic switch in E. coli
We first made an autogenously regulated lac genetic switch by placing the lacI 
gene fused to mCherry after the natural lac promoter.  A reporter gene, YFP, was 
included after an 18 base pair spacer (Figure 5.1).  Prokaryotes are capable of 
expressing a poly-cistronic message where multiple genes are expressed off of a single 
promoter (which is how the lacZ, lacY, and lacA genes are naturally expressed), 
therefore we expected this single plasmid to make both a lac repressor-mCherry fusion 
protein and the YFP reporter gene.  
123
Figure 5.1. Plasmid organization for prokaryotic autogenously regulated lac 
genetic switch.  The native lacZ/Y/A promoter under control of the O1 natural lac 
operator controls two genes: lac repressor fused to mCherry and YFP.  Lac-mCherry 
binds to O1 leading to autoregulation and the YFP acts as a cytoplasmic readout of the 
switch.
The autogenously regulated prokaryotic  switch was tested in EPB229 cells 
growing in minimal media supplemented with glucose.  Both mCherry and YFP were 
measured in living cells in the same manner as the in vivo experiments of Chapter 4. 
Figure 5.2 shows that the autogenously regulated lac genetic switch successfully turns 
off YFP expression and induces to a lower value than the constitutive lac genetic switch.  
Essentially, the autoregulation diminishes the overall dynamic range of the prokaryotic 
switch, which is expected because the promoter that drives the lac repressor in E. coli is 
well tuned to have a maximal dynamic range switch. Figure 5.3 shows that the 
autoregulation also regulates the lac repressor.  The induction is much less than what is 
seen for YFP.  One thing to note is that the calculated lac repressor concentration from 
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the autogenously regulated switch is actually much higher than was measured from the 
constitutive plasmid in Chapter 4.
Figure 5.2. Autogenously regulated lac genetic switch versus constitutively 
regulated.  The autogenously regulated (Self Regulated) switch has a similar leakiness 
to the constitutively regulated (WT LacI) but it cannot induce to as high of levels.
The reporter operator is much stronger than the natural lacI promoter that makes 
constitutive lac repressor.  The autogenously regulated stronger promoter actually 
makes more repressor than the constitutive weak promoter.  That is why leakiness is not 
greater in the autogenously regulated as expected.  On the flip side, there is so much 
repressor that the switch cannot turn fully on.  Clearly the strength of the promoter that is 
being autogenously regulated plays a significant role in the functional output of the 
genetic switch.
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Figure 5.3. Autoregulation of the lac repressor as measured by mCherry signal.  
Lac repressor levels are seen to rise upon IPTG induction as would be expected for a 
autogenously regulated repressor.  The measured levels of repressor are higher than 
measured from the constitutive plasmid.
It is unlikely that placing an autogenously regulated switch on most promoter will 
result in a gene regulation profile that fits the needs of gene therapy.  We would like to 
use the known mutants of the lac repressor to be able to improve upon the genetic 
switch. The question is: do lac repressor mutants still give rise to the same phenotypes 
in an autogenously regulated switch?  We tested both the DNA binding domain mutants 
(Figure 5.4) and effector pocket mutants (Figure 5.5) from Chapter 4 on the 
autogenously regulated lac genetic switch in prokaryotes.  The two DNA binding domain 
mutants clearly follow the same phenotypic changes seen in the constitutive switch 
therefore we can change leakiness and dynamic range by mutating the DNA binding 
domain.  The effector pocket mutants also exhibited changes in leakiness, dynamic 
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range, and [E]50 as previously found.  Therefore we can mutate the effector pocket to try 
to optimize any of the three phenotypic properties.
Figure 5.4. DNA binding domain mutants in the prokaryotic autogenously 
regulated switch.  Q18A is still leakier and Q18M is still less leaky than wild type, just 
as observed in the constitutive switch.  The tradeoff between leakiness and dynamic 
range is still present.
The demonstration of the autogenously regulated lac genetic switch in E. coli 
essentially established that, as expected, the lac repressor is functional autogenously 
regulated and that the phenotype is malleable through point mutation of either the DNA 
binding domain or the effector binding pocket.  Furthermore, the strength of the promoter 
significantly effects the levels of protein that are made.  
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Figure 5.5. Effector pocket mutants in the prokaryotic autogenously regulated 
switch. Four point mutants in the effector binding pocket are seen to alter the leakiness, 
dynamic range and [E]50 of the autogenously regulated switch.  Clearly this region of the 
repressor is still an ideal target for mutagenesis to alter the phenotype of the of the 
switch.
5.3 The Autogenously Regulated Genetic Switch in HEK293T Cells
We next sought to test the autogenously regulated lac repressor in transiently 
transfected HEK293T cells to test its ability to regulate a reporter gene. We first 
developed a plasmid that has the minimal CMVI promoter with the Lsym lac operator 
between the TATA box and the transcription start site (Figure 5.6).  Eukaryotes do not 
translate poly-cistronic mRNA messages so an alternative strategy is needed to express 
the two genes.  We first used an Internal Ribosomal Entry Sequence (IRES) that allows 
the ribosome to translate a second gene within the mRNA and therefore make an 
autogenously regulated switch.  We used YFP as the reporter gene and the lac 
repressor sequence was the codon optimized sequence corrected for a splice site, which 
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we term EuLac, which was then fused the mCherry (Cronin et al., 2001).  
EuLac::mCherry fusion has the canonical nuclear localization sequence (NLS) on the C-
terminus to localize the repressor to the nucleus.
Figure 5.6. The pIRES-EuLacmCh-YFP plasmid.  This plasmid expresses an 
autogenously regulated dimeric lac repressor mCherry fusion construct which can bind 
one Lsym operator site and has YFP as a readout.
This autogenously regulated IRES plasmid was transiently transfected into 
HEK293T cells and media was supplemented either with or without 2.5 mM IPTG. 
Figure 5.7 shows that both the YFP and the lac repressor are induced upon addition of 
IPTG.  YFP is dispersed throughout the cell while the mCherry signal is localized to the 
nucleus (labeled blue by Hoechst nuclear stain). The autogenously regulated IRES 
switch clearly is functional in transient transfections of HEK293T cells.  This construct is 
not however ideal for applications in AAV-mediated gene therapy.  The mCherry tag is 
unnecessary now that we know the NLS correctly localizes lac repressor to the nucleus.  
Second, the IRES is more than 300 base pairs.  A smaller sequence is known to be able 
to express two genes in eukaryotes from a single promoter in the 2A sequence.  The 2A 
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sequence encodes for a protein that causes a slippage as it is being translated through 
the ribosome.  The result is that, with a certain frequency, two proteins are made rather 
than one large fusion protein.  One benefit of the 2A sequence is that the two proteins 
are made in equimolar amounts which is not necessarily true for IRES sequences.
Figure 5.7. Autogenously regulated IRES lac genetic switch in HEK293T cells.  YFP 
and lac repressor (mCherry) both are induced upon addition of IPTG.  YFP is dispersed 
throughout the cell whereas the mCherry signal is localized to the nucleus (labeled by 
Hoechst stain).  
We next developed a minimal length cassette with the goal of using it in an AAV 
viral delivery vector.  This cassette again uses the same minimal CMV I promoter with a 
Lsym operator DNA sequence.  The gene order has been switched so the EuLac gene is 
first, followed by the 2A sequence, followed by GFP as the readout (Figure 5.8).  
Extraneous DNA was trimmed and unique restriction enzyme cleavage sites were 
designed around every gene in the cassette for easier downstream cloning.  The same 
plasmid was made with luciferase as the readout gene.
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Figure 5.8. The pSW-GFP plasmid.  This plasmid expresses an autogenously 
regulated dimeric lac repressor construct which can bind one Lsym operator site and has 
GFP as a readout. This cassette easily fits into the AAV viral capsid.  The same plasmid 
expressing luciferase rather than GFP is called pSW-Luc.
We first need to verify the efficiency of the 2A sequence to split the two proteins.  
HEK293T cells were transiently transfected with either: 1. the original autogenous IRES 
plasmid, 2. the new autogenous 2A plasmid, or 3. a constitutively expressed GFP under 
control of the chicken β-actin (CBA) promoter.  Cells were grown in varying 
concentrations of IPTG and whole cell lysate was harvested for western.  We performed 
a western with α-GFP antibodies (Figure 5.9).  The original plasmid only has a single 
band for YFP (which is also detected with α-GFP) which induces ~ 2-fold with IPTG.  
The autogenous 2A plasmid has three primary bands: the highest band corresponds to 
Lac::2A::GFP fusion protein, the middle band is truncated 2A fused to GFP, and the third 
band is likely a degradation product.  Comparing the highest band to the middle band we 
estimate ~90% breakage of the fusion protein to separated lac repressor and GFP.  We 
also see induction of GFP with increasing IPTG, again approximately 2-fold (Figure 
5.10).  
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Figure 5.9. α-GFP western of HEK293T cells.  Construct 1 is the autogenously 
regulated IRES plasmid from Figure 5.6.  Construct 2 is the autogenously regulated 2A 
plasmid from Figure 5.8.  CBA is the CBA promoter constitutively expressing GFP.  We 
see induction with IPTG for both construct 1 and construct 2, both with maximal 
induction of approximately 2-fold.  For the 2A cassette there is clearly a higher, unbroken 
fusion protein.  We see approximately 90% splitting of the fusion protein into the two 
desired proteins, lac repressor and YFP.  
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Figure 5.10.  Quantification of autogenously regulated 2A cassette from western.  
We see clear induction at only 6.26 μM IPTG and a maximal 2-fold induction.  
5.4 The Autogenously Regulated Genetic Switch in Different Cell Types
A secondary question is whether the switch functions correctly in different cell 
types.  Ideally the switch would function well in every cell type as gene therapy has 
many potential targets: liver, muscle, eye, brain, etc.  We therefore set out testing the 
switch to measure its functionality in two additional cell culture lines: COS-7 (CV-1 
(simian) in Origin and carrying the SV40 genetic material) which are fibroblast-like and 
derived from monkey kidney tissue, and ARPE-19 (Retinal Pigment Epithelial) which are 
human derived RPE cells.
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We transiently transfected the autogenously regulated 2A plasmid from Figure 5.8 into 
COS-7 cells.  Figure 5.11 shows the quantified induction curve which again shows a 2-
fold induction with IPTG.
Figure 5.11.  Induction profile of autogenously regulated 2A cassette in COS-7 
cells. 
We next wanted to quantitatively test the 2A autogenously regulated cassette in 
ARPE-19 cells.  We made a large lac truncation from residues 18-290 to create a 
positive control cassette where the readout gene is unregulated.  We then transiently 
transfected HEK293T cells with the autogenously regulated 2A cassette and separately 
transiently transfected HEK293T cells with the positive control plasmid. Figure 5.12 
shows the normalized expression of the 2A autogenously regulated cassette.  The 
switch is not very efficient in its current form; it only represses approximately half the 
constitutive expression and induces to 80%.  Clearly, we have a lot of room to improve 
the switch.
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Figure 5.12. Normalized regulation of the autogenously regulated 2A cassette in 
ARPE-19 cells.  The cassette poorly represses, reducing expression only down to ~ 
45%.  This switch approximately has two-fold induction.  This switch would not be useful 
in AAV-mediate gene therapy.
The switch functions in three different cell lines and has approximately the same 
induction ratio (~2-fold) in all three cell lines.  There appears to be no cell specific bias, 
however if the switch is to be used in a new setting it would strongly be recommended to 
test its functionality in cell culture first.
5.5 Using Tetrameric Lac Repressor to Improve the Autogenously Regulated 
Genetic Switch
The lac repressor construct we used has the 11 C-terminal residues of the lac 
repressor truncated to create a dimeric repressor.  While we have used a dimeric 
repressor for clarity of understanding and studying allostery in Chapters 3 and 4, here 
we just want a more effective switch.  With that goal in mind we sought to restore the 
tetramerization domain and multiple operator DNA sequences to restore the allosteric of 
lac repressor to two DNA operators.  
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First, we cloned a second Lsym operator DNA sequence 92 base pairs 
downstream of the first Lsym site (Figure 5.13).  We did not necessarily expect this 
downstream site to be able to directly regulate transcription.  We transiently transfected 
dimeric lac repressor with one Lsym operator (pSW-Luc) and dimeric lac repressor with 
two Lsym opeartors (pSW-Luc Lsym x2) into ARPE-19 cells and assayed for luciferase 
with and without IPTG (Figure 5.14). The addition of a second operator decreased both 
leakiness and maximal expression.  
Figure 5.13. The pSW-Luc Lsym x2 plasmid.  This plasmid expresses an 
autogenously regulated dimeric lac repressor construct which can bind two Lsym 
operator sites and has luciferase as a readout.
Figure 5.14. Effect of adding of a second Lsym operator with dimeric lac 
repressor. The pSW-Luc construct expresses dimeric lac repressor and has a single 
Lsym operator DNA.  The pSW-Luc Lsym x2 construct has a second Lsym operator DNA 
site 92 base pairs downstream.  The addition of this second operator decreases 
leakiness (green arrow) but also decreases maximal expression (red arrow).
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Next, the 11 C-terminal residues were re-inserted into the EuLac gene to make 
what we will call EuLacTet to make the pSW2-Luc/GFP plasmids (Figure 5.15).  This 
gene still has the 11 amino acid linker and NLS sequence following the full lac repressor 
itself, not to mention the partial 2A protein appended to the C-terminus.  We first wanted 
to see if the EuLacTet protein could form tetramers after 2A breakage.  We cloned the 
EuLacTet with a 6x Histidine tag (His-tag) into our standard pBAD expression vector and 
followed the standard lac repressor purification protocol.  We also purified the original 
construct without the 11 C-terminal insertion which should be dimeric.  These putative 
dimeric and tetrameric proteins were run on a native electrophoresis gel where 
oligomeric state will be preserved and stained for protein.  The native gel confirmed that 
the tetrameric protein ran at twice the molecular weight of the dimeric protein (Figure 
5.16).  
Figure 5.15. The pSW2-Luc plasmid.  This plasmid expresses an autogenously 
regulated tetrameric lac repressor construct which can bind two Lsym operator sites and 
has luciferase as a readout.  Two DNA operators are known to allosterically bind 
tetrameric lac repressor to increase the operator binding affinity and decrease 
repression.  One model of this behavior is through DNA loops (pictured) wherein the 
spacing between the two operator DNA sites is critical.
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Figure 5.16. Native gel electrophoresis to discern oligomerization state.  The 
EuLac construct which lacks 11 C-terminal residues known to form a coiled-coil domain 
has two primary bands near ~84 kDa and ~42 kDa which correspond to dimeric and 
monomeric species, respectively.  The EuLacTet construct, which has the 11 C-terminal 
residues restored, forms a single tight band near the predicted ~174 kDa which 
corresponds with a tetrameric species.  The highest band in both wells is a 
contamination from the purification.  Both constructs are oligomerizing as designed.
We transiently transfected tetrameric lac repressor with two Lsym operators 
(pSW2-Luc) into ARPE-19 cells and assayed for luciferase with and without IPTG 
(Figure 5.17). The addition of the tetramerization domain decreased leakiness and 
increased maximal expression over the dimeric construct.  Overall however, the potential 
cooperative effect of tetrameric lac repressor binding to two operators was less than has 
typically been seen in E. coli.  This construct has an approximately 3-3.5-fold induction 
with IPTG and the leakiness is decreased to ~25% of constitutive expression.  These are 
both significant gains from the starting pSW-Luc construct, however it does not appear 
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that it is necessarily due to the allosteric advantages of binding two operators with 
tetrameric lac repressor.
Figure 5.17. Effect of adding of a second Lsym operator with tetrameric lac 
repressor. The pSW2-Luc construct expresses tetrameric lac repressor and has two 
Lsym operator DNA sequences.  The decreased leakiness is maintained (lower right 
green arrow) and the maximal expression is marginally improved (upper right green 
arrow).  Overall a significant improvement from the starting pSW-Luc construct has been 
obtained.
To measure if the tetramerization is playing a significant role we sought to repeat 
a classic experiment from E. coli. It is known that the spacing between the two operator 
DNA sites critically effects the ability of lac repressor to regulate gene expression 
resulting in a periodicity of optimal spacing (Müller et al., 1996).  Optimal spacing was 
found at 70.5, 81.5 and 92.5 base pairs with significant drop offs in repression by altering 
the spacing even 1 or 2 base pairs.  With this in mind we inserted or removed one or two 
base pairs between the two operator sites and also changed to spacing entirely to 70 
base pairs.  We tested these constructs in transient transfections of ARPE-19 cells with 
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and without IPTG (Figure 5.18).  There was no significant difference in measured 
induction ratios between these constructs.  Either the cooperative effect is minimal in cell 
culture or further construct optimization is needed.
Figure 5.18. Alternate Lsym operator DNA base pair spacings.  It has been observed 
in E. coli that optimal repression by tetrameric lac repressor occurs when the two 
operator sequences are properly spaced.  We found no significant change in induction 
ratio with alternative spacings.
We did reduce leakiness and increase dynamic range by using tetrameric lac 
repressor and two operator DNA sites.  It is unclear however if the system is working as 
has been previously reported in bacteria. 
5.6 Using Lac Repressor Mutations to Improve the Autogenously Regulated 
Genetic Switch
We have ample evidence that point mutations of the lac repressor can decrease 
leakiness, increase dynamic range, and change the affinity for effector molecules such 
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as IPTG.  We selected two mutants from Chapter 3 that should improve our eukaryotic 
autogenously regulated switch: Q18M which decreases leakiness and dynamic range 
and F161W which decreases leakiness and improves dynamic range.
Figure 5.19. Point mutations of dimeric lac repressor with one Lsym operator 
(pSW-Luc).  Q18M decreases leakiness from wild type (WT) lac repressor but it also 
decreases the maximal induction.  This is the classic tradeoff between leakiness and 
dynamic range that was studied in Chapters 3 and 4.  F161W decreases leakiness 
below that even of Q18M and maintains the same maximal induction.  The combination 
mutant was less leaky than WT but leakier than either point mutation alone, and it had 
the worst dynamic range.
We tested Q18M and F161W and the combination mutant Q18M F161W in the 
pSW plasmid in ARPE-19 cells with and without IPTG. We found that both the Q18M 
mutation and the F161W mutation functioned as has been previously found in E. coli in 
the non-autogenous genetic switch (Figure 5.19). Q18M exhibited the classic tradeoff 
between decreased leakiness and decreased dynamic range that was found in Chapter 
3 when only the repressor-operator DNA affinity, KRO, is increased.  F161W had both 
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decreased leakiness and increased dynamic range, just as was found in bacteria, due to 
its simultaneous changes to repressor-effector affinities and conformational equilibrium.  
We were unsure if the mutations would have additive effects; the Q18M F161W double 
point mutant shows that the two mutations do not work in concert.  We hypothesized in 
Chapter 3 that Q18M does not primarily alter KRO but instead the conformational 
equilibrium KRR*, which is also altered by F161W.  If that is the case it is unsurprising that 
the two mutants do not work together.
Figure 5.20. Microscopy of point mutants of pSW2-GFP.  GFP microscopy shows 
that there is a clear induction of GFP with increasing IPTG concentration.  The intensity 
of the Q18M point mutant is significantly less both at no IPTG (basal leakiness) and 
maximally induced with 2.5 mM IPTG.  This is more consistent with what we saw with 
the dimeric cassette pSW-Luc.  F161W looks very similar to wild type repressor.  Of note 
is the unexpected increased GFP signal in the nucleus (DAPI stained, blue).  
We next tested the two single mutants with the tetrameric cassette. The 
luciferase assay does not have a control for number of cells and therefore is not ideal for 
absolute comparison between different plasmids.  It does function very well for 
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establishing intra-plasmid behavior (i.e. measuring IPTG induction ratios). With that in 
mind, we decided to measure the Q18M and F161W mutants in the tetrameric cassette 
regulating GFP (pSW2-GFP).  We transiently transfected ARPE-19 cells and grew the 
cells in varying concentrations of IPTG.  Cells were fixed and GFP was measured by 
fluorescent microscopy (Figure 5.20). Q18M was seen to be less leaky than both wild 
type and F161W and similarly has a decreased maximal expression.  F161W did not 
appear to have the improved leakiness and dynamic range that was measured for the 
dimeric cassette.  
Point mutations to the lac repressor appear to be potentially useful in improving 
the phenotypic qualities of the autogenous genetic switch, however their application is 
not straightforward due to the more complicated nature of the switch.  Both Q18M and 
F161W functioned similarly in the dimeric autogenous switch with a single Lsym 
operator, but only Q18M worked as designed in the tetrameric autogenous switch with 
two Lsym operators.  This approach can certainly be used to further improve the switch 
but point mutations will have to be verified to be functional in the each autogenous 
switch design.
5.7 Comparing with Tet-On Technology
The gold standard for prokaryotic derived eukaryotic gene regulation is the tet 
repressor derived tet-On and tet-Off systems.  To see if our levels of leakiness and 
dynamic range are comparable with these systems we first set out to make a single 
plasmid tet-On system.  We did this by isolating the tet-On activator and its promoter 
from the pTet-On plasmid and inserting it into the pTRE-GFP plasmid.  This plasmid will 
constitutively express Tet-On activator and control the expression of GFP through the Tet 
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Regulatory Element (TRE) via the effector doxycycline; we called this plasmid pTRE-On-
GFP.
ARPE-19 cells were transiently transfected with pTRE-On-GFP side by side with 
the pSW2-GFP and mutants (Figure 5.21).  The pTRE-On plasmid clearly induces GFP 
upon addition of doxycycline. The inherent leakiness and dynamic range of the pTRE-On 
plasmid is very similar to the wild type tetrameric pSW2 plasmid.  It seems to induce to a 
slightly higher level.  The Q18M tetramer is less leaky than the pTRE-On which is 
encouraging if minimal leakiness is required.
Figure 5.21. Microscopy of point mutants of pSW2-GFP and pTRE-On-GFP.  Our 
autogenously regulated switch performs very similarly to the tet-On technology.  Q18M is 
actually less leaky than tet-On despite the limits of autogenous regulation.  The dynamic 
range of the tet-On switch however appear to be superior.  Note the lac of nuclear 
localization of GFP in the TRE-On system.
One thing that was revealed by the microscopy was an unexpected localization 
of GFP to the nucleus.  This was much more prevalent at the highest IPTG 
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concentrations of the pSW2 plasmids (and hence highest GFP concentrations).  This 
could be due to un-broken Lac repressor::2A::GFP fusion proteins being localized to the 
nucleus through the NLS signal on the repressor.   This certainly will have a confounding 
effect on the analysis.  It is unknown if for some reason the 2A is breaking less efficiently 
in this experiment (although no IPTG dependence was noted in the western).  It is also 
unknown if the repressor::2A::GFP protein is dimeric or tetrameric which could be 
impeding the ability of tetrameric lac repressor to allosterically bind the two Lsym 
operators.  Finally, the half-life of the fusion protein in the nucleus versus the half life of 
GFP in the cytoplasm will certainly have some effect on the quantification of these 
experiments.  
The TRE-On plasmids do not have this concentration of GFP in the nucleus.  
There is no 2A site or NLS associated with the GFP on the TRE-On plasmid in anyway.  
This strongly hints that the high nuclear GFP signal in the lac repressor expreriments is 
due to the 2A and/or NLS signals.
5.8 Testing the Autogenously Regulated Genetic Switch in Mice
The end goal of this work is to develop a lac repressor based genetic switch that 
is usable in AAV-mediate gene therapy.  To move towards that goal we wanted to test 
our autogenously regulated cassette in a mouse model.  
We inserted the cassette from the pSW2 plasmid which has two Lsym operators 
and tetrameric lac (Figure 5.15) into a plasmid which will make serotype 8-AAV virus.  
Virus was made at a virus core facility and confirmed to function in HEK293T cells.
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Figure 5.22. Autogenously lac genetic switch controlling luciferase in mice.  Mice 
were live images for luciferase signal after being either on normal water (blue boxes) or 
after being gavaged with 1M IPTG (red boxes).  There is significant mouse to mouse 
variation, however we always see potent induction after IPTG gavage.  Luciferase is 
seen to drop within 2 days of water feeding and re-induce.  The autogenous lac genetic 
switch is a reversible regulator of a transgene in mice.
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We performed tail-vein injections of 12 nude mice with SW2-Luc (same cassette 
as pSW2-Luc (Figure 5.15)) virus (Multiplicity of Infection (MOI): 1e11) to target the liver.  
The 12 mice were split into two cohorts of 6 to differentiate between time dependent 
changes in luciferase signal and IPTG dependent changes in luciferase signal.  Non-
injected mice were also included as a control and showed no measurable luciferase 
signal.
Four mice died in the study, either due to complications with gavage or unknown 
circumstances.  Of the remaining mice, two from each cohort appeared to have 
luciferase correctly targeted to their livers in the imaging.  Many mice had significant 
luciferase signal in muscle tissue in the tail and surrounding region and were excluded 
from further analysis.  Mice were fed sequential diets of either water or gavaged (force 
feeding) 1M IPTG.  We previously confirmed that gavage of 1M ITPG provides 
concentrations of IPTG in excess of 100 μM in brain, retina, vitreous, muscle, liver, 
kidney, serum and urine.  Mice were given intraperitoneal (IP) injections of luciferin and 
scanned on a live animal imaging scanner throughout the experiment (Figure 5.22).
All four animals have low but measurable levels of luciferase one month after the 
tail-vein injection.  There is noticeable animal to animal variation with mouse #281 being 
particularly leaky.  The mice were not age and gender matched and they were all given 
the same amount of viral vector regardless of weight which could account for some of 
the variation.
The first cohort (Mice #288 and #281) were initially kept on a normal water diet 
throughout the first week (Figure 5.23).  There is a ~2-fold increase in luciferase signal 
throughout this time.  The second cohort (Mice #295 and #269) were gavaged two times 
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a day for three days; there is a potent increase (>20-fold increase) in luciferase signal in 
these two mice (Figure 5.24).  
The first cohort was then gavaged with IPTG and saw a ~4-fold increase in 
luciferase.  Meanwhile the second cohort was put back on regular water and saw a ~3-
fold decrease in signal after 2 days and ~8-fold decrease after 6 days.  Both cohorts 
were then re-gavaged with IPTG to re-induce and there was a wide range of luciferase 
signal increase from ~3-fold to ~30-fold.  This re-induction confirms that the mice still 
have AAV infected cells capable of regulating luciferase signal through the lac 
autogenous genetic switch.
Figure 5.23. Quantification of luciferase counts for cohort 1 mice.  The overall 
signal level between the two mice is quite different but the same trend exists: luciferase 
signal increases upon IPTG gavage and is low on a water diet.
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Figure 5.24. Quantification of luciferase counts for cohort 2 mice.  Again the 
expected trend is observed: luciferase signal increases upon IPTG gavage and is low on 
a water diet.
Since both cohorts were induced with IPTG and repressed upon removal of IPTG 
during water feeding, we averaged across cohorts (Figure 5.25).  The mouse to mouse 
variability of luciferase counts is very large which could be due to several factors: we did 
not age and sex match the mice and we injected the same amount of viral vector 
regardless of mouse weight.
We then used the averages to measure first induction ratio, repression ratio with 
removal of IPTG (water feeding), and second induction ratio (Figure 5.26).  Again there 
is a very large variability but the trend is striking; there is an ~8-fold first induction, ~14-
fold repression, and ~8-fold second induction.
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Figure 5.25. Average luciferase counts for mice throughout the experiment.  The 
luciferase signal significantly increases with the first gavage (p < 0.05) compared with 
the initial water readings and significantly decreases upon returning to water (p < 0.05).  
The luciferase signal increases a second time upon return to IPTG gavage, however the 
change is not significant due to the large variation between mice.
Figure 5.26. Luciferase ratios upon switching from water to IPTG (Induction) or 
IPTG to water (Repression).  A ratio of 1 would be no change upon switching to or from 
IPTG.  Both the first and second induction had large luciferase signal increases with ~8-
fold increases.  The repression was stronger with a ~14-fold decrease in signal upon 
removal of IPTG.
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The repression ratio is notably larger than the first induction ratio.  Since the lac 
repressor is autogenously regulated in this switch, we are inducing not only luciferase 
but also lac repressor; more lac repressor will be present in the nucleus after induction.  
Upon removal of IPTG from the diet this excess repressor can and will bind the two 
operator DNA sites and repress transcription.  Since the lac repressor concentration will 
exceed the equilibrium concentration before induction it is not surprising that the switch 
would go even more “off”.  
5.9 Discussion
The goal of this chapter was to develop a lac genetic switch that was functional in 
AAV-mediated gene therapy.  We showed that an autogenously regulated lac repressor, 
which is small enough to pack into an AAV viral capsid along with a transgene, is 
functional in both prokaryotes and eukaryotes.  Furthermore, the eukaryotic switch can 
function with either the IRES or 2A sequence to mediate the expression of both the lac 
repressor and the transgene from a single promoter.  We showed that the eukaryotic 
autogenous switch is functional in HEK293T, COS-7, and ARPE-19 cell culture as well 
as live mice.  The switch appears to be broadly applicable to different cell types.  
The first generation of autogenous switches were not particularly efficient gene 
regulators; only repressing about half of the constitutive level and having a 2-fold 
induction ratio.  We showed that the lac repressor point mutations from Chapters 3 and 4 
also change the gene regulatory phenotype in the autogenously regulated lac genetic 
switch in prokaryotes.  We then showed that these same point mutations can be used to 
decrease the leakiness of the switch or to increase the dynamic range.  Finally, we found 
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that multiple DNA operator sites and a tetrameric lac repressor could both decrease the 
leakiness of the switch and increase the dynamic range.
The autogenous switch was shown to function from transductions of AAV virus-
encoding transgenes in cell culture and in living mice.  The living mice were stably 
expressing the AAV-encoded luciferase nearly 1 month post infection and were capable 
of reversibly regulating the expression of luciferase in their liver.  
A curious finding is that the induction ratios measured in mice actually surpass 
those from cell culture.  The nature of our transient transfection experiments could 
partially be to blame.  The time window in which the cells are dense enough for 
experiment and not too dense to have contact inhibition effects is small.  The cells may 
not have had enough to time reach an equilibrium before we were required to measure 
their transgene signal.  Regardless, it is very encouraging that the switch appears to 
function better in living organisms which of course is much more relevant to our end goal 
of developing a regulator for AAV-mediated gene therapy.
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Chapter 6 
Conclusions
The lac repressor hasn't changed, but its measured properties have (Sharp, 
2011).  This is due to the wide variety of techniques, buffers, constructs, etc. that have 
been applied over the years in order to best measure the property of interest given the 
best technique of the day.  This thesis sought to bring together this often discordant 
information to link protein structure to genetics to in vivo phenotype to in vitro 
measurements all through the use of the MWC model of allostery.  
We have found that point mutations of certain amino acids can specifically alter 
repressor binding affinities to effectors and that these changes agree with the structural 
location of those amino acids.  Two residues in the specificity region of the DNA binding 
domain (Y17 and Q18) make specific contacts with positions 5 and 6 of the DNA 
operator sequences.  Point mutations to these two residues (Y17I and Q18A) result in 
gene regulatory phenotypes that are well explained by reductions to the repressor-
operator DNA affinity, KRO.  All other thermodynamic parameters are unaffected; mutants 
bind effector with the same affinity and have the same conformational equilibrium.  One 
residue in the specificity region of the effector binding domain (Q291) makes specific 
contacts with the substituent group of thiogalactosides.  A point mutation to this residue 
(Q291K) results in a gene regulatory phenotype that is well explained by reductions to 
the repressor-effector affinities, KRE and KR*E.  All other thermodynamic parameters are 
unaffected; this mutant binds operator DNA with the same affinity and has the same 
conformational equilibrium.
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These three point mutations are a wonderful confirmation of the MWC model of 
allostery for the lac genetic switch.  Many mathematical functions can recreate the curve 
shape of proteins binding to ligands, however they are just that: functions.  They have no 
basis in biophysical reality other than they happen to look like reality.  One could throw a 
ball and see that the trajectory looks a lot like a parabola; the fact that the physics of 
throwing the ball predict a parabolic trajectory give the mathematical function meaning.  
Now we can throw a ball, fit it to a parabola, and use that fit to measure the initial 
velocity of the throw.  Analogously, we see the normalized expression from the lac 
genetic switch as a function of effector, we fit it to the curve shape predicted by the MWC 
model, and use that to fit the inherent thermodynamic parameters of the lac repressor.  
The point mutations Y17I, Q18A, and Q291K show that we can use the structure of the 
lac repressor to specifically perturb individual binding affinities.  The MWC model of the 
lac repressor splits the binding affinities into individual properties that could be 
independently manipulated to create unique gene regulatory phenotypes; these three 
point mutations exactly fall into that model.  Structure agrees with genetics agrees with 
in vivo phenotype given the MWC model of allostery.
Now of course we studied much more than these three point mutants.  The lion 
share of point mutations were seen to perturb the conformational equilibrium between 
the two primary structural conformations of the lac repressor, R and R*.  Furthermore, 
we saw that the conformational equilibrium could be manipulated from a variety of 
locations in the protein: Q18, L148, F161, Q291, and L296.  Using the Boltzmann we 
saw that the wild type lac repressor only has an energetic difference of about 1 kcal/mol 
between the R and R* state (the R* state has lower energy and is favored).  It is not 
surprising therefore that even a single point mutation could alter the conformational 
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equilibrium.  We measured conformational equilibrium parameters of lac repressor point 
mutations that changed the energy between the two states as much as 3 kcal/mol (in 
favor of the R* state for L148D and L148W; in favor of the R state for Q291I and 
L296W).  The Boltzmann distribution is sensitive to the exponential of the energy; 
therefore even relatively small energy differences have profound changes on the 
populations of the two conformations.  For these point mutations we see the 
conformational equilibrium change nearly 100-fold which has profound effects on the 
phenotype of the lac genetic switch.
The observation that the conformational equilibrium is changed upon point 
mutation may be the strongest test of the MWC model of allostery.  The entire basis of 
the MWC model is that the net function of a population of proteins can be altered by 
shifting the population to a different conformation with altered properties.  Multiple 
structural conformations with different properties is inherent in this model.  Consider 
instead a model of the lac repressor with only one conformation, R, which can bind 
operator DNA with an affinity KRO and effector with an affinity KRE.  We then mutate the 
effector binding pocket (F161W for example) and see that the genetic switch is 
drastically less leaky: how is this possible?  The point mutation is nowhere near the DNA 
binding domain so KRO should be unaffected.  The lac repressor still induces upon ITPG, 
better even than wild type (Figure 3.10), so the lac repressor itself must be folding 
correctly and functioning.  The only other explanation is that there is more repressor, 
however we measured the total repressor concentration and found no change from wild 
type in vivo  (Figure 3.14).  Additionally, more repressor would impede maximal 
expression.  A single conformation model simply cannot explain the F161W mutant given 
the data on hand.  The MWC model of the lac repressor perfectly explains the in vivo 
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phenotype.  The conformational equilibrium between the two states is tipped 1.5 
kcal/mol in favor of the R state reducing the leakiness.  Meanwhile the mutation is in the 
effector binding pocket and increases the affinity for IPTG for the R* state relative to the 
affinity for the R state; adding IPTG more greatly populates the R* state than wild type 
leading to greater induction.  The structural location of the F161W mutant combined with 
the in vivo phenotype can only be explained by an MWC model with at least two 
structural conformations.  
Of note are four point mutations from the literature: A110T, A110K, L148F, and 
S151P (Müller-Hartmann & Müller-Hill, 1996; Swint-kruse et al., 2003).  None of these 
mutations are within the DNA binding domain of the lac repressor yet all four were found 
to alter the net repressor-DNA affinity; all four altered the leakiness of the switch.  Unlike 
the targeted residues from this study, A110 and S151 are not part of the effector binding 
pocket; both are within the N-terminal region of the core domain.  The structure clearly 
indicates that neither residue contributes to DNA binding or effector binding directly, yet 
point mutations to both regions alter both parameters simultaneously.  Again, the 
conformational equilibrium parameter comes to the rescue.  Figure 3.4 shows that, given 
thermodynamic binding values similar to wild type lac repressor, increasing the 
conformational equilibrium (favoring the R* state) creates a leakier genetic switch which 
responds to less effector; effective DNA affinity is lowered and effective IPTG affinity is 
increased.  This is exactly what is observed for A110T and L148F.  Conversely, if the 
conformational equilibrium is decreased (favoring the R state) then the genetic switch is 
less leaky and needs more IPTG to induce; effective DNA affinity is increased and 
effective IPTG affinity is decreased.  This is exactly what is observed for A110K and 
S151P.   The structural location of these residues is perfectly consistent with the ability to 
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alter the stability of the repressor conformations and hence change conformational 
equilibrium upon point mutation.  A conformational equilibrium between the two states 
that is close to one is ideal as it is most easily changed by single point mutations.  Wild 
type lac repressor has a conformational equilibrium of approximately 6-fold in favor of 
the R* state which corresponds to only a 1 kcal/mol energy difference between the two 
states.  The conformational equilibrium is  easy to perturb in the lac repressor due to the 
small energy difference between its two conformations.
The other effector pocket mutants showed that the interplay between the 
conformational equilibrium, the magnitudes of the repressor-effector affinities, and the 
ratio of the two repressor-effector affinities define the resultant phenotype.   The DNA 
binding domain mutants showed that conformational equilibrium and repressor-DNA 
affinity could be altered but they had the same resultant phenotype.  The effector binding 
pocket turned out to be much more interesting in terms of potential phenotypes upon 
point mutation.  So why did point mutations to the DNA binding domain give such a one 
dimensional response?  It is because the output (transcription and translation of a gene) 
is linked to the occupancy of the operator DNA by repressor.  RNA polymerase does not 
care if IPTG is bound to the repressor but it does care if the IPTG bound repressor 
drastically lowers the occupancy of DNA.  You can alter the phenotype of the lac genetic 
switch through mutating the DNA binding domain but to get more ideal lac genetic 
switches (lower leakiness, higher dynamic range, lower [E]50) you need to target the 
allosteric effector site, namely the effector binding pocket.  
Many novel lac repressor genetic switches have been identified with properties 
that could potentially be impactful.  One obvious future direction would be the use of 
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tighter binding lac repressors in the regulation of toxic proteins being recombinantly 
expressed.  
Utilizing genetics of the lac repressor to link structure to in vivo phenotypes with 
the MWC model was a powerful technique.  The next obvious “missing link” in the lac 
repressor literature was the connection between in vitro data derived from purified 
compenents and in vivo gene regulation taking place in living bacteria.  We can measure 
binding affinities via fits of the in vivo data to the MWC model but if our measured 
affinities do not agree with the isolated proteins, DNA and effectors we are claiming to 
model we are potentially missing key components of the system.  Furthermore, it is not a 
foregone conclusion that in vivo results will agree with in vitro predictions.  One group 
found a 25-fold discrepancy for a hybrid repressor between in vivo and in vitro data 
(Tungtur et al., 2011).  For the lac repressor itself, one study found very good agreement 
between published in vitro values and in vivo values (Sharp, 2011).  There was however 
a major limitation to the data of the lac repressor study; the concentration of the lac 
repressor itself was not taken into account.  We did measure the lac repressor 
concentration to be around 650 nM in vivo which agrees with previously reported values 
for our promoter and the estimated copy number.  We would expect wild E. coli with a 
single lacI promoter expressing lac repressor to have ~10-20 fold less repressor (the 
copy number of our plasmid) which corresponds to 30-65 nM lac repressor in vivo.  
Using the values from Table 4.1 and the assumption free solution to the MWC model 
from Chapter 4 we found that the thermodynamic binding values curated by Sharp could 
not regulate gene expression because repressor-DNA affinities were too high (Figure 
4.5).  This is not an artifact of the more complicated model solution.  If we simply take 
the repressor-operator DNA affinity values and concentration of the repressor we can 
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easily calculate the r parameter (r = KRO [R]tot): Chapter 4, r = 278; Sharp set 1, r = 2.2e6; 
Sharp set 2, r = 6.6e4; Sharp set 3, r = 1e6.  Figure 6.1 shows that the three curated 
sets from the Sharp paper all are way over-repressed.  We can, as before, model what is 
occuring in natural E. coli by estimating [R]tot = 30 nM which reduces the r values 20-fold 
and should lessen the drastic over-repression.  Figure 6.2 shows that only Set 2 could 
induce with IPTG given the thermodynamic parameters.  
Figure 6.1.  Simulated induction curves from various in vitro derived values at a 
repressor concentration of 650 nM.  Chapter 4 are the values measured from the in 
vitro transcription experiment. Sets 1, 2 and 3 are derived from the published values in 
(Sharp, 2011).  The in vitro values from the literature are drastically over-repressed.
The in vitro measured values of Chapter 4 agree with previous in vitro 
measurements for repressor effector binding and conformational equilibrium.  The 
repressor-operator DNA affinity was several orders of magnitude weaker than in vitro 
results but agreed with a published value for affinity at conditions within the E. coli cell.  
Regardless, only the in vitro values of Chapter 4 are capable of predicting lac genetic 
switches that would function at the measured concentration of lac repressor in vivo.  
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Figure 6.2.  Simulated induction curves from various in vitro derived values at a 
repressor concentration of 30 nM.  Chapter 4 are the values measured from the in 
vitro transcription experiment. Sets 1, 2 and 3 are derived from the published values in 
(Sharp, 2011).  Chapter 4 predicts a leaky repressor, however the values are derived 
from dimeric lac repressor with a single operator DNA, which is known to be leakier than 
the wild type operon.  Set 2 predicts a very tight repressor that is capable of some 
induction.  Sets 1 and 3 are still drastically over-repressed.
Chapter 4 shows the inherent difficulty in rectifying in vivo and in vitro data.  We 
specifically set out with this goal and therefore were able to use the same lac repressor 
construct and same DNA operator sequence in both our in vivo and in vitro experiments.  
When attempting to compare values with literature values the setups rarely agree.  
Furthermore, we used an in vitro technique that attempts to closely mimic the in vivo 
assay.  The in vitro transcription experiment takes place at the same temperature, in the 
solution phase, in buffer conditions where RNA polymerase is active and hence 
reminiscent of in vivo buffer, involves RNA polymerase to probe the operator DNA 
occupancy (although our in vivo and in vitro experiments do not use the same promoters 
or RNA polymerases), and uses long DNA strands.  The comparison is not perfect but it 
is closer than most techniques such as gel shift or nitrocellulose binding.  Next, we had 
an in vivo system where we could accurately estimate the total concentration of operator 
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(due to a tightly controlled copy number of its plasmid) and effector (due to the removal 
of thiogalactoside-permease from the E. coli limiting IPTG access to passive diffusion 
through the cell membrane).  Then we were able to measure the repressor concentration 
throughout the experiment through the mCherry tag on the lac repressor and even able 
to calibrate our experiment to get an absolute in vivo concentration that agreed with 
previously published values.  Finally, we had to develop a solution to the MWC model 
that would work in all of our experimental conditions.  This required coming up with an 
assumption free solution so total operator, total effector and total repressor are directly 
represented in the solution.  This was important in the fitting of the in vitro transcription 
data where we were able to titrate in lac repressor to more accurately measure 
repressor-operator affinity.  This experiment violated the assumption of our original 
solution to the MWC model that [R]tot >> [O]tot but it was easily modeled with the 
assumption free solution.
Despite our best efforts, Figure 4.4.A shows that the in vitro thermodynamic 
parameters predict a leakier genetic switch than we measured in vivo.  There is 
approximately a 2-fold difference between our measured repressor-operator DNA affinity 
and that which would be needed to decrease the leakiness of the switch to agree with in 
vivo.  This difference could potentially be rectified by including the well known 
phenomenon of cell crowding.  We modeled the increased effective concentration of the 
lac repressor by dividing our measured concentration by effective cell volume.  When the 
effective cell volume is 40% of the total E. coli volume the in vitro data does an excellent 
job predicting the in vivo phenotype.  The value of 40% available volume agrees with 
previously published values for E. coli (Kubitschek & Friske, 1986). In vivo phenotype 
can be linked to in vitro binding parameters using in vitro experiments that attempt to 
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mimic the in vivo setting.  It is non-trivial to compare in vivo to in vitro data and it requires 
knowing not just the binding constants of the various species but also the concentrations 
of the species themselves.  Trying to compare without knowing the concentration could 
potentially lead to erroneous agreement.
While it is gratifying to link structure, genetics, in vivo data, and in vitro data 
through a single MWC model, the entire enterprise is enriched by a real world 
application.  With that in mind we set out to apply what we know about the lac repressor 
genetic switch to AAV-mediate gene therapy.  
There was one primary limitation in AAV-mediated delivery of a lac genetic 
switch: delivering two promoters and two genes to a cell through AAV capsids is not 
possible due to genome size limitations.  Only 5 kilobases of DNA can practically be 
packaged within an AAV capsid (Wu, Yang, & Colosi, 2010).  We therefore re-wired the 
lac repressor to be autogenously regulated; the lac repressor controlled its own 
expression.  We demonstrated that an autogenously regulated lac genetic switch 
functioned in both E. coli and three different eukaryotic cell types in cell culture 
(HEK293T, Cos-7, and ARPE-19).  We found that our first generation of eukaryotic 
autogenous lac switches were not ideal; we measured 45% leakiness and only 2-fold 
induction.  Just about every method we thought of to improve the switch worked.  
Addition of a second operator DNA site downstream of the promoter decreased 
leakiness.  Restoration of the tetramerization domain of the lac repressor marginally 
increased dynamic range while maintaining the decreased leakiness.  The Q18M 
mutation in the DNA binding domain deceased leakiness at the expense of maximal 
expression; Q18M functions has the same phenotype in E. coli.  The F161W mutation 
decreased leakiness and increased dynamic range in the dimeric lac repressor but may 
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not function the same for the tetrameric lac repressor.  Other groups have shown that 
operator DNA can repress transcription in many locations relative to the promoter (Hu & 
Davidson, 1987) and that the lac repressor functions with different promoters than the 
minimal CMV promoter we studied (Brown et al., 1987; Caron et al., 2005; Liu et al., 
1989; Ulmasov et al., 1997).  We are therefore extremely confident that many more 
improvements are possible by systematic exploration of lac repressor mutation and 
promoter/operator DNA combinations.  Finally, different gene therapy applications may 
be optimized by different leakiness and maximal expression values; some transgenes 
need to be very, very off while others could tolerate leakiness if it meant higher 
expression upon induction.  Tailored autogenous lac repressor genetic switches for 
specific gene therapy applications could be an incredibly important future direction of this 
work.  
It is currently not known if the tetrameric lac repressor is functioning as desired in 
the eukaryotic autogenous switch.  We have demonstrated that it is a tetramer however 
the expected gain in dynamic range from cooperativity was not measured.  Several 
important experiments could shed light on the issue.  First, if the 2A sequence is not 
splitting the two genes efficiently enough and causing a dimeric lac repressor-2A-YFP 
fusion protein to localize to the nucleus as the microscopy suggests, then the 2A needs 
to be replaced with an IRES sequence which will make two separate genes.  All of the 
lac repressor will necessarily be tetrameric as there can be no C-terminal fusion from 
this construct.   This would easily be tested with microscopy and the cooperativity could 
be tested with the assay varying the spacing between the first and second Lsym 
operators.  Secondly, the ability of the second operator site to repress is a confounding 
factor.  The second operator could be placed far upstream of the CMV promoter after the 
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ITR region.  This operator could be tested alone to confirm that it does not repress.  
Once that has been established it could be tested in combination with the first Lsym site 
to see if there is an improvement.  This improvement would have to be attributed to 
cooperativity of binding by the tetrameric lac repressor.  Similarly, this construct could be 
tested with the dimeric lac repressor to confirm that tetramerization is necessary.
Finally, we were able to test the behavior of our autogenous lac genetic switch on 
the organism level.  We showed that the tetrameric autogenous lac genetic switch was 
capable of reversible regulation of luciferase in the livers of living mice.  Surprisingly, the 
induction ratios in mice surpassed those measured in cell culture resulting in 
approximately 8-fold induction upon IPTG gavage and 14-fold repression after mice 
were returned to normal water drinking.  This study will need to be confirmed in an age 
and sex matched mouse study and the functionality of the switch in additional tissues 
such as the retina, where the field of gene therapy has enjoyed success, are important 
future directions.  
This thesis studied the lac repressor in purified in vitro experiments, in living E. 
coli, in living eukaryotic cells, and finally in living mice.  We have found good agreement 
when comparing in vitro to in vivo E. coli.  We have found good agreement between 
structurally relevant mutations of the lac repressor and in vivo E. coli and even in cell 
culture of eukaryotic cells.  Finally,  autogenous switches which were shown to function 
in cell culture were also shown to function in the liver of a mouse.  The functionality of 
the switch on all of these scales are well explained by the Monod, Wyman, and 
Changeux model of protein allostery.  
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Appendices
A.1. An Assumption Free Model of the Autogenous Lac Genetic Switch
We can use the solution for the MWC model from Chapter 4 to model the 
autogenous lac genetic switch.  First, we define the concentration of the lac repressor for 
a given unregulated promoter to be [R]tot.  We measured [R]tot for our experimental 
system in Chapter 4; for ~10-20 copies of the lacI promoter in EPB225 cells [R]tot ≈ 650 
nM.  It is important to remember that [R]tot will be a function of promoter strength and 
copy number of the promoters in the cell.  The equilibium value of repressor in the cell 
for the autogenously regulated (AR) system is then defined as,
[R ]tot
AR= [O]
[O ]tot
[R]tot (124)
Of course we know that the autogenously regulated repressor concentration is 
bound by reality, such that,
0mM≤[R]tot
AR≤[R ]tot (125)
We then will start with Equation (109) which we will re-define here,
[R ]=
[R ]tot
AR
B1+[O ]B2 (126)
We will then insert Equation (124) into Equation (126) and isolate the free 
operator concentration [O],
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[R ]=
[O ]
Otot
[R]tot
B1+[O ]B2
(127)
[R ]B1+[R ][O ]B2=
[R ]tot
[O]tot
[O ] (128)
[R ]B1=(
[R ]tot
[O ]tot
−[R]B2)[O ] (129)
Now we can insert the formula for free operator from Chapter 4 (Equation (110)) 
into Equation (129),
[R ]B1=(
[R ]tot
[O ]tot
−[R]B2)
[O]tot
1+[R]B2 (130)
Now we will re-arrange Equation (130) as we did in Chapter 4,
[R ]B1+[R ]
2B1B2=[R]tot−[R ][O ]tot B2 (131)
[R ]2B1B2+[R](B1+[O]tot B2)=[R]tot (132)
ϕ2
AR=B1+B2Otot (133)
[R ]2ϕ1+[R]ϕ2
AR=[R]tot (134)
It is now abundantly clear that Equation (134) will take the place of Equation 
(117).  Just as before we have two Equations (134) and (120) which are polynomials of 
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[R] and [E].  Again, as before, we guess at values of [E], calculate [R] from each 
equation, and minimize the difference.
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